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 Alcohol use disorder is a global public health issue that affects millions across the world. 
Alcohol use disorder can result in negative physical and mental health outcomes, and currently 
treatment options are limited and rates of relapse are high. Identifying genes that affect aspects 
of ethanol behaviors in model organisms, such as Drosophila melanogaster, can serve to 
eventually develop more robust therapeutic interventions for those experiencing alcohol use 
disorder or other forms of alcohol dependence. Previous studies have identified a relationship 
between a person’s initial sensitivity to alcohol and their abuse potential for the drug in later life. 
Therefore, we can study sedation behaviors in Drosophila melanogaster to better understand 
genes that affect alcohol sensitivity. Work in the Grotewiel laboratory has identified the gene 
Mef2 as a key regulator of ethanol sedation. The major goals of these studies were to identify 
genes downstream of Mef2 that produce a consistent behavioral impact on sedation when 
knocked down (Chapter 2), and to identify global gene expression changes when Mef2 is 
knocked down (Chapter 3). We found RNAi transgenes against two genes, spin and unc79 
consistently and significantly increase the amount of time it takes for flies to become sedated 
when exposed to ethanol. Additionally, through RNA-seq studies, we identified several Mef2 
dependent differentially expressed candidates for future study in ethanol sedation. We 
compared whether these differentially expressed genes were shared between other gene sets 
of interest, finding that one set of differentially expressed genes had a significant overlap with 
genes previously known to bind Mef2. Overall, the studies in this thesis support a number of 
novel hypotheses regarding the role of Mef2 and its downstream genes in ethanol sedation that 





CHAPTER 1: INTRODUCTION 
 
1. Overview of alcohol use in humans 
1a. Alcohol use disorder and alcohol consumption patterns 
 Alcohol use disorder (AUD) is a pattern of problematic alcohol consumption that results 
in significant impairments or distress, and problems completing daily tasks. Features of AUD 
include an inability to limit alcohol consumption, development of cravings or tolerance to alcohol 
and the exhibition of withdrawal symptoms when alcohol is unavailable (NIAAA, SAMHSA 
2019). Conditions such as alcohol abuse, dependence and addiction are components of AUD 
(WHO 2018). In 2016, 15.1 million American adults (aged 18 years or more) were estimated to 
suffer from AUD, while globally, an estimated 283 million adults aged 15 years or more met 
some criteria for AUD (WHO 2018). AUD risk varies considerably by gender: in the United 
States approximately 9.2 million males and 5.3 million females were affected in 2016 (WHO 
2018). This is consistent with broader patterns – 237 million men and 46 million women are 
affected globally. AUD is also prevalent in adolescent communities. In 2018, 400,000 
adolescents were predicted to suffer with AUD in some capacity (WHO 2018). Alcohol 
consumption patterns also vary by geographic location. Although AUD impacts some groups 
more frequently than others, it is clear that AUD impacts large numbers of individuals across a 
wide variety of populations. 
 Alcohol use can have significant health consequences. In 2016, alcohol use contributed 
to approximately 3 million deaths and 132.6 million disability-adjusted life years (DALY’s) (WHO 
2018). These metrics equate to 5.3% of all deaths and 5.3% of all DALY’s worldwide; alcohol 
related mortality thus surpasses deaths from diseases such as tuberculosis, HIV/AIDS and 
diabetes (WHO 2018). Alcohol related deaths fall into several categories, including injuries 
(28.7%), digestive disease (21.3%), cardiovascular disease (19%), infectious disease (12.9%) 
and cancer (12.6%) (WHO 2018).  
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Alcohol consumption has also been linked to a plethora of diseases. For example, 
increased or irregular heavy alcohol consumption has been strongly associated with 
hypertensive heart disease and cardiomyopathy, among other types of ischemic heart diseases 
(Briasoulis et. al 2012, WHO 2018). Mechanisms related to ethanol metabolism, or the oxidation 
of alcohol (Cederbaum 2012) are causally linked to several types of liver damage, including 
alcoholic hepatitis and liver cirrhosis (WHO 2018; Gao & Betaller 2011). Rising rates of alcoholic 
liver disease could cause significant burden on health systems (WHO 2018). There is also a 
causal link between alcohol use and various types of cancer including esophageal, liver, colon 
and female breast cancer (Bagnardi et. al 2015, WHO 2018). Alcohol is thought to operate via 
numerous biological pathways to advance cancer growth (Bagnardi et. al 2015). Specifically, 
alcohol is able to cause lasting DNA damage and impede normal DNA repair processes 
(Bagnardi et. al, Cao et. al 2015). Alcohol related cancer risk is generally higher in females than 
males. This could, in part, be due to alcohol’s ability to alter estrogen signaling pathways (Cao 
et. al 2015, Bagnardi et. al 2015, WHO 2018).  
 Furthermore, alcohol abuse has been linked to weakening of the immune system and 
therefore, increased susceptibility to infectious disease (Sarkar et. al 2015). In the upper and 
lower airways alcohol metabolism, or the oxidation of alcohol, facilitated by alcohol and 
aldehyde dehydrogenase enzymes respectively (detailed in later sections) (Cederbaum 2012) 
plays a role in disrupting ciliary function and weakening epithelial cells (Sarkar et. al 2015). 
Additionally, alcohol impairs the function of immune cells like neutrophils and alveolar 
macrophages. This can lead to more serious disease in drinkers vs. non-drinkers (Sarkar et. al 
2015). This is relevant when considering how essential the immune system is for treatment of 
various diseases - for example, in cancer patients, chemotherapy is most effective when the 
immune system is fully functional (Sarkar et. al 2015). Additionally, immune signaling in the 
brain may be a contributing factor to development of AUD. Alcohol leads to neuroimmune 
signaling, which can further increase alcohol consumption (Sarkar et. al 2015). Furthermore, 
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alcohol use is associated with many mental, behavioral and neurodevelopmental disorders 
including anxiety disorders, depression, dementia and Alzheimer’s disease (WHO 2018).  
The mechanisms driving negative health consequences of alcohol consumption can be 
grouped into three broad categories: 1) alcohol toxicity on various tissues and organs leading to 
conditions such as liver disease, heart disease, cancer and immune dysfunction; 2) 
development of alcohol dependency altering the patient’s self-control and potentially 
contributing to the development of mental disorders such as depression and psychoses; and 3) 
the psychoactive effects of intoxication (Babor et. al 2010, WHO 2018). It is clear that alcohol 
use is widespread and alcohol abuse can have dire effects on individual health outcomes as 
well as broader population health patterns. Therefore, it is essential to better understand AUD 
with the aim of eventually developing better diagnostic or therapeutic tools for affected 
individuals.  
 
1b. AUD diagnostics and DSM definitions 
 Diagnostic criteria for AUD are described in the fifth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5). The DSM-5 diagnosis of AUD is based on the 
answers to 11 questions; to be diagnosed with AUD, a person must experience a minimum of 2 
symptoms listed. The sub-classification of an individual’s AUD is based on the number of listed 
symptoms they experienced (mild: 2-3 symptoms, moderate: 4-5 symptoms and severe: 6+ 
symptoms). (NIAAA 2016). Examples of questions in the DSM-5 include: 
- In the past year, have you: 
- Had times when you ended up drinking more, or longer, than you intended? 
- Spent a lot of time drinking? Or being sick or getting over other aftereffects? 
- Found that drinking - or being sick from drinking - often interfered with taking care 
of your home or family? Or caused job troubles? Or school problems? 
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- Given up or cut back on activities that were important or interesting to you, or 
gave you pleasure, in order to drink? 
The DSM 5 is the first version of the DSM that has a specific diagnosis for AUD.NIAAA 
2016). Previous iterations of the DSM separated diagnoses of alcohol abuse and alcohol 
dependency. Under DSM-IV guidelines, individuals experiencing more than one criterion would 
be diagnosed with “alcohol abuse,” and those experiencing 3+ symptoms would be diagnosed 
with “alcohol dependency” (NIAAA 2016).  While general themes are consistent between the 
two manuals, there are also key differences between the actual criteria: the DSM-5 removes a 
criterion referencing legal troubles stemming from alcohol use and adds one regarding alcohol 
craving as indicators of inappropriate alcohol use (NIAAA 2016). 
 
1c. Externalizing behaviors  
 Defining features of externalizing behaviors include impulsivity and behavioral 
disinhibition (Dick et. al 2003, Barr et. al 2020). They include psychiatric, non-clinical, substance 
abuse (including alcohol abuse) and antisocial conditions as well as risky behaviors (Dick et. al 
2003). Externalizing behaviors can generally be thought of as those that have direct 
consequences on the external world relative to the individual exhibiting the behaviors. This 
separates them from internalizing behaviors, such as anxiety or depression, that have direct 
effects on the patient (Barr et. al 2020). Externalizing behaviors are quite common; substance 
and impulse control disorders have lifetime prevalence rates of 29% and 24.8% respectively, 
and exhibit strong co-morbidity (Barr et. al 2020). These behaviors are responsible for causing 
significant social burden (Dick 2003, Barr 2020). Twin studies, and more recently, GWAS 
(genome wide association studies) studies in large populations have identified that all 
externalizing behaviors have genetic components, but the work of causally linking genetic 
variants to phenotypes is still incomplete (Dick 2003).  
5 
 
 It is thought that the same sets of genes underlie several externalizing behaviors, 
including ethanol behaviors, as they are observed together more often than would be expected 
by chance (Aliev et. al 2015). Aliev et. al evaluated associations between a panel of genes and 
single nucleotide polymorphisms (SNPs) previously associated with alcohol related traits and 
various externalizing phenotypes. Examples of phenotypes analyzed include: conduct disorders, 
adult antisocial disorders, illicit drug use and sensation seeking behaviors (Aliev 2015). It was 
found that the alcohol-related behavior SNPs were significantly enriched for each externalizing 
phenotype of interest. Thus, there may be a shared genetic liability that predisposes an 
individual to a host of externalizing behaviors including alcohol-related behaviors (Aliev 2015). 
 
1d. AUD, alcohol abuse and alcohol dependence as complex disorders 
 Understanding the cause of AUD and behaviors such as alcohol dependence is a crucial 
first step of lessening the negative consequences of alcohol abuse. Historically, twin studies 
have been a key way to determine the relative contribution of genes and environmental factors 
in the development of alcohol misuse. Twin studies are a common method to identify the source 
of variance in a specific trait (Kendler 1992). By comparing phenotypic correlations between 
monozygotic and dizygotic twins, it is possible to quantify the amount of phenotypic variance 
due to genetic factors, the shared environment and the unique environment (Kendler 1992). 
 The ACE model considers the following categories: additive genetic factors (A), the 
common environment (C) and the unique environment (E). If a specific category is taken out but 
the model still fits the data well, that factor was non-significant in its contribution to the 
phenotype. In early twin studies, it was found that the AE model fit twin data best, indicating that 
the common environment was not significant (Kendler 1992). However, more recent meta-
analysis of twin and adoption studies found that the estimate of heritability of AUDs across 13 
twin studies was 0.51, meaning that 51% of the risk of developing AUD is genetic (Verhulst et. 
al 2015, Ducci & Goldman 2008). The same genes are responsible for development of AUD in 
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males and females because correlations between same sex and opposite sex twin pairs were 
not significantly different. Contribution of the common environment was lower (0.083), but was 
still significant in males and females. The contribution of the unique environment was 0.39. It is 
well accepted that ~50% of the risk for developing AUD is genetic (Verhulst et. al 2015, Ducci & 
Goldman 2008).  
Previous findings also suggest there is a relationship between alcohol sensitivity and 
alcohol abuse. A study comparing alcohol response level at age 20 to whether the individual 
developed alcoholism showed that initial sensitivity to alcohol is associated with lower abuse 
potential in later life, and initial resistance is associated with higher abuse potential (Schuckit 
1994, Schuckit 1997).  
The Self Rating Effects (SRE) of Alcohol aims to quantify whether a person has a low or 
high alcohol sensitivity based on how many drinks it took for them to feel different, exhibit 
dizziness or slurred speech, show uncoordinated movements and sleep or pass out (Schuckit 
1997). The standard SRE asks participants to answer the questions based on the first five times 
they consumed alcohol, but can be modified to consider different drinking periods. Numerous 
studies have shown that the SRE is a highly robust indicator of alcohol use outcomes (Ray et. al 
2011). 
 
1e. Identification and function of genes influencing AUD risk 
Historically, attempts to identify genes that contribute to the risk of developing alcoholism 
were in the form of linkage studies in large families consisting of affected and unaffected 
individuals (Lipner et. al 2018). The basis of linkage studies is to determine whether any known 
markers or SNPs segregate with affected individuals more than chance would predict (Lipner et. 
al 2018). Linkage studies rely on recombination; recombination is unlikely when the marker loci 
and disease loci are close together, so they are more likely to segregate together than if they 
were located further away (Ott et. al 2015). Linkage studies are important as they can give 
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important information about inheritance patterns, penetrance, gene-gene interactions and co-
segregation (Lipner et. al 2018). They are highly useful when researchers do not have 
preliminary insight into what genes may be involved in the pathogenesis of a specific condition, 
as it is unbiased and takes the entire genome into consideration (Ott et. al 2015, Lipner et. al 
2018). However, linkage studies are limited in their scope. They are most informative when 
diseases follow a Mendelian inheritance pattern and the chromosomal regions implicated are 
often too large to be functionally meaningful without considerable follow-up (Lipner et. al 2018). 
In more recent years, GWAS have become a leading method for identifying genetic 
polymorphisms contributing to a phenotype. The basic principle of GWAS is to scan the entire 
genome of unaffected and affected individuals to assess whether any polymorphisms are 
observed more often in the affected population than the unaffected (Lipner et. al 2018). GWAS 
has several strengths, including the ability to identify common variants that may account for a 
percentage of overall disease risk. Additionally, due to their case-control structure, collecting 
data from families is unnecessary and statistical analysis is relatively straightforward (Ducci & 
Goldman 2008, Lipner et. al 2018). However, very large sample sizes are needed to provide 
informative results (Ducci & Goldman 2008, Lipner et. al 2018). In complex phenotypes like 
alcohol use, individual genes tend to have small effects. This, coupled with a high proportion of 
studies being underpowered make it difficult to unambiguously identify involved genes (Ducci & 
Goldman 2018). Another issue is phenotype heterogeneity. It is important to note that in order to 
be diagnosed with some level of AUD, individuals must experience a minimum of two of the 
criteria laid out by the DSM-V. Given the number criteria and the different classifications of 
severity, there are hypothetically 2036 ways for an individual to meet the criteria (Edenberg et. 
al 2018). Also, DSM-V criteria are very different from previous DSM-IV criteria; therefore, it can 
be difficult to reproduce older data under new definitions (Edenberg et. al 2013, Edenberg et. al 
2018). Additionally, different studies use different inclusion and exclusion criteria and often use 
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different alcohol phenotypes (response level, alcohol dependency, AUD, etc.) making 
reproducibility difficult (Edenberg et. al 2013, Edenberg et. al 2018)  
Given these challenges, there are a limited number of genes with consistent evidence 
linking them to AUD. There is very reproducible evidence of the involvement of ADH (alcohol 
dehydrogenase) and ALDH (aldehyde dehydrogenase) genes in risk of developing alcohol 
dependence (Edenberg et. al 2018). These genes are involved in the metabolism of ethanol to 
aldehyde and aldehyde to acetate, respectively (Edenberg et. al 2018). There are seven ADH 
genes; proteins corresponding to six have been isolated in vivo (Edenberg et. al 2018). Class I 
ADHs consist of ADH1A, ADH1B and ADH1C and have been shown to have significant roles in 
ethanol metabolism and together, can affect risk for development of alcohol dependence 
(Edenberg et, al 2018). These genes are 90% identical and arose from gene duplication events 
(Edenberg et. al 2018). Given their similarity, the gene products can heterodimerize (Edenberg 
et. al 2018). Variants in these chromosomal regions are generally in linkage disequilibrium and 
inherited together. ADH1B is highly expressed in the liver and is believed to be most involved in 
the oxidation of alcohol to aldehyde (Edenberg et. al 2018). ADH1B has three isoforms: 
ADH1B*1, ADH1B*2 and ADH1B*3. Each isoform is associated with specific rates of alcohol 
oxidation, and frequencies of these alleles are population specific (Edenberg et. al 2018). For 
example, ADH1B*1 metabolizes alcohol the most slowly and is most commonly observed 
globally (Edenberg et. al 2018). It is associated with a 3-fold increase in alcohol dependence 
risk compared to ADH1B*2 (Edenberg et. al 2018). ADH1B*2 is associated with rates of 
metabolism 11x that of the ADH1B*1 isoform and candidate gene studies strongly show that it is 
associated with a protective effect against alcohol dependence in Asian populations (Edenberg 
et. al 2018). However, there is heterogeneity in allele frequencies and amount of protection, 
even within Asian populations (Edenberg et. al 2018). It is difficult to assess the impact of this 
isoform on other populations, as its frequency is very low in European and African populations. 
GWAS has also shown that ADH1B*2 is associated with Alcohol Use Disorder Identification 
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Test (AUDIT) scores (Sanchez-Roige et. al 2019). AUDIT is a screening tool made up of ten 
items spanning three dimensions (consumption (AUDIT-C), dependence and problematic 
alcohol use (AUDIT-P). GWAS of UK BioBank and 23and Me for AUDIT-C and AUDIT-P 
identified that ADH1B*2 was strongly associate with AUDIT (Sanchez-Roige et. al 2018; 
Edenberg et. al 2018). The third isoform, ADH1B*3 is primarily found in African populations and 
is also associated with a protective effect against alcohol misuse (Edenberg et. al 2018). 
ADH1B*2 and ADH1B*3 are both coding variants that increase kinetic activity of ADH1B 
(Edenberg et. al 2018). ADH1C, which is expressed in the liver at about 30% the expression of 
ADH1B has two isoforms: ADH1C*1 shows protective effect against alcoholism, has high 
metabolic activity and is more highly expressed in various population groups than ADH1C*2 
(Edenberg et. al 2018). 
ALDHs consist of 19 genes, although ALDH2, ALDH1A and ALDH1B are the primary 
genes that are involved in the irreversible oxidation of acetylaldehyde to acetate (Edenberg et. 
al 2018). Gene products from all three form homotetramers. ALDH1A1 and ALDH1B1 have 
minor effects on risk of developing alcohol dependence (Edenberg et. al 2018). ALDH2 is 
ubiquitously expressed with high expression levels in the liver (Edenberg et. al 2018). It has two 
isoforms: ALDH2*1 and ALDH2*2. ALDH2*1 is most commonly expressed in individuals globally 
(Edenberg et. al 2018). ALDH2*2 is primarily found in some Asian populations and is protective 
against alcoholism (Edenberg et. al 2018). It makes the ALDH2 homotetramer inactive, causing 
individuals with the mutation to have higher blood aldehyde levels. Consequently, when 
individuals with the ALDH2*2 variant consume alcohol, there is a toxic buildup of 
acetylaldehyde, leading to symptoms such as severe flushing, nausea and increased skin 
temperatures (Edenberg et. al 2018). These negative side effects cause people with the 
mutation to generally consume less alcohol and therefore, decrease the risk of developing 
alcohol dependence.  
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 Recent GWAS (genome wide association study) performed with large sample sizes 
have identified genes of strong interest for further molecular study. Sanchez-Roige et. al 
performed a GWAS on AUDIT-C and AUDIT-P scores from a UK BioBank and 23andMe 
population and identified several associated risk loci, some of which map to the following genes: 
LINC01833, GCKR, KLB, METAP1, JCAD, and the alcohol metabolism gene ADH1C (Sanchez-
Roige et. al 2019). Another GWAS studying the genetic etiology of alcohol and tobacco use had 
a population cohort of 1.2 million individuals (Liu et. al 2019). Liu et. al identified several genes 
associated with drinks consumed per week, including: ADH1B, GCKR, SLC39A8, SERPINA1, 
ACTR1B, TNFSF12-13 and HGFAC (Liu et. al 2019). Genes identified by GWAS, and 
especially those that are tagged by multiple GWAS could be meaningful candidates for further 
study in model organisms.  
 
2. Drosophila melanogaster as a model organism for alcohol-related behaviors 
2a. Conservation between D. melanogaster and humans 
 Given the complexity and potential confounding social factors of studying AUD in 
humans, model organism studies have become a key platform to identify and investigate the 
contribution of genes thought to be involved in alcohol-related behaviors and molecular 
mechanisms. The fruit fly, Drosophila melanogaster is a powerful model organism to functionally 
and mechanistically characterize the function of various genes for several reasons. Flies 
possess orthologs for 75% of human disease-causing genes (Yamaguchi & Yoshida 2018; 
Engel et. al 2019) and have 80% conserved functional protein domains (Yamaguchi & Yoshida 
2018) D. melanogaster are low cost, are easy to maintain, take up little space and have fast 
generation times (Engel et. al 2019). It is possible to perform many types of high throughput 
genetic analyses and easily manipulate individual genes of interest. Additionally, a breadth of 




 Flies are a useful model organism to study alcohol-related behaviors due to shared 
nervous system molecular machinery (reviewed in Grotewiel & Bettinger 2015, Engel et. al 
2019). Additionally, flies exhibit conserved behavioral responses to alcohol exposure as 
humans: when exposed to low doses, both species show increased psychomotor and locomotor 
activity. High doses lead to sedation in both species (Engel et. al 2019). Like humans, flies also 
develop tolerance and withdrawal to alcohol as well as reward learning and memory behaviors 
(Engel et. al 2019). Though the fly is extremely short lived compared to humans, it is important 
to note that relatively, the time to develop tolerance and withdrawal symptoms is similar to 
humans (Adkins et. al 2017). 
 
2b. Approaches used to investigate genes contributing to alcohol behaviors in flies 
 Specific phenotypes associated with AUD, including alcohol sensitivity, tolerance and 
preference can be studied in flies through the use of a diverse range of behavioral assays. Initial 
sensitivity to alcohol is one of the most compelling predictors of whether a person later develops 
alcohol use disorder (Schuckit 1997, Engel et. al 2019). Thus, measuring the amount of time it 
takes flies of different genotypes to become sedated upon ethanol exposure (which is 
essentially a measure of ethanol sensitivity) can identify genes that contribute to the 
development of AUD. Several methods exist to measure ethanol sedation times. One example 
is the inebriometer. An inebriometer device is essentially a glass column with mesh slats that 
flies can attach to (Sass et. al 2020; Berger et. al 2004). Once flies become sedated, they drop 
to the bottom of the column, and the number of sedated flies is measured every minute (Sass 
et. al 2020; Berger et. al 2004). This method has historically been prevalent; however, it is low 
throughput and inefficient for studying individual flies (Sass et. al 2020; Berger et. al 2004). 
Sedation can also be measured by exposing groups of flies to ethanol vapor and recording the 
number of flies that become sedated at predetermined time intervals. This data can be used to 
calculate the Sedation Time 50 (ST50), or the amount of time required for 50% of flies in a 
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group to become sedated. Increased ST50 times indicate increased resistance to ethanol, and 
vice versa (Sandhu et. al 2015). This method is higher throughput, allows multiple genotypes to 
be assessed at once and is group based.   
 Like humans, flies can develop tolerance to alcohol. Generally, tolerance can be thought 
of as needing an increased amount of the drug to obtain the same response after chronic or 
multiple exposures, or the same amount of drug eliciting a lower response level (Engel et. al 
2019, Berger et. al 2004,). Humans and flies can develop three types of tolerance: acute 
tolerance, rapid tolerance and chronic tolerance. Acute tolerance is the development of 
tolerance within a single session of consumption (for example, binge drinking), rapid tolerance is 
a decrease in the intensity of response after recovery from a first alcohol exposure and chronic 
tolerance is developed from multiple repeated exposures (Engel et. al 2019). In flies, developing 
tolerance can look like exhibiting lower levels of locomotor impairment or taking longer to 
become sedated. Rapid tolerance can be measured using sedation assays. Flies undergo a first 
exposure to alcohol and are then allowed to recover in the absence of alcohol. They are then re-
exposed. ST50’s from the first and second exposure are compared to determine whether they 
have developed rapid tolerance. ST50 values from the second exposure being significantly 
higher than the first is evidence of rapid tolerance (Engel et. al 2019, Berger et. al 2004). Flies 
can also be raised on alcohol containing food to model chronic tolerance (Engel et. al 2019). 
 Preference assays build on the idea that the rewarding properties of alcohol contribute to 
the development of AUD (Engel et. al 2019). An example of an assay to assess fly preference is 
the proboscis extension response (PER) (Kaun et. al 2011). This assay consists of fixing 
individual starved flies to a plate. Flies are offered small amounts of alcohol and nonalcoholic 
food and the rate at which they extend their proboscii is measured. Increased rate of extension 
is associated with more appetitive substances (Kaun et. al 2011, Shiraiwa 2007). Another 
example is the two-choice Capillary Feeder (CAFÉ) assay. Flies are able to choose which of 
two capillaries containing ethanol and non-ethanol containing liquid food they would like to feed 
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on (Devineni et. al 2009, Engel et. al 2019). Results are measured by calculating the preference 
index (PI); a value that quantifies the ratio of alcoholic food consumption relative to total 
consumption (Devineni et. al 2009). Positive and negative PI scores indicate ethanol preference 
and repulsion respectively. CAFÉ assays have shown that flies increase their preference for 
alcohol over time: a study conducted by Devnineni et. al found that flies' PI value for alcohol 
consumption increased steadily over the five days they were exposed to alcohol containing food 
in the experiment and self-administered alcohol to pharmacologically relevant levels (Devineni 
et. al 2009). Flies were offered a choice between alcohol containing food laced with quinine, an 
aversive substance to flies, and regular food. Flies developed a preference for quinine laced 
alcoholic food compared to non-alcoholic food, showing that they overcame negative stimuli to 
access alcohol (Devineni et. al 2009, Engel et. al 2019).   
 Humans and flies both experience hyperactive nervous systems and seizures as a 
potential consequence of alcohol withdrawal. Alcohol is a depressant of the central nervous 
system (CNS). Chronic alcohol exposure results in long term excitatory neural adaptations to 
maintain homeostatic balance (Robinson et. al 2013). Upon withdrawal however, these 
adaptations result in an overactive nervous system, consequently causing seizures. Robinson 
et. al found that D. melanogaster larvae raised on alcohol containing food show hyper-excitable 
nervous systems when they are removed from alcohol containing food (Robinson et. al 2013). 
Seizure susceptibility can be measured in flies by using electrodes to shock the fly brain and 
induce seizures. Flies undergoing withdrawal were shown to need a lower stimulus voltage to 
induce seizures (Ghezzi et. al 2014). These experiments show that flies can be powerful models 
to study withdrawal. 
 Relapse is commonly observed in individuals attempting to cease problematic alcohol 
consumption (Melemis 2015). Devenini et. al showed that flies can be used to study relapse 
behavior by conducting a CAFÉ assay where flies were given the choice between alcoholic and 
nonalcoholic food (Devineni et. al 2009). Once flies demonstrated a preference for alcohol 
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containing food, they were deprived of it. During this period, PI values neared 0, since all food 
tubes available to flies were nonalcoholic. However, when alcohol was reintroduced PI values 
quickly returned to peak values indicating that flies are able to maintain strong memories of 
ethanol (Devineni et. al 2009).  
 
2c. Genetic manipulation of the fly genome 
 There are various approaches to manipulate the fly genome to study underlying genetic 
mechanisms that may be involved in behavioral alcohol response. A fundamental strategy is the 
GAL4-UAS system, a bipartite strategy that allows for ectopic expression or knockdown of 
essentially any transgene or gene in various tissues (Southall et. al 2008, Caygill et. al 2016, 
Duffy et. al 2002). GAL4 is endogenously expressed and regulates galactose metabolism in 
yeast (Caygill et. al 2016). The GAL4 protein consists of 881 amino acids and contains an N 
terminal DNA binding domain and C terminal transcription activation domain (Duffy et. al 2002). 
GAL4 dimerizes and binds the Upstream Activation Sequence (UAS), a specific 17-nucleotide 
sequence. Mediator and essential transcription machinery are recruited, leading to transcription. 
This activity is retained when GAL4 is expressed in D. melanogaster (Southall et. al 2008, 
Caygill et. al 2016). 
 In flies, the system requires two transgenic parental lines: the gene of interest is 
expressed under the control of the UAS, while the other parental line contains the GAL4 driver. 
When these lines are crossed, the gene of interest, or an RNA interference (RNAi) is expressed 
in the progeny (Caygill et. al 2016). The UAS-GAL4 system has several advantages that make it 
an attractive method. Since it is a bipartite system and GAL4 and UAS are in distinct parental 
lines, it is possible to use a particular UAS with various GAL4 drivers to study the effect of that 
specific gene in multiple tissue types (Southall et. al 2008). On the other hand, it is possible to 
use a singular GAL4 driver to study the effect of various genes in a particular tissue type. In the 
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absence of GAL4, UAS is generally silent or expressed at low levels. Therefore, this system can 
be used to study toxic or apoptotic proteins (Southall et. al 2008).  
 Apart from expressing genes of interest, this system can also be used to express RNAi. 
RNAi is an endogenous cellular mechanism that results in the degradation of RNA molecules. 
When double stranded RNA (dsRNA) is detected, a protein complex containing DICER is 
formed (Heigwer et. al 2018). This complex degrades the dsRNA into 21 bp fragments. These 
dsRNA fragments bind argonaute that subsequently binds to other proteins, forming the RNAi-
induced silencer complex (RISC) (Heigwer et. al 2018). RISC is able to recognize mRNA 
complementary to the dsRNA fragment bound by it, and degrade it, effectively silencing the 
gene of interest (Heigwer et. al 2018). This system can be applied in coordination with the UAS-
GAL4 system. When RNAi is under the control of UAS, the gene of interest will essentially be 
knocked down when GAL4 is present.  
 There are several extensions of the UAS-GAL4 system. For example, GeneSwitch (GS) 
uses a modified GAL4 driver to induce gene expression at specific times (Osterwalder et. al 
2001). In this inducible system, GAL4 is in an inactive conformation until exposure to a steroid, 
mifepristone (RU486). Upon mifepristone treatment, GAL4 conforms to its active state, binds 
UAS to activate the gene or RNAi of interest (Osterwalder et. al 2001). There are several 
advantages of this system compared to traditional UAS-GAL4 in regards to flexibility in the 
timing of gene expression/knockdown. Genes can be variably expressed in different life stages, 
allowing for the study of specific genes at particular developmental stages. By using this 
system, it is possible to conduct experiments involving genes that are essential to 
developmental processes, and for which constitutive knockdown would be lethal (Osterwalder 






2d. Genes involved in Drosophila melanogaster alcohol behaviors 
 Upwards of 150 fly genes with roles in alcohol-related behaviors have been identified 
(reviewed in Grotewiel & Bettinger 2015). Some of those genes that have been well 
characterized will be discussed below. Mef2 (myocyte enhancer factor 2), the central gene for 
my thesis project, is known to modulate ethanol sensitivity and is discussed in the subsequent 
sections. 
 Autism susceptibility gene (AUTS2) is a human gene that has been implicated in several 
neurological disorders including autism spectrum disorder and developmental delay (Schumann 
et. al 2011). AUTS2 has been identified as relevant to alcohol-related behaviors in multiple 
species. A GWAS studying alcohol consumption identified an intronic SNP in AUTS2 as 
significantly associated with alcohol consumption in humans (Engel et. al 2019, Schumann et. al 
2011). In mice, the gene was identified between high and low alcohol preferring (HAP1 and 
LAP1, respectively) lines (Engel et. al 2019). Tay, the fly ortholog of AUTS2 is a negative 
regulator of the epidermal growth factor receptor (EGFR) pathway (Engel et. al 2019, 
Schumann et. al 2011, Morozova et. al 2015). Mutations or neuronal RNAi leading to decreased 
expression of tay is associated with a decreased sensitivity to alcohol. Thus, AUTS2 may play a 
role in AUD via affecting alcohol sensitivity (Engel et. al 2019, Morozova et. al 2015).  
Other examples are the ALDH and ADH genes. Like humans, naturally occurring 
variation has been observed in these genes and they are involved in ethanol metabolism. AdhF 
has higher enzymatic activity than AdhS and is associated with flies that are more resistant to 
alcohol (Edenberg et. al 2018). This is similar to naturally occurring isoforms of human 
ADH1B/A that are associated with higher or lower enzymatic activity and consequently, altered 
risk of developing alcohol dependence.  
Many genes of interest have been identified via GWAS. While GWAS is a powerful 
method of identification, it has some limitations (Engel et. al 2019). For example, GWAS cannot 
capture genes because they exhibit changes in expression due to chronic alcohol exposure 
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(Engel et. al 2019). Transcriptomics level experiments like microarray and RNA-seq are well 
suited for this. Microarrays have advanced quite a bit since their inception; however, they are 
still limited by the number of probes available (Engel et. al 2019, Hitzemann et. al 2013). Unlike 
microarray, RNA-seq is not limited by probe quantity, and well suited to identify transcriptional 
complexities such as alternative splicing and non-coding RNA (Hitzemann et. al 2013). 
Slowpoke (slo) is a BK channel and ethanol exposure induces expression of the gene in the 
nervous system. Alternative splicing in the slo gene has been found to mediate tolerance in flies 
(Cowmeadow et. al 2015).  
These types of genomic and transcriptomic level studies have not only been crucial to 
identifying individual genes involved in the phenotype, but have also provided insight into the 
functional networks within which these genes operate. Networks regulating metabolic activity, 
stress pathways, chromatin remodeling and immune response, among others, have all been 
implicated in alcohol behavior (Morozova et. al 2015).  For example, Ghezzi et. al and Krishnan 
et. al used Chromatin immunoprecipitation sequencing (ChIP-seq) to elucidate histone 
acetylation changes related to mutations in the slo genes (Ghezzi et. al 2014, Krishnan et. al 
2016). 6b is an element of slo that is important for behavioral tolerance. ChIP-seq showed that 
flies that had been sedated with ethanol vapors and allowed to recover showed a spike in 6b 
acetylation from the 6-hour mark until the 48-hour time point (Krishnan et. al 2016). The 
antibody used tags all acetylated histone H4, but spikes were only observed in element 6b. 
Normal flies show effects of rapid tolerance up to 14 days post initial sedation, but flies with 
mutated element 6b (sloΔ6b) showed tolerance lasting at least 21 days (Krishnan et. al 2016). 
Therefore, slo may play a role in developing ethanol tolerance.  
Other genes, such as icarus (ics) have been shown to affect ethanol sensitivity. Ics 
encodes Rsu1, the fly ortholog of human RSU1 (Ras suppressor 1) (Ojelade et. al 2015). RSU1 
is associated with AUD and lifetime frequency of drinking in adults and adolescent populations, 
respectively (Ojelade et. al 2015). In flies, interrupting ics by a P-element leads to decreased 
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ethanol sensitivity and expression of UAS-Rsu1 led to rescue of the phenotype (Ojelade et. al 
2015). This could potentially be a therapeutic avenue to explore further.  
Overall, given the ability to model specific genetic questions and the number of alcohol 
related genes identified in flies, they are a powerful method to investigate the molecular genetic 
mechanisms underlying the pathogenesis of AUD in humans. 
 
3. Myocyte enhancer factor 2 (Mef2) 
3a. Mef2 in vertebrates and Drosophila melanogaster 
 In vertebrates, the myocyte enhancer factor-2 (MEF2) family encodes a transcription 
factor family with myriad functions including key roles in myogenesis and morphogenesis of 
skeletal, cardiac and smooth muscle cells (Pon & Marra 2016). Evolutionarily, these proteins 
belong to the ancient MADS (MCM1, agamous, deficiens, serum response factor) box family 
(Black & Olson 1998, Pothoff & Olson 2007, Sivachenko et. al 2013). Mammals have four MEF2 
genes: MEF2A, MEF2B, MEF2C and MEF2D. Each gene encodes a protein with a highly 
conserved MADS-box and MEF2 domains at the N terminus (Pon & Marra 2016). These 
domains are crucial to dimerization, DNA binding ability and cofactor binding. Between species, 
these areas are more than 80% conserved (Crittenden et. al 2018). C-terminal transcriptional 
activation domains are less conserved and can undergo complex splicing patterns. In mammals, 
MEF2’s role is highly dependent on which cofactors are present (Crittenden et. al 2018). For 
example, in culture, MEF2 and Nkx2.5, MEF2 and MASH1 and MEF2 and myogenin coactivate 
to induce cardiac muscle formation, neuronal phenotypes and skeletal muscle differentiation, 
respectively (Crittenden et. al 2018)..  
Given this complexity, studying MEF2 in Drosophila, which possess a single copy of the 
gene (Mef2) can help understand MEF2’s conserved roles in a streamlined way. Like 
mammalian species, Drosophila Mef2 has been shown to be essential for the differentiation of 
numerous cell lines (Crittenden et. al 2018). Neuronally, Mef2 is localized in Kenyon neurons, 
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which make up the mushroom bodies in the fly brain. Mef2 is crucial to mushroom body 
formation in the embryonic fly brain as null or hypomorphic Mef2 mutants exhibit significantly 
fewer differentiated mushroom body neurons (Crittenden et. al 2018). Additionally, adult flies 
with Mef2 mutations were found to have abnormal wings showing that the gene is essential to 
normal wing development (Crittenden et. al 2018). Mef2 has also been shown to be required for 
the daily fasciculation/defasciculation cycle in small ventral lateral neurons (s-LNv) and 
contribute clock information to neuronal remodeling machinery (Sivachenko et. al 2013).  
As previously detailed, Mef2 is a transcription factor (Black & Olson 1998). Sivachenko 
et. al conducted a ChIP-seq using fly brains that revealed that 342 fly genes were bound by 
Mef2. (Sivachenko et. al 2013) These fly genes are orthologous to over 500 human genes. Mef2 
and the genes it binds are the main focus of this thesis project.  
 
3b. Mef2 influences ethanol sedation in Drosophila melanogaster 
 Mef2 has been shown to influence ethanol sedation in D. melanogaster. As previously 
outlined, initial resistance to ethanol is a key predictor of later alcohol abuse in humans. The 
SRE is a questionnaire designed to elucidate whether a person has a high or low initial 
sensitivity to alcohol (Schuckit 1997). A meta-analysis of two population based GWAS studies of 
SRE interrogating upwards of 18,000 genes showed that 37 were nominally significant (p < 
0.001) for SRE (Schmitt et. al 2019). Schmitt et. al found that 29 of those 37 genes had 
appropriate Drosophila orthologs and ultimately selected nine human genes (APP, BORC8, 
MEF2B, GPD2, ISL1, PCDH15 and SFSWAP) to follow up on based on reports suggesting their 
potential involvement in behavior or neurological disease (Schmitt et. al 2019). 
 The nine chosen genes are orthologous to 12 fly genes (Schmitt et. al 2019). RNAi 
transgenes against each gene of interest was expressed in fly neurons using the GAL4-UAS 
system with a neuron specific GAL4 driver (elaV-GAL4) and UAS-RNAi construct (Schmitt et. al 
2019). Sedation experiments were performed for each RNAi. Three separate RNAi transgenes 
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against and mutations in Mef2 were shown to increase ST50 values compared to controls 
(Schmitt et. al 2019). Additionally, another study reported that pan-neuronal expression of Mef2 
RNAi increases ethanol sensitivity and dominant negative Mef2 in all neurons or mushroom 
bodies alone decreases tolerance (Adhikari et. al 2018). This study also reported that Hr38, a 
gene downstream of Mef2, influences ethanol tolerance and preference behaviors (Adhikari et. 
al 2018)  
  
4. Significance 
As previously discussed, AUD is a significant public health concern and a leading cause 
of injury, development and progression of various physical and mental diseases, loss of 
productivity and preventable death in the US and abroad (NIAAA 2016, WHO 2018). Treatment 
options are limited. Only three medicines are approved to treat AUD: disulfiram, naltrexone and 
acamprosate (Kranzler & Soyka 2018). These drugs have distinct mechanisms. Disulfiram for 
example, causes negative symptoms like nausea and skin flushing when an individual 
consumes alcohol. If a person knows that drinking will cause these side effects, they may be 
deterred from consumption. Naltrexone and Acamprosate are aimed at curbing cravings by 
targeting neural reward systems (Kranzler & Soyka 2018). However, these options are limited 
and rates of relapse are high. Behavioral counseling is also a viable treatment option; however, 
many rates of relapse are high (Kranzler & Soyka 2018, Melemis 2015).  
Given the level of conservation between humans and D. melanogaster, experiments in 
flies can be powerful avenues to identify candidate genes relevant to alcohol related behaviors. 
AUD is a complex disease, and better understanding the molecular genetic mechanisms 
underlying pathogenesis of the disease is a springboard for developing more robust therapeutic 





CHAPTER 2: RNAi SCREEN OF CANDIDATE GENES DOWNSTREAM OF MEF2 
1. Introduction & rationale  
 Studies in the Grotewiel laboratory demonstrated that mutations in Mef2 or neuronal 
expression of RNAi transgenes against Mef2 decrease ethanol sensitivity in flies (Schmitt et. al 
2019). Additionally, Wolf and co-workers (Adhikari et. al 2018) reported that pan-neuronal 
expression of Mef2 RNAi increases ethanol sensitivity in flies and that dominant negative Mef2 
in all neurons or mushroom body neurons alone decreases ethanol tolerance. This study also 
showed that genes regulated by Mef2 play a role in ethanol related behaviors. Hr38 is a 
Drosophila homolog of the mammalian Nr4a1/Nr4a2/Nr4a3 gene family (Adhikari et. al 2018). In 
humans, these genes are transcriptionally activated by MEF2 (Adhikari et. al 2018). When drug 
naive flies were exposed to ethanol, Hr38 was the only surveyed gene with induced expression 
(Adhikari et. al 2018). Flies heterozygous for Hr38 were observed to display significantly altered 
ethanol tolerance and preference (Adhikari et. al 2018). Similarly to mammals, Hr38 was 
transcriptionally induced by Mef2, in the presence of alcohol (Adhikari et. al 2018). In other 
words, alcohol activates Mef2, allowing it to induce Hr38. Increased levels of Hr38 were 
associated with higher tolerance and increased preferences for alcohol, but did not have an 
effect on ethanol sensitivity. Another group performed ChIP-seq on DNA isolated from fly heads 
and identified 342 Mef2-bound genes (Sivachenko et. al 2013). Exploring the function of genes 
downstream of Mef2 in ethanol sedation is a primary goal of this thesis, and particularly, of this 
chapter. 
 Given that Mef2 regulates ethanol sedation (Schmitt et. al 2019, Adhikari et. al 2018), is 
a transcription factor (Black & Olson 1998; Taylor & Hughes 2017), is known to bind 342 genes 
in flies (Sivachenko et. al 2013) and at least one gene downstream of Mef2 (Hr38) influences 
ethanol tolerance and preference (Adhikari et. al 2018), we hypothesized that other genes 
downstream of Mef2 play a role in ethanol sedation. We began testing this hypothesis by 
identifying genes of interest by determining the intersection of (i.e. overlap between) genes 
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bound by Mef2, genes associated with human externalizing behavior (Dick, personal 
communication 2020, Linnér et. al 2020), genes known to influence fly and worm alcohol 
behavior (reviewed in Grotewiel & Bettinger 2015), human genes associated with expression 
changes related to alcohol consumption (Silviu Bacanu, personal communication) and genes 
related to human/mouse disease linked genes and gene ontology (Michael Miles, personal 
communication). This approach identified the genes spin, unc79, Bx, CtBP, Fas2 and For as 
being bound by Mef2, associated with externalizing behavior in humans, and (for spin) 
associated with alcohol consumption in humans. These six genes of interest were therefore high 
priority candidates that I investigated for roles in fly ethanol sedation. 
 
1a. Functions of genes of interest 
 The functions of the genes of interest are quite varied. spin is the fly ortholog of the 
human SPNS1 gene. In flies, the spin gene encodes a multi-pass transmembrane late 
endosomal/lysosomal protein (Kim 2017, Sweeney & Davis 2002). spin is known to be involved 
in nervous system development, cell death control and is required for TGF-β signaling (Kim 
2017). Additionally, spin is involved in eye development via control of glial cell migration in flies 
(Yuva-Aydemir et. al 2011). Loss of function spin mutants displayed patterns of early endosome 
recycling. This led to accumulation of autophagosomes and autolysosomes, leading to 
abnormal head growth (Kim 2017). spin mutant females are also known to avoid mating (Kim 
2017). Previous work by Katlyn Myers in the Grotewiel laboratory found that neuronal 
expression of RNAi transgenes against spin and transposon insertions in or near the spin locus 
made flies resistant to ethanol sedation, strongly suggesting the gene is involved in ethanol 
sedation sensitivity (Myers 2020). 
 unc79 is the fly ortholog of the human UNC79 gene. In flies, it is known to be involved in 
sleep homeostasis and locomotor activity (Joiner et. al 2013). The fly Narrow Abdomen (NA) ion 
channel is orthologous to the mammalian NALCN sodium leak channel (Joiner et. al 2013). In 
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both humans and flies, NALCN/NA function in clock neurons to support behavioral rhythmicity. 
Loss of function mutations in unc79 lead to serious defects in circadian locomotor rhythmicity 
(Lear et. al 2013). Immunoprecipitation and tissue specific RNAi experiments show that unc79 
operates in pacemaker neurons (Lear et. al 2013). unc79 is also involved in behavioral 
responses to anesthetics. Flies with loss of function mutations in unc79 display an increased 
response to anesthesia (Joiner et. al 2013). unc79 is also known to be involved in alcohol 
behaviors in worms (reviewed in Grotewiel & Bettinger 2015). Worms with mutations in unc-79, 
the worm ortholog of the human UNC79 gene were found to be dramatically hypersensitive to 
ethanol exposure in regards to swimming behavior (Speca et. al 2010). Additionally, the same 
study found that mice with a point mutation in the mouse homolog of unc-79 were similarly 
sensitive to alcohol exposure, as well as exhibiting a high preference for alcohol (Speca et. al 
2010), suggesting a conserved function of the gene.  
Beadex is the fly ortholog of the human gene LMO1 (Milan et. al 1998). Bx encodes the 
dLMO transcription factor, which contains two conserved LIM homeodomains (Milan et. al 
1998). This gene is known to be involved in cytoskeletal organization, cell specification and 
differentiation and organ development (Milan et. al 1998). Misexpression of dLMO is associated 
with disturbed dorsal-ventral boundaries and wing patterning and extraneous wing growth (Zeng 
et. al 1998). Additionally, flies with a loss of function point mutation in Bx showed enlarged 
abdomens due to decreased gastric emptying (Ren et. al 2014). Bx is also involved in blood cell 
development. Knockdown mutants of Bx are associated with an increased crystal cell count 
(Chatterjee et. al 2019). In addition, Bx is involved in follicle cell development. To that end, it has 
been shown to be essential to female reproduction (Karaimkonda & Nongthomba 2018). Eggs 
of female flies with decreased levels of Bx have multiple defects due to its involvement in follicle 
cell development (Kairamkonda & Nongthomba 2018). Bx is known to be involved in alcohol 
behaviors in flies (Grotewiel & Bettinger 2015). Flies with loss of function (LOF) mutations in Bx 
display increased resistance to ethanol, whereas flies with an overexpression construct of the 
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gene exhibit the opposite phenotype (Lasek et. al 2011). This relationship has also been 
observed in mice, suggesting a conserved effect of the gene (Lasek et. al 2011) 
CtBP is the fly ortholog of the human gene of the same name. It is a transcriptional co-
regulator and plays a role in regulating gene expression (Hoang et. al 2010). Hoang et. al found 
that Drosophila CtBP interacts with other proteins to mediate gene expression at multiple stages 
of eye development to prevent over proliferation of eye precursors (Poortinga et. al 1998). 
Additionally, CtBP has been reported to inhibit the Wnt signaling pathway by blocking β-catenin 
from binding T-cell factors (Poortinga et. al 1998). Interestingly, Fang et. al found that CtBP is 
involved in activating targets of the Wnt signalling pathway and blocks expression of Wnt targets 
(Fang et. al 2006). CtBP is known to be involved in alcohol behaviors in worms (Grotewiel & 
Bettinger 2015). Worms with mutations in ctbp-1, the worm ortholog of the human CTBP gene 
displayed increased time to develop acute functional tolerance, or the normalization of neural 
function in spite of the presence of alcohol, compared to wild type worms (Bettinger et. al 2012). 
Additionally, worms with increased expression of ctbp-1 displayed faster development of AFT 
and resistance to alcohol (Bettinger et. al 2012). 
 Fas2 is the fly ortholog of the human neural cell adhesion molecule (NCAM). Both are 
part of the Ig (immunoglobulin) domain superfamily and possess homophilic cell-cell adhesion 
mediator activity (Neuert et. al 2020). Sivachenko et. al found that Mef2 negatively regulates 
Fas2, and both genes are involved in circadian rhythm control (Sivachenko et. al 2013) in flies. 
Fas2 is a player in neuron-glia signaling and has several isoforms that display different 
membrane attachment patterns and cytoplasmic domains (Neuert et. al 2020). Additionally, 
Fas2 is involved in organ morphogenesis, nervous system development and synapse 
organization (Neuert et. al 2020). Mao et. al showed that Fas2 inhibits EGFR (epidermal growth 
factor receptor) signaling during development of the eyes, wings and notum, as decreased 
levels of Fas2 are associated with EGFR hyperactivity phenotypes (Mao & Freeman 2009). 
Fas2 is known to be involved in alcohol behaviors in flies (reviewed in Grotewiel & Bettinger 
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2015). Loss of function Fas2 mutants displayed increased sensitivity to ethanol vapors when 
tested using an inebriometer (Cheng et. al 2001). Expression of Fas2 transgenes did not rescue 
this phenotype, suggesting that the role the gene plays in ethanol sensitivity is complex (Cheng 
et. al 2001). 
 For is the fly ortholog of the human gene PRKG1. For encodes a cGMP (cyclic 
guanosine-3’, 5’-monophosphate)-dependent protein kinase and is known to be expressed in 
ellipsoid-body ring neurons in flies (Kent et. al 2009). Previous studies have shown that flies and 
larvae harboring for mutations display altered learning patterns and associative olfactory 
learning (Kunz et. al 2012). Additionally, for is known to be involved in visual pattern memory 
and visual orientation memory. for has naturally occurring isoforms: forS, or “sitter” and forR, or 
“rover'' (Wang et. al 2008). Flies with the sitter variant have lower cGMP-dependent protein 
kinase levels and display both deficient visual pattern and visual orientation memory (Wang et. 
al 2008). Rover and sitter variants have altered movement and socialization patterns. As their 
name implies, rover larvae move further while foraging for food, whereas sitters tend to group 
together collectively (Wang et. al 2008). Rovers also display longer short-term memory and are 
more sensitive to heat, hypoxia and starvation, but can resist starvation stress (Wang et. al 
2008). On the other hand, sitters show better learning patterns while in groups, showing that for 
is quite important in fly behavior (Wang et. al 2008). It is known to be involved in worm      
alcohol behaviors (reviewed in Grotewiel & Bettinger 2015). Worms with mutations in egl-4, the 
worm ortholog of the human PRKG1 gene display normal responses to ethanol when they are 
drug naive, but do not display symptoms of withdrawal (Mitchell et. al 2010). 







2. Materials & methods 
2a. Fly husbandry and stocks 
Flies were raised in an environmental chamber operating on a 12-hour light/dark cycle at 
25°C and 60-65% relative humidity. Drosophila food medium consisted of 10% sugar, 3.3% 
cornmeal, 2% yeast, 1% agar, 0.1 g/L ampicillin, 0.125 g/L chloramphenicol, 2 g/L tegosept, 
0.02 g/L tetracycline and live yeast (Schmitt et. al 2019).  
Twenty-one RNAi transgenes against the six genes of interest were obtained either from 
the Bloomington Drosophila Stock Center (BDSC, Bloomington, IN) or the Vienna Drosophila 
RNAi Center (VDRC, Vienna, Austria) (Table 1). Whenever possible, multiple RNAi transgenes 
were ordered per gene of interest. The VDRC online interface was used to assess the number 
of predicted off-target effects of each RNAi from this stock center. VDRC defines an “on-target” 
as any gene that is a perfect match to at least 80% of a construct’s 19-mers, or 19 nucleotide 
length sequences (Dietzl et. al 2007). Off-targets are defined as any genes that matches to less 
than 80% of a construct’s 19-mers, but possesses at least one match (Dietzl et. al 2007). Each 
RNAi is assigned a specificity score (s19), calculated as s19 = ∑(on target matches) / ∑(on target 
matches + off target matches) (Dietzl 2007). A specificity score of 0.5 indicates a gene that 
matches perfectly to a construct 50% of the time, or a gene that is considered on-target (Dieztl 
et. al 2007). Only VDRC RNAi transgenes with less than two predicted off target effects were 
used.  
 
2b. Identification of fly-human gene orthologs 
Fly genes bound by Mef2 (Sivachenko et. al 2013) were converted to their human 
orthologs by calculating DIOPT scores using the DIOPT – DRSC Integrative Ortholog Prediction 
Tool version 8 (Hu et. al 2011, DRSC). DIOPT allows for rapid identification of orthologous 
genes by integrating several approaches to allow users to identify the most appropriate 
orthologs for further analysis (Hu et. al 2011). The tool reports several metrics, including a 
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DIOPT score which is determined by the number of predictive tools that have paired the two 
orthologs (Hu et. al 2011). Higher DIOPT scores indicate increased tools predicting the two 
genes as an ortholog pair, and is a metric by which to prioritize output gene lists (Hu et. al 
2011). In our work, each gene of interest was entered into the website using the appropriate 
input and output species and only orthologs with a DIOPT score greater than or equal to 5 were 
considered further.  
 
2c. Ethanol sedation 
  Ethanol sedation was assessed as described previously (Sandhu et. al 2015, Chan et. 
al 2014). One to three-day-old female flies were collected in groups of 11 under brief CO2 
anesthesia. All collected flies visually appeared healthy, were of similar size, had normal wings 
and were not virgins. Eight vials of flies were collected per genotype for a total of 24 vials of flies 
per experiment to assess an individual RNAi transgene. Collected flies were allowed to recover 
overnight in inverted, non-yeasted food vials in the environmental chamber (25°C, 60-65% 
humidity). Eighty-five % ethanol was made a maximum of 1 week before each sedation 
experiment. All sedations were conducted in the same behavioral room at 20-23°C, relative 
humidity at 55-65% and with standard laboratory lighting. Flies were allowed to adjust to the 
conditions of the room for approximately 60 minutes prior to beginning each experiment.  
 Prior to beginning each experiment, each vial was randomly assigned an alphanumeric 
code such that they are in 6 sets of 4 vials each. The experimenter (AT) was blind to genotypes. 
Flies were transferred from the food collection tubes they had been housed in overnight to 
correspondingly labelled empty vials. Vials were sealed with a cotton flug. Flugs were pressed 
down to a uniform height and the number of immobile flies before any ethanol application was 
recorded. At 0 minutes, ethanol was added to each vial in the first set at five second intervals 
and sealed with a silicone plug. At 30 seconds, the number of sedated flies in vial 1 was 
counted, and each subsequent vial in set 1 was counted at 5 second intervals. Ethanol was 
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added into the second set of vials every five seconds, and so on. Each vial was tapped and 
counted every six minutes as described by Sandhu et. al (Sandhu et. al 2015). 
 The ST50, or amount of time it takes for 50% of the flies in a vial to become sedated was 
ascertained from a sigmoidal curve fits of the ethanol sedation time-course data (Sandhu et. al 
2015). Vials were decoded and sorted by genotype. ST50 values were compiled for each 
genotype. 
 
2d. Testing genes of interest in ethanol sedation 
 The effect of each RNAi transgene on ethanol sedation was assessed in individual 
experiments with three genotypes, each derived from three crosses performed in parallel. The 
elav-GAL4 driver stock was used to express each RNAi transgene pan-neuronally. Additionally, 
two other genotypes, an elav-GAL4 control and an RNAi control were also tested for ST50 using 
the ethanol sedation assay outlined in the following section to determine whether the RNAi-
expressing group displayed significant ethanol sedation resistance or sensitivity compared to 
controls. All crosses are outlined in Table 2. All flies tested were in an F1 hybrid genetic 
background consisting of 50% w[A] (Grotewiel laboratory stock) and 50% w[VDRC] (the 
background used to generate most RNAi transgenes). 
 
2e. Statistical analyses  
 Fisher’s exact test was performed in R Studio (R Studio Version 1.4.1717). The exact 
script used was provided by Dr. Michael Miles’ lab and is in the appendix. p ≤ 0.05 was 
considered significant. One-way analysis of variance (ANOVA) and Bonferroni’s multiple 
comparisons (BMC) were performed using GraphPad Prism version 9 for each sedation 





Genotype Stock # Description Source 
w1118; P{GD2579}v8392 8392 Fas2 RNAi VDRC 
w1118; P{GD2579}v8393 8393 Fas2 RNAi VDRC 
w1118; P{GD14486}v36350 36350 Fas2 RNAi VDRC 
w1118; P{GD14486}v36351 36351 Fas2 RNAi VDRC 
P{KK100888}VIE-260B 103807 Fas2 RNAi VDRC 
y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02918}attP2 e[*] 28990 Fas2 RNAi BDSC 
y[1] sc[*] v[1] sev[21]; P{y[+t7.7] v[+t1.8]=TRiP.HMS01098}attP2 34084 Fas2 RNAi BDSC 
P{KK108401}VIE-260B 107313 CtBP RNAi VDRC 
y1 v1; P{TRiP.JF01291}attP2/TM3, Ser1 31334 CtBP RNAi BDSC 
y1 sc* v1 sev21; P{TRiP.HMS00677}attP2 32889 CtBP RNAi BDSC 
w1118; P{GD6843}v38319 38319 For RNAi VDRC 
P{KK101298}VIE-260B 101298 For RNAi VDRC 
y1 v1; P{TRiP.JF01449}attP2/TM3, Ser1 31698 For RNAi BDSC 
y1 sc* v1 sev21; P{TRiP.GL00026}attP2 35158 For RNAi BDSC 
y1 sc* v1 sev21; P{TRiP.HMS04486}attP40 57041 For RNAi BDSC 
y1 v1; P{TRiP.JF03390}attP2 29454 Bx RNAi BDSC 
y1 sc* v1 sev21; P{TRiP.GL00484}attP2/TM3, Sb1 35637 Bx RNAi BDSC 
y1 sc* v1 sev21; P{TRiP.HMC04776}attP40 57465 Bx RNAi BDSC 
P{KK102682}VIE-260B 108132 unc79 RNAi VDRC 
w1118; P{GD11587}v45780 45780 unc79 RNAi VDRC 
y1 sc* v1 sev21; P{TRiP.HMC03213}attP2 51471 unc79 RNAi BDSC  
y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02782}attP2 27702 spin RNAi BDSC 
w1118; P{GD5039}v15550 15550 Mef2 RNAi VDRC 
w[VDRC] N/A VDRC control strain, w1118 VDRC 
w[A] N/A lab control strain, w1118 BDSC 











Virgin ♀ ♂ Group 
elav-GAL4 w[VDRC] elav-GAL4 control 
w[A]   RNAi RNAi control 
elav-GAL4  RNAi Presumed knockdown 
 

























3. Results & Discussion 
3a. Identifying genes of interest  
 Considering that Mef2 is a transcription factor (Black & Olson 1998; Taylor & Hughes 
2017) that influences ethanol behaviors in flies and possibly humans (Schmitt 2019, Adhikari 
2019), we hypothesized that genes bound (and presumably regulated) by Mef2 would be good 
candidates for functioning downstream of Mef2 to regulate ethanol sedation. We also 
hypothesized that additional human genetic information could be used to prioritize genes bound 
by Mef2 as downstream mediators of Mef2. Toward testing these two interrelated hypotheses, 
we used DIOPT (DRSC, Hu et. al 2011) to convert the 342 genes bound by Mef2 (Sivachenko 
et. al 2013) to 581 human orthologs. Dr. Danielle Dick's laboratory had identified 928 human 
genes associated with externalizing behavior (defined as a group of behaviors that are directed 
outwardly and pertain to self-regulation). Examples include substance abuse, antisocial disorder 
and poor impulse control (Dick et. al 2020); Danielle Dick, personal communication 2020; Linnér 
et. al 2020), and further found that 39 of the 581 human orthologs of genes bound by Mef2 were 
associated with externalizing behaviors (Table 3, first column; Danielle Dick, personal 
communication 2020). Although Fisher’s exact test indicates that the overlap of 39 genes 
between the human orthologs of Mef2 bound genes and 928 human externalizing behavior 
genes is not significant (Table 4), these genes might still ultimately prove to be high-priority 
candidates for roles in ethanol behavior given their connections to Mef2 and/or externalizing 
behavior.  
I compared the 36 unique fly genes that are bound by Mef2 (Table 3) and are 
orthologous to 39 human genes that were associated with externalizing behavior (Table 3, 
Linnér et. al 2020) to a comprehensive list of 91 and genes involved in at least one aspect of fly 
alcohol behavioral responses (reviewed by Grotewiel & Bettinger 2015). I then converted these 
genes to their worm orthologs and compared them to a list of genes involved in worm alcohol 
responses (reviewed by Grotewiel & Bettinger 2015).  
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Human Gene Mef2 bound 
fly gene 
DIOPT Score p-value 
NCAM1 Fas2 11 1.59E-48 
SEMA6D Sema1a 8 1.00E-39 
SDK1 sdk 10 6.98E-36 
PDE4B dnc 12 2.03E-25 
CELF2 aret 14 6.65E-20 
PRKG1 for 13 3.15E-15 
PHC2 ph-p 6 8.54e-14 
BIRC6 Bruce 15 2.60E-13 
NFAT5 Nfat 7 2.67E-11 
NFIA nfl 12 5.83E-11 
CHD3 mi-2 12 25.96E-11 
CALB1 Cbp53e 10 8.32E-11 
FXR1 Fmr1 12 3.37E-10 
UNC79 unc79 14 5.18E-10 
CALB2 Cbp53e 11 1.08E-09 
LONRF2 CG32369 12 1.20E-09 
FMNL2 Frl 11 1.68E-09 
PTPRN2 IA-2 10 1.75E-09 
CYP3A43 Cyp9f2 8 2.69E-09 
MLLT10 Alh 6 3.43E-09 
MEF2C Mef2 11 4.09E-09 
OAZ3 Oda 7 4.54E-09 
SCL17A3 CG3649 6 5.84E-09 
ASPG CG6428 13 6.00E-09 
ARIH2 ari-2 15 1.20E-08 
IGF1R lnR 12 3.34E-08 
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MAPT tau 7 5.67E-08 
MAP4 tau 6 8.14E-08 
SLC22A12 CG8654 6 8.42E-08 
ISYNA1 Inos 13 1.12E-07 
EXT1 ttv 13 1.25E-07 
PFKFB2 Pfrx 11 2.06E-07 
SPNS1 spin 13 2.09E-07 
REEP1 ReepA 8 9.14E-07 
LMO3 Bx 7 1.02E-06 
CYP3A5 Cyp9c1 8 1.23E-06 
CYP3A4 Cyp6wi 9 1.49E-06 
PDE4D dnc 10 1.71E-06 
CTBP1 CtBP 12 2.45E-06 
 
Table 3. Thirty-nine human genes implicated in externalizing behaviors, their respective fly 
orthologs, DIOPT scores and whether the gene is present in the list of the 342 Mef2 bound fly 
genes. P-value refers to the Bonferroni corrected p-value of the association of the gene with 

















39 total 29.5678 1.2070 0.2729 
 
Table 4. Fisher’s exact test to determine whether the number of genes overlapping between the 





This identified six high priority candidate genes (Bx, CtBP, Fas2, For, spin, unc79) that 
are all bound by Mef2 (Sivachenko et. al 2013), have orthologs associated with human 
externalizing behavior (Dick, personal communication 2020, Linner et. al 2020) and have been 
previously reported to be involved in or have orthologs that are involved in fly or worm alcohol 
behaviors (Grotewiel & Bettinger 2015). The steps taken to identify these six candidate genes 
are outlined in Figure 1. 
The gene spin was previously examined as a locus involved in ethanol sedation by 
Katlyn Myers, a student in the Grotewiel lab as part of her Master’s thesis. Within human 
orthologs of the 342 Mef2-bound genes (Sivachenko et. al 2013), a GSCAN (GWAS & 
Sequencing Consortium of Alcohol and Nicotine Use, Dr. Silviu Bacanu, personal 
communication) identified 15 genes including spin as being nominally associated with gene 
expression changes associated with alcohol consumption (Bacanu, unpublished). Katlyn found 
that flies expressing an RNAi transgene targeting spin pan-neuronally and flies with transposon 
insertions near or in the spin locus had increased ST50 values (Myers and Grotewiel, 
unpublished). We also searched for our other five candidate genes (Bx, CtBP, Fas2, For, 
unc79) within the GSCAN data. Additionally, we searched for our six candidate genes within 
data from a compilation of gene ontology and human/mouse disease linked genes from Dr. 
Miles’ lab (Michael Miles, personal communication). These additional analyses via Drs. Bacau 
and Miles did not further implicate the candidate genes in ethanol behavior. In summary, we 
identified six genes or orthologs of genes for further study that are bound by Mef2, known to be 
involved in fly or worm alcohol behavior, and associated with externalizing behavior (Table 5). 
One of these six genes, spin, is also associated with gene expression changes related to 





Figure 1. Outline of the steps taken to identify high priority candidate genes for possible roles in 
ethanol sedation. Initial Mef2 bound genes identified by Sivachenko et. al (Sivachenko 2013) 
were converted to human orthologs, filtered by human genes involved in human externalizing 
behavior, converted back to fly and worm orthologs and then filtered against lists of genes 






342 Mef2 bound fly genes identified via 
ChIP-seq (Sivachenko et. al). 
Mef2 bound fly genes converted to 581 
human orthologs using DIOPT scores.  
Human orthologs compared to genes 
identified by Dick et. al known to be 
involved in human externalizing behaviors. 
39 genes overlap. 
Orthologs of 39 human externalizing 
behavior genes are compared to genes 
compiled by Grotewiel & Bettinger to be 
involved in fly and worm alcohol behaviors 
6 Mef2 bound genes known to be involved in 
fly or worm alcohol behaviors and with human 
orthologs involved in externalizing behaviors 




Human orthologs are converted back to 


























































Table 5. Six candidate genes, their human orthologs, their past implication in fly or worm 
alcohol behavior, ranking and adjusted p-values from Dr. Dick’s analyses of human 
externalizing behaviors and Dr. Bacanu’s work on gene expression changes related to alcohol 
consumption. Rank and p-value represent the represent the relative order of the gene on gene 
of interest, and all p-values indicate that each gene is significantly associated with the 











3b. Confirmation and testing of roles for genes in ethanol sedation 
 
 To confirm that neuronal expression of RNAi targeting Mef2 makes flies resistant to 
ethanol sedation as the Grotewiel laboratory previously reported (Schmitt et. al 2019), I 
assessed ethanol sedation in flies with the elav-Gal4 (pan-neuronal driver) expressing a 
validated RNAi transgene against Mef2 (v15550). Expression of v15550 in neurons (elav-
Gal4/+;v15550/+) increased ST50 values compared to both controls (elav-Gal4/+ and v15550/+; 
Figure 2A). Knockdown of Mef2 in neurons therefore made flies resistant to ethanol sedation in 
my studies as previously reported by the Grotewiel laboratory (Schmitt et. al 2019). 
 To test the role of the 6 candidate genes (Table 5) in ethanol sedation, we expressed 
RNAi transgenes targeting each of the genes in neurons via elav-Gal4 with the same overall 
approach as used for Mef2 (Figure 2A). Expression of spin RNAi (elav-GAL4/+;JF02782/+) 
increased ST50 compared to both the elav-GAL4/+ and JF02782/+ controls (Figure 2B). My 
data on spin JF02782 RNAi confirm those of Katlyn Myer (Myers and Grotewiel, unpublished). 
Furthermore, Katlyn also found that transposon insertions in the spin locus increased ST50 
values. Together, data from my and Katlyn’s studies strongly suggest that spin influences 
ethanol sedation in flies. 
 Regarding the other 5 candidate genes (Table 5), expression of the unc79 v45780 RNAi 
transgene (elav-GAL4+/v45780/+) significantly increased ST50 compared to the elav-GAL4 
control, but not the v45780/+ control (Figure 3A). Neuronal expression of the KK102682 RNAi 
transgene (elav-GAL4+/KK102682/+) increased ST50 compared to both the elav-GAL4/+ and 
KK102682/+ controls (Figure 3B). The standard ethanol sedation protocol used for the studies 
in Figures 3A and 3B in the Grotewiel laboratory exposes flies to vapor from 85% ethanol. To 
explore the possibility that the effect of expressing unc79 RNAi might depend on the 
concentration of ethanol used, these experiments were repeated using vapor from 65% ethanol. 
At this lower concentration of ethanol, expression of both RNAi transgenes (v45780 and 
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KK102682) significantly increased resistance compared to both controls (Figures 3C and 3D). 
Expression of another unc79 RNAi transgene (elav-GAL4/+;HMC03213/+) was lethal. Taken 
together, these experiments show that unc79 may influence ethanol sedation, as multiple RNAi 
transgenes against the gene result in significant increases in ST50.  
 Experiments with RNAi transgenes targeting the remaining four genes were less 
informative. Expression of a Bx RNAi transgene (elav-GAL4/+;JF03390/+) and a CtBP RNAi 
transgene (elav-GAL4/+;JF01291/+) did not significantly increase resistance or sensitivity to 
ethanol compared to the respective controls (Figures 4 and 5). Expression of other Bx (elav-
GAL4/+;KK108513/+, elav-GAL4/+;GL00484/+) and CtBP RNAi transgenes (elav-
GAL4/+;KK108401/+, elav-GAL4/+;HMS00677/+) were lethal. Expression of the v8393 Fas2 
RNAi (elav-GAL4/+;v8393/+) significantly increased resistance compared to both controls 
(Figure 6A). Expression of four other Fas2 RNAi’s, (elav-GAL4/+;v36350/+; elav-
GAL4/+;v8392/+; elav-GAL4/+;HMS01098/+ and elav-GAL4/+;JF02918/+) significantly changed 
ST50 values compared to one control (Figures 6B, 6C, 6D, 6E), but the direction of the change 
(resistance vs. sensitivity) was not consistent. Expression of another Fas2 RNAi transgene, 
v36351 (elav-GAL4/+;v36351/+) did not produce any significant changes (Figure 6F) and the 
KK100888 transgene (elav-GAL4/+;KK100888/+) was lethal. Expression of the for RNAi 
transgenes v38319 and GL00026 (elav-GAL4/+;v38319/+ and elav-GAL4/+;GL00026/+) 
significantly increased resistance compared to one control group (Figure 7A, D), whereas 
expression of two other for RNAi transgenes JF01449 and KK101298 (elav-GAL4/+;JF01449/+ 
and elav-GAL4/+;KK101298/+) did not produce significant changes (Figure 7B, C). Expression 
of another for RNAi transgene, HMS04486 (elav-GAL4/+;HMS04486/+) was lethal. Overall, my 
data on Bx, CtBP, Fas2 and for did not support the hypothesis that these genes function in 





 spin, unc79, Bx, CtBP, Fas2 and for are all Mef2-bound genes that were previously 
shown to influence ethanol behaviors in flies or (via orthologs) worms and have human 
orthologs that were associated with externalizing behavior. They were therefore lead candidates 
for influencing ethanol sedation by functioning downstream of Mef2. Expression of RNAi 
transgenes targeting spin and unc79 (Figure 2 and Figure 3) consistently changed ST50 values 
compared to RNAi and elav-Gal4 controls. All viable RNAi transgenes against unc79 produced 
an effect in the same direction and at two concentrations, though the v45780 (elav-
GAL4/+;v45780+) was significantly different from both control genotypes only when using vapor 
from 65% ethanol. These results implicate spin and unc79 in ethanol sedation and also raise the 
possibility that ethanol sedation (assessed in Drosophila) and externalizing behavior (assessed 
in humans) might be driven or influenced by shared genetic mechanisms as similarly suggested 
by studies in worms and humans (Mathies et. al 2017). 
Expression of neuronal RNAi targeting the other candidate genes did not consistently 
impact ST50. This lack of effect could be explained by several possibilities including (i) the 
genes do not affect ethanol sedation by functioning in neurons, (ii) the RNAi transgenes did not 
sufficiently knockdown expression of their target genes or (iii), that lethality associated with 
constitutive, pan-neuronal expression RNAi transgenes is preventing us from observing the 
phenotype. To better understand the potential role of these genes in ethanol sedation, future 
studies could include expression of the transgene only in adulthood or with a different GAL4 
driver that would express the transgene in select neurons, rather than pan-neuronally, thereby 
circumventing lethality associated with elav-Gal4 pan-neuronal expression. Additionally, genetic 
manipulation of the genes via mutations, overexpression or expression of dominant negatives 






































Figure 2. Confirmation that expression of Mef2 and spin RNAi in neurons increases ST50 
values. Data presented are ST50 values of flies with pan-neuronal expression of (A) Mef2 (elaV-
Gal4;v15550) and (B) spin (elaV-Gal4;JF02782) RNAi along with their respective controls 
(v15550/+, JF02782/+ and elaV-Gal4/+) exposed to vapor from 85% ethanol. Overall, genotype 
significantly affected ST50 (individual one-way ANOVAs, p<0.0001 for both panels, n=8). 
Expression of the Mef2 (elaV-Gal4;v15550) and spin (elaV-Gal4;JF02782) RNAi transgenes 
increased ST50 compared to their respective controls. (Bonferroni’s multiple comparisons, lines 
indicate pairwise comparisons with resulting p values above each line). 
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Figure 3. ST50 values of flies with pan-neuronal expression of unc79 RNAi exposed to vapor 
from 85% (A, B) or 65% (C, D) ethanol. Data presented show RNAi expressing (A, C: elaV-
Gal4;v45780; B, D: elaV-Gal4;KK102682) flies and their respective controls (v45780/+, 
KK102682/+ and elaV-Gal4/+). Genotype significantly affected ST50 values in all studies 
(individual one-way ANOVAs: A, p=0.0332, n=16; B, p<0.0001, n=16; C, p<0.0001, n=8; D, 
p<0.0001, n=8). ST50 values in RNAi expressing groups were significantly higher than both 
controls for all planned comparisons except for elaV-Gal4;v45780 vs 45780/+ in panel A. 
(Bonferroni’s multiple comparisons, lines indicate pairwise comparisons with resulting p values 



















Figure 4. ST50 values of flies with pan-neuronal Bx RNAi (elaV-Gal4;JF03390) and controls 
(JF03390/+, elaV-Gal4/+) exposed to vapor from 85% ethanol. Genotype did not significantly 























Figure 5. ST50 values of flies with pan-neuronal expression of CtBP RNAi (elaV-Gal4;JF01291) 
and controls (JF01291/+, elaV-Gal4/+) exposed to vapor from 85% ethanol. Genotype did not 











Figure 6. ST50 values of flies with pan-neuronal expression of Fas2 RNAi (A, elav-Gal4;v8393; 
B, elav-Gal4;v36350; C, elav-Gal4;8392; D, elav-Gal4;HMS01098; E, elav-Gal4;JF02918; F, 
elav-Gal4;v36351) and their respective controls (v8393/+, v36350/+, v8392/+, HMS01098/+, 
JF02918/+, v36351/+ and elav-Gal4/+) exposed to vapor from 85% ethanol. Overall, genotype 
significantly affected ST50 in all studies except those in panel F (individual one-way ANOVAs; 
A, p<0.0001; B, p=0.0023; C, p=0.0002; D, p=0.0304; E, p=0.0073; F, p=0.1256; n=8). ST50 in 
flies expressing RNAi were different than both controls in panel A, and different than one control 
in panels B, C, D and E (Bonferroni’s multiple comparisons, lines indicate pairwise comparisons 




Figure 7. ST50 values of flies with pan-neuronal expression of For RNAi (A, elaV-Gal4;v38319; 
B, elaV-Gal4;KK101298; C, elaV-Gal4;JF01449; D, elaV-Gal4;GL00026) and their respective 
controls (v38319/+, KK101298/+, JF01449/+, GL00026/+ and elaV-Gal4/+) exposed to vapor 
from 85% ethanol. Overall, genotype significantly affected ST50 in all studies (individual one-
way ANOVAs; A, p=0.0126; B, p=0.0474; C, p=0.0378; D, p=0.0013; n=8). Pan-neuronal 
expression of (A) v38319 (elaV-Gal4;v38319) increased ST50 compared to both controls, 
whereas expression of (D) GL00026 (elaV-Gal4;GL00026) RNAi increased ST50 compared to 
only a single control. Expression of the KK010298 (C) and JF01449 (D) transgenes did not 
significantly change ST50 relative to either controls (Bonferroni’s multiple comparisons, lines 




CHAPTER 3: IDENTIFICATION OF MEF2-DEPENDENT GENE EXPRESSION CHANGES 
1. Introduction and Rationale 
 Identifying gene expression changes in response to Mef2 knockdown can help us begin 
to explore and understand mechanisms pertaining to ethanol sedation. To get a picture of global 
gene expression changes that result from Mef2 knockdown, we performed an RNA-seq 
experiment comparing gene expression levels in three groups: elav-gal4/v15550/+ Mef2 
knockdown (hereafter KD), an elav-GAL4/+ control (hereafter Gal4) and a v15550/+ RNAi 
control (hereafter RNAi). Specific questions we addressed are: 
- Are any of our six previously identified genes of interest (detailed in Chapter 2) regulated 
by Mef2? 
- Are any of the 342 genes that bind Mef2 (Sivachenko et. al 2013) regulated by Mef2? 
- Are any known fly or worm alcohol genes (reviewed in Grotewiel & Bettinger 2015) 
regulated by Mef2? 
- Are fly orthologs of previously identified genes implicated in human SRE (Schmitt 2019) 
regulated by Mef2? 
- Are fly orthologs of genes implicated in human externalizing behaviors (Dick 2020, 
personal communication; Linnér et. al 2020) regulated by Mef2? 
- What gene ontology terms are over-represented in the Mef2-dependent differentially 
expressed genes? 
We hypothesized that knockdown of Mef2 would result in expression changes in genes 
represented by each of these lists. Additionally, we hypothesized that gene ontology analysis 
would reveal biological processes in which the Mef2-dependent differentially expressed genes 
function. Together, we predicted that this study would mechanistically connect Mef2 with genes 
previously implicated in alcohol-related behavior and relevant biological processes. 
 
2. Materials and Methods 
48 
 
2a. Drosophila husbandry 
 Flies were grown under the same conditions described in Chapter 2. Each week, three 
crosses were set up in parallel: elav-GAL4 virgin females were crossed to v15550 (Mef2 RNAi) 
males to express the Mef2 RNAi pan-neuronally (hereafter KD for knock-down), w[A] virgin 
females were crossed to v15550 RNAi males to generate the RNAi controls (hereafter RNAi), 
and elav-GAL4 virgin females were crossed to w[VDRC] males to generate the elav-Gal4 
controls (hereafter Gal4). All progeny were in a uniform F1 hybrid genetic background of 50% 
w[A] and 50% w[VDRC].  
At one to three days of adulthood, approximately 350 female flies of each genotype were 
collected under brief CO2 anesthesia. Flies were collected in a rotating manner in regard to 
genotype. As an illustration, in collection one, KD flies were collected first, then RNAi flies, 
followed by Gal4 flies. In collection two, RNAi flies were collected first, then Gal4 flies and 
subsequently, KD flies. The order of genotypes collected from each subsequent round of 
crosses was similarly rotated to avoid batch effects. Flies were collected under CO2 and 
immediately transferred to a 50 mL conical tube on water ice. The tube was labelled with the 
genotype and number of flies collected, and quickly transferred to a -80˚C freezer. Flies were on 
water ice for a maximum of two minutes before being transferred to the freezer. The process 
was repeated with the next genotype of that week’s collection, and so on. After one bottle of 
females was collected of all three genotypes, the cycle was repeated, beginning with the first 
genotype and working through that week’s order of collections until approximately 350 flies of 
each genotype were collected per cross. This was repeated weekly until six collections were 
obtained. 
 
2b. Isolation of fly heads 
 Heads were isolated in batches from approximately 250 frozen flies of each genotype. 
Liquid nitrogen and dry ice were collected in a dewar and styrofoam box, respectively, from the 
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Sanger Hall supply center. Head preps were performed in the same rotating order as the fly 
collections outlined in the previous section. All head collections were performed at 4˚C. 
Holes were punched through the lid of a 50 mL conical tube using a heated 18-gauge 
needle. The tubes of flies of the first genotype were removed from the -80˚C freezer, kept on dry 
ice and filled with approximately 35 mL of liquid nitrogen. The cap with holes was screwed on 
and the tube was vortexed for approximately one minute or until all the liquid nitrogen 
dissipated. This was repeated, filling the tube with about 25 mL of liquid nitrogen for a second 
round of vortexing. Vortexing flies in liquid nitrogen causes heads, wings, legs, abdomens and 
thoraxes to break apart. 
A sieve was used to separate the bodies of the flies from the heads. Prior to adding flies 
to the sieve, it was confirmed that the layers of the sieve were in the correct order and liquid 
nitrogen was slowly poured into the sieve to ensure it was cold enough to prevent flies from 
sticking to it. Flies were added to the top layer of the sieve and the sieve was repeatedly struck 
laterally with forceps for at least three minutes to help move the fly body parts to various levels 
of the sieve. Heads, representing the smallest body parts, were collected in the bottom vessel of 
the sieve. 
Collected heads were transferred into labelled 1.7 mL snap-cap tubes and kept on dry 
ice, then quickly transferred to a -80˚C freezer. The bodies of the flies were quickly examined 
under the microscope to ensure that heads were actually separated from other body parts. The 
sieve was cleaned and dried and the process was repeated with the next two genotypes in the 
order determined for that week. Throughout the head isolations, protective gear such as safety 
glasses, a lab coat and cryo-gloves were worn. This procedure was repeated for all six 
collections. The full protocol is in the Appendix. 
 
2c. Preparation of RNA 
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 Prior to beginning RNA preps, the lab bench, pipettes, pipette boxes and anything else 
on the lab bench were wiped down thoroughly with 100% ethanol. Plastic pestles were placed 
into a 50 mL conical tube and covered with chloroform (to inactivate RNAses) under the fume 
hood. After soaking for 20 minutes, the pestles were transferred to a new tube and allowed to 
dry for another 20 minutes. 
 Total RNA was isolated using a combination of a previously published protocol (Weston 
et. al 2021; Lee et. al 2021) and Qiagen reagents. Tubes of fly heads were retrieved from the 
80˚C freezer and immediately placed on ice. For the rest of the RNA extraction protocol, 
samples were processed in a rotating order in regard to genotype, as described in previous 
sections. A chloroform-soaked pestle was properly secured to an electric drill. 50 µL of Trizol 
(ThermoFisher Scientific) was very slowly added to the first tube of heads and homogenized 
with the drill for 30 s. Another 200 µL of Trizol was added to the same vial, and the flies were 
again homogenized for 90 s. This was repeated with all remaining genotypes. 100 µL of 
chloroform was added to each vial. Vials were then vortexed for 15 seconds and incubated at 
room temperature for 3 minutes. Samples were taken to the cold room and centrifuged at 
14,000 x g for 15 minutes. After centrifugation, new vials were labelled for each genotype and 
the upper aqueous layer was transferred to the appropriate new vial, taking care not to pipette 
any fly parts or other layers. Qiagen RNeasy Mini Kit and on-column DNase digestion protocols 
were performed per the manufacturer’s instructions (Qiagen), with a final elution in 60 µl of 
RNase free water. Eluted RNA samples were stored at -80˚C until being sent for sequencing. 
The full protocols are in the Appendix. 
 
2d. Initial RNA quality assessments 
 Concentration and initial quality assessments were performed by taking absorbance 
readings of 1:20 dilutions of each sample at 260 nm and 280 nm using a Pharmacia Biotech 
Ultraspec 2000 spectrophotometer. From these values, RNA concentration and the A260/A80 
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ratio were calculated. Generally, an A260/280 ratio of between ~1.8 - 2.1 is indicative of purified 
RNA (ThermoFisher Scientific 2012). 
 1:20 dilutions of all samples were also run on the Agilent Bioanalyzer as an additional 
measure of concentration and to assess RNA quality (performed by Sati Afshari in Dr. Babette 
Fuss’ laboratory, Virginia Commonwealth University). The Bioanalyzer calculates an RNA 
integrity (RIN score) from peaks at 28s and 18s ribosomal RNA (rRNA) for mammalian samples; 
however, fly RNA has a double peak at 18s, precluding the calculation of a reliable RNA 
integrity number (RIN). Therefore, I assigned grades (A, B, C, etc.) to each trace from the 
Bioanalyzer based on visual inspection noting subjective interpretations of peaks beyond the 
28s and 18s peaks (which if present, would indicate degradation). Samples that appeared to 
have higher degradation were assigned lower scores, and those with decreased degradation 
received higher grades. The five sets of three samples each that overall received the best 
grades were ultimately sent for sequencing by GeneWiz. The remaining three RNA samples 
were not analyzed further. 
 
2e. RNA-sequencing and related analyses performed by GeneWiz 
 GeneWiz guidelines recommended sending at least 2 µg of RNA at a minimum 
concentration of 50 ng/µl per sample. The amount of RNA to send was calculated per sample. 
For all samples, at least 1.5 times, and whenever possible, double the amount of sample 
required was sent. Each sample vial was labelled, sealed and packaged in dry ice in a 
Styrofoam box. The package was overnighted to GeneWiz’ facilities in South Plainfield, NJ for 
standard RNA-seq analysis. 
 GeneWiz performed their standard bioinformatic analysis as part of the RNA sequencing 
package. Their overall workflow consisted of assessing RNA integrity, generating cDNA libraries 
from my RNA samples, sequencing the cDNAs on a single lane of an Illumina Hi-Seq machine 
with 150 base paired-end reads, evaluating sequence quality, trimming reads, mapping reads to 
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the BDGP6 version of the fly genome, generating hit counts for genes and exons, comparing 
counts to assess read depth and differentially expressed genes and analyzing initial gene 
ontology as outlined in Figure 1. GeneWiz also performed initial differential gene expression 
analyses with a two-fold cut-off, but we did not use these analyses and instead performed our 
own differentially expressed gene analysis using iDEP as described below. 
 
2f. Identification of differentially expressed genes and related analyses using iDEP 
 iDEP9.2 (integrated Differential Expression and Pathway analysis version 9.2) is a web-
based tool for exploratory data analysis that integrates R/Bioconductor packages frequently 
used for RNA-seq analysis, such as DESeq2, to analyze RNA-seq data. It is available at 
http://ge-lab.org/idep/. Users are able to upload gene expression data and the tool allows 
detection of differentially expressed genes (DEGs), creation of Venn diagrams to visualize the 
overlap of DEGs, perform principal component analyses (PCA), identify gene ontology terms 
and perform pathway analysis. 
 We uploaded raw read counts received from GeneWiz into iDEP and set the species to 
Drosophila melanogaster. In the pre-processing stage, iDEP allows users to filter out genes that 
have extremely low read counts (less than 0.5 counts per million). iDEP transforms the data for 
downstream clustering and PCA analysis. We selected to transform the data using the edgeR 
package. Using the “plot gene” function of iDEP’s pre-processing stage, we plotted levels of 
specific genes of interest, such as the white marker gene and Mef2.  
 Next, we used iDEP to perform principal component analyses. We assessed all possible 
pairwise combinations of principal components 1-5. We also used iDEP to view differentially 
expressed genes using the website’s “DEG1” tab. We set the method to identify differentially 
expressed genes to the R/Bioconductor DESeq2 package, the false discovery rate (FDR) to 0.1 
and the fold change to 1. This identifies all differentially expressed genes with an adjusted FDR 
less than or equal to 0.1 regardless of the fold-expression level. We also generated Venn 
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diagrams of all DEGs, and then specifically of up- and down-regulated DEGs by using the “Venn 
diagram” tab. On this tab, we also downloaded gene lists of the differentially expressed genes to 
later filter in MS Excel to understand overlaps between the DEGs and other biologically relevant 
gene sets. 
 
2g. Analysis of overlapping genes 
 We used the conditional formatting tool in Microsoft Excel (version 1808, Redmond, WA, 
USA) to determine the overlap between DEGs identified by our analyses in iDEP and other 
biologically relevant gene sets. Fisher’s exact test (R Studio Version 1.4.1717) was used to 
assess whether the amount of overlap we observed between our DEGs and other gene lists 
was significantly different than that expected by chance. The R script used was provided by Dr. 
Michael Miles and Maren Smith (provided in the appendix). P values ≤ 0.05 were considered 
significant. 
 
2h. Gene Ontology (GO) 
 DAVID (Database for Annotation, Visualization and Integrated Discovery version 6.8, 
https://david.ncifcrf.gov/) was used for gene ontology (GO) analyses. Using the functional 
annotation tool, we uploaded our list of DEGs into DAVID and set the species to Drosophila 
melanogaster. In the annotation summary results, we looked at the Biological Process 
(GOTERM_BP_DIRECT), Cellular Component (GOTERM_CC_DIRECT) and Molecular 
function (GOTERM_MF_DIRECT) tabs to understand the various gene ontology terms tagged 
and the genes associated with each one. Additionally, we used the “functional annotation 
clustering” selection for a combined view. Each GO term, the category it was associated with, 
the genes involved, the percentage of genes involved in the GO term compared to the full list of 













3. Results & Discussion 
3a. Rationale and overall experimental design 
Mef2 is a transcription factor (Black & Olson 1998; Taylor & Hughes 2017) that regulates 
ethanol sedation behaviors (Schmitt et. al 2019; Adhikari et. al 2018). Mef2 binds 342 genes in 
flies (Sivachenko et. al 2013) and Hr38, a gene downstream of Mef2, influences ethanol 
preference and tolerance (Adhikari et. al 2018). Thus, we were interested in identifying other 
genes downstream of Mef2, as these genes may also play a role in ethanol-related behaviors, 
specifically sedation. Additionally, we hoped to understand the relationship between Mef2 and 
individual, previously identified genes connected to ethanol-related behaviors. We hypothesized 
that an RNA-seq study would both identify genes that were differentially expressed upon Mef2 
knockdown and elaborate on the direction by which Mef2 regulates its downstream genes. 
 We had three groups of flies in this experiment, as described in the Methods section of 
this chapter. The KD group had an RNAi transgene against Mef2 expressed pan-neuronally, 
and the elav-Gal4 (Gal4) and RNAi groups served as our two controls. As Mef2 was knocked 
down pan-neuronally, we used fly heads as the starting material for RNA isolations. After 
preparing RNA, it was sent for sequencing and the RNA-seq data we received are the basis of 
the analyses described in this chapter.      
 
3b. RNA & RNA-seq Quality Control Assessments  
RNA preps were performed in six sets of three samples each. Each set consisted of one 
sample of each genotype, and absorbance measurements of 1:20 dilutions of each sample 
were taken at 260 and 280 nm (A260, A280) to estimate concentration and purity (Koetsier et. al 
2019). Pure RNA has an A260/A280 ratio of 2.1; a decreased ratio corresponds to protein 
contamination (Koetsier et. al 2019). My RNA samples had A260/A280 ratios of 1.85-2.29 and 




 1:10 dilutions of each sample were analyzed on Dr. Babette Fuss’ lab’s Agilent 
Bioanalyzer machine. The Agilent 2100 Bioanalyzer system is an automated, microfluidic chip-
based electrophoresis machine that has utility in measuring RNA quality for downstream 
applications (Agilent 2020), in our case, RNA-seq. The machine works by measuring the quality 
of ribosomal RNA to generate an RNA integrity (RIN) score. RIN scores are an indicator of 
sample integrity, which has significant implications on downstream applications (Agilent 2020). 
However, the 18S and 28S eukaryotic RNA ribosomal peaks the machine uses to calculate the 
RIN score are not consistent with insect RNA, which has a double peak at 18s, rendering it 
impossible for the BioAnalyzer to generate reliable RIN scores. Therefore, I visually inspected 
each Bioanalyzer sample trace and assigned each a relative grade (A, B, C, etc.) based on the 
perceived amount of degradation as indicated by peaks beyond the 18s and 28s rRNA peaks. 
Figure 2 shows each trace, while Table 1, column 7 shows the grades assigned. Ultimately, the 
five sets of three samples with the best grades (outlined in black boxes in Table 1) were sent for 














Grade RIN DV200 Quality 
score 
1 KD 0.325 0.165 1.97 260.0 C n/a n/a n/a 
2 RNAi 0.351 0.172 2.04 280.8 B n/a n/a n/a 
3 Gal4 0.378 0.182 2.08 302.4 B n/a n/a n/a 
4 KD 0.625 0.292 2.14 500.0 B+ 9.7 94.69 35.71 
5 RNAi 0.162 0.075 2.16 129.6 B+ 9.8 93.27 35.69 
6 Gal4 0.595 0.280 2.13 476.0 A 10.0 94.27 35.75 
7 KD 0.403 0.198 2.04 322.4 A 10.0 93.01 35.73 
8 RNAi 0.134 0.068 1.97 107.2 A 10.0 92.19 35.70 
9 Gal4 0.072 0.039 1.85 57.6 A 9.6 92.36 35.70 
10 KD 0.917 0.421 2.18 733.6 A- 10.0 94.67 35.73 
11 RNAi 0.344 0.177 1.94 275.2 A- 10.0 94.07 35.75 
12 Gal4 0.664 0.314 2.11 531.2 B+ 9.9 92.92 35.76 
13 KD 0.169 0.089 1.90 135.2 B 9.4 92.45 35.77 
14 RNAi 0.060 0.032 1.88 48.0 B 9.4 83.36 35.75 
15 Gal4 0.160 0.060 2.67 128.0 A 10.0 93.37 35.78 
16 KD 0.204 0.089 2.29 163.2 B+ 9.8 91.04 35.76 
17 RNAi 0.102 0.047 2.17 81.6 A 10.0 94.03 35.76 
18 Gal4 0.196 0.090 2.18 156.8 B+ 10.0 94.94 35.75 
 
Table 1. RNA sample number and sample genotypes are shown in columns 1 and 2, 
respectively. Absorbance values at 260 nm, 280 nm, and the ratio between these values (for 
1:20 dilutions) are shown in columns 3-5. RNA concentrations based on the A260 values are in 
column 6. Quality grades based on visual assessments of chromatograms in Figure 2 are 



















































Figure 2. Bioanalyzer traces for each RNA sample. Qualitative grades were assigned to each 
sample (Table 1, column 7) based on the amount of degradation evidenced by peaks to the left 
























RNA quality control data (RIN and DV200 values) were also provided by GeneWiz 
(Table 1, columns 8-9). These were determined through the Agilent TapeStation system. Like 
the Bioanalyzer, this is an automated electrophoresis machine that is used for determining 
nucleic acid size, concentration and integrity (Graf 2017). GeneWiz provided chromatogram 
outputs generated via TapeStation and corresponding RIN scores for each sample (Figure 3). 
Chromatograms are generally consistent, with the largest peaks at the lower end and 18S. 
Visually, samples with increased noise in the areas between the lower and 18S peaks (such as 
Figure 3, samples 1 and 6) or smaller 18S peaks (such as Figure 3, samples 10 and 11) tended 
to have relatively lower RIN scores. Sample 7 is noticeably different from the rest of the samples 
in that there was an additional peak at 28S and more degradation than other samples. However, 
the GeneWiz RIN is 10.0 for this sample, and representatives from GeneWiz confirmed the 
accuracy of the score. Overall, all RNA samples had RINs (Table 1, column 8) that were well 
above GeneWiz’s recommended minimum suggestion of 7 for samples to be sequenced. 
To address the accuracy of my grading system, I plotted my grades against the 
respective RIN values provided by GeneWiz. My grades generally corresponded to the RIN 
values, and were very strongly correlated with the RIN values (Figure 4). We therefore feel 
confident that visual grading can be a useful method of analyzing Bioanalyzer traces for 
Drosophila RNA (Figure 2) and (of the 18 RNA samples prepared) that we selected the 15 
samples of the highest quality (Table 1). 
Another indicator of RNA sample quality is DV200, or percentage of RNA fragments 
longer than 200 nucleotides. Like sample integrity, fragment size is an important contributor to 
good library yield and sequencing downstream (Graf 2017). Samples with a DV200 less than 
30% are not recommended for downstream applications (Illumina 2016). All of our samples had 
DV200 values much higher than this minimum threshold, with our lowest DV200 value being 
83.36 (Table 1, column 9). Taken together, my subjective grades coupled with the more formal 
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DV200 and RIN scores from GeneWiz indicate our RNA samples were appropriate for library 
preparation and sequencing. 
 Differences in sequencing depth can affect downstream analyses. Data provided by 
GeneWiz (Figure 5) show that across all samples and genotypes, RNA-seq read counts from 
our RNA samples were consistent. Quality scores from sequencing ranged from 35.69 - 35.77. 
Quality score is defined by the formula: Q = -10log10(e), where e is the estimated probability of 
the base call being incorrect (Illumina 2016). Higher scores are indicative of high quality, 
whereas lower scores are associated with increased rates of false positives and potentially 
unusable data. Quality scores above 30 indicate a 1 in 1000 chance of a base being called 
incorrectly and correspondingly, a base call accuracy of 99.9% (Illumina 2016). As all our 
samples had Q scores well above 30 (Table 1, column 10), we are confident that the 
sequencing is accurate. Additionally, representatives from GeneWiz confirmed that libraries 
were generated together and all samples were run on the same lane of the same sequencing 
machine at the same time to avoid batch effects. 
 Together, the data in Table 1 and Figures 2-5 indicate that the RNA samples sent for 
sequencing were of high quality and that the sequencing itself was of high quality, supporting 









































Figure 3. TapeStation chromatogram traces and RIN scores provided by GeneWiz. Generally, 
samples with increased noise between lower and 18S peaks, or relatively smaller 18S peaks 






Figure 4. Relationship between the grades assigned to each sample and their RIN scores. RIN 
values correlated with grades (Spearman correlation, r=0.8238, p=0.005, n=15). Some X-Y 























Figure 5. Distribution of normalized read counts for all samples, generated by GeneWiz. Panels 
A, B and C show pairwise comparisons of read counts for KD//Gal4, KD//RNAi and Gal4//RNAi 








3c. Analysis of Mef2-dependent differentially expressed genes 
Principal component analysis (PCA) linearly transforms data (RNA-seq data for my 
project) to allow for visualization on a two-dimensional plane (GeneWiz). Each principal 
component accounts for an amount of variance, with principal component 1 accounting for the 
largest single factor for the variance, and each subsequent component accounting for less 
(GeneWiz). A priori, we expected to see each genotype cluster separately from the other two. 
The PCA analysis of the first two components of the RNA-seq data did not show a clean 
clustering or segregation of the three genotypes (Figure 6A). To determine whether additional 
principal components might provide cleaner clustering patterns, we generated PCA plots with all 
possible combinations of principal components 1-5 using iDEP (Figure 6). No combination of 
principal components 1-5 produced obvious clustering of genotypes (Figure 6), suggesting there 
might not be large-scale, consistent patterns of differential gene expression across the three 
genotypes. As part of their analyses, GeneWiz provided a heatmap of the top 30 DEGs 
(identified by p-value) between the KD and Gal4 groups (Figure 7). The expression levels of 
these genes in each genotype were very similar, suggesting that these two samples did not 
have large scale differences in the most significantly differentially expressed genes. 
Given that the PCA (Figure 6) and heatmap data (Figure 7) were not consistent with 
large-scale, substantive changes in Mef2 expression in knockdown animals, we explored 
whether sample mishandling at some point in the workflow could have occurred. We addressed 
this possibility by examining the expression of the white gene. white is a marker for the RNAi 
and Gal4 transgenes that we expected to be expressed at a molecular level corresponding to 
the observable eye pigmentation phenotype regulated by the white gene. Of the three 
genotypes in our study, RNAi flies have the least eye pigmentation, Gal4 flies have an 
intermediate level of eye pigmentation, and KD flies (because they harbor both the RNAi and 
Gal4 transgenes) have the strongest eye pigmentation. Reassuringly, levels of white were 
lowest in RNAi flies, intermediate in Gal4 flies, and highest in KD flies (Figure 8). This pattern of 
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expression level is evident in the mean raw counts as well as the raw counts from individual 
samples (Figure 8), fully consistent with the recorded genotypes used to generate RNA samples 
and the RNA-seq data. Additionally, Mef2 expression was slightly decreased in the KD 
compared to the two control groups, although this was significantly different only relative to the 
RNAi control (Figure 8B). Given that expression of this same Mef2 RNAi transgene in neurons 
using the same elav-Gal4 driver decreases expression of Mef2 protein in the central fly brain 
(Schmitt et. al 2019), we believe that the marginal knockdown of Mef2 observed in our RNA-seq 
study is likely due to endogenous expression of Mef2 in other head tissues including head 
muscle (Velasco et. al 2006) contributing to the overall Mef2 read counts. Importantly, the white 
and Mef2 expression levels from the RNA-seq data strongly indicate that no sample 
mishandling or mislabeling occurred that could explain the somewhat unexpected similarities in 
gene expression in our three genotypes.  
In many transcriptomics studies, including those from flies using Gal4 to express RNAi 
transgenes (e.g. Nitta 2017, Picchio 2013, Zeng 2018), differentially expressed genes (DEGs) 
are defined relative to a single Gal4 control. The standard design of experiments using Gal4 to 
drive transgene expression (like our study), however, has two control genotypes, one for the 
Gal4 driver alone and another for the RNAi transgene alone. We therefore identified and 
analyzed Mef2-dependent DEGs using two approaches. In the first approach, we defined DEGs 
relative to the Gal4 control alone. In the second approach, we defined DEGs as being 
consistently changed relative to both the Gal4 alone and the RNAi alone. Additionally, we 
tabulated DEGs between the Gal4 and RNAi controls themselves. 
Using a false discovery rate of 0.1 (Ge et. al 2018) and allowing for any level of fold-
change, we found 172 DEGs in KD vs Gal4 fly head RNA samples (Figure 9, Table 2). This 
KD//Gal4 set of DEGs was of principal interest and was further analyzed below. Unexpectedly, 
we found that the number of DEGs (1,063) was considerably greater in KD//RNAi fly heads, and 
was even greater (2,238) in Gal4//RNAi (Figure 9). The overlap between these three sets of 
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DEGs followed a pattern generally consistent with their sizes (Figure 10). There were 51 genes 
common to the 172 KD//Gal4 and 1,063 KD//RNAi DEGs. These 51 KD//Gal4//RNAi DEGs are 
differentially expressed in KD compared to both controls, also warranting their further analysis 
below. 
Although we do not understand why the greatest number of DEGs was found between 
the two control genotypes, this relatively large number of DEGs is not related to differences in 
genetic background (both controls are in the same F1 hybrid genetic background), RNA sample 
or sequence quality (Table 1, Figures 2 and 3), batch effects due to the order of sample 
preparation or sequencing (see earlier descriptions of experimental design), or sample 
misidentification (Figures 8A, 8B). Additionally, this relatively large number of DEGs does not 
appear to have a major effect on ethanol sedation (Chapter 2, Figure 2A). It is possible that the 
large gene expression differences between controls is driven by the insertion of the v15550 
RNAi transposon. However, if that were the case, we would also expect to observe these DEGs 
in the KD//Gal4 group, which we largely do not. Given that we frankly do not have a satisfactory 
explanation for this large set of DEGs at this time and that this set of DEGs does not seem to be 








   
 
    
Figure 6. PCA plots showing all combinations of two PCAs for the first 5 components.  
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Figure 7. Clustering heatmap provided by GeneWiz to show the similarity between the top 30 
DEGs (sorted by p value) between the KD//Gal4. Samples 1, 4, 7, 10 and 13 (light blue cluster) 
are the KD group and samples 3, 6, 9, 12 and 15 (dark blue cluster) are the Gal4 group. The 













Figure 8. Raw read counts of the white (Panel A), Mef2 (Panel B) genes across three 
genotypes. As expected, for the white gene (A), the KD group has highest counts, followed by 
the Gal4 group, and lastly, the RNAi group (one-way ANOVA p<0.0001) For Mef2 (B), the KD 
group did display decreased levels of gene expression, but was only statistically significant 
when compared to the Gal4 group (one-way ANOVA p=0.0335). (n=5 per genotype; 
Bonferroni’s multiple comparisons, lines indicate pairwise comparisons with resulting p values 


















Figure 10. Venn Diagram showing the overlap between all sets of DEGs with FDR of 0.1 and 









3d. Analysis of KD//Gal4 DEGs 
Of 172 KD vs Gal4 DEGs, 148 genes had detectable expression in high throughput 
studies of adult fly brains (FlyAtlas-RNA.adult, FB2021_03 and Table 2). Of these 148 genes, 
51 had moderate to high to very high expression and an additional 52 had lower, but detectable, 
expression in fly brains (Table 2). Eight-seven percent of the set of 172 DEGs is therefore 
known to be expressed in the fly brain, increasing our confidence that our overall experimental 
design identified potential molecular determinants of brain function and behavior. The 172 
DEGs were examined for enrichment for categories of the gene ontology terms Biological 
Processes, Cellular Components and Molecular Function (Table 3). However, among all 
categories, only the cellular adhesion term was significantly enriched, based on the Benjamini 
adjusted p-value (Table 3). The Benjamini-Hochberg Procedure is a form of multiple testing 
corrections to minimize false discovery (Huang et. al 2009). Additionally, the 172 DEGs 
represented four annotation clusters (Table 4). (Huang et. al 2009) The largest of these clusters 
contains terms for oxido-reduction processes, while the other clusters involve GTPase activity, 
extracellular matrix components, and splicesomes; however, the only significant term based on 
the Benjamini-Hochberg adjusted p-value is endoplasmic reticulum membrane (Table 4). We 
also performed functional annotation clustering, a measure of the extent of shared genes 
between annotations (Huang et. al 2009) All enriched GO terms and functional annotation 
clusters are included in Tables 3 and 4 for completeness. The set of 172 DEGs might be 




Gene Function Up- or 
down- 
regulated 
FDR Expressed in 
neurons? 
Actin 87E involved in cell motility and muscle contraction down 0.044 low (25.6) 
Amylase 
proximal 
dietary enzyme required to hydrolyze starch down 0.004 no data 
Cytochrome 
p450 6a2 
involved in breakdown of synthetic insecticides and insect 
hormone metabolism 
up 5.50E-55 low (47.7) 
Pka-C3 encodes a cAMP-dependent protein kinase down 0.000194 moderate 
(276.9) 
engrailed encodes a homeodomain-containing transcription factor needed 
to posterior compartment identity  
down 0.072957 low (14.5) 




encodes a tyrosine-protein kinase involved in formation of actin 
cables during embryogenesis 
down 0.000409 low (98.9) 
fushi tarazu predicted to play a role in specifying neuronal identity and known 
to be required in embryogenesis 




encodes a protein involved in determination of lifespan and 
response to heat shock and starvation 




involved in embryogenesis and normal nervous system 
development 
down 0.004864 moderate 
(421.7) 
knirps-like encodes a nuclear hormone receptor with C4 zinc finger motif and 
no ligand-binding domain 
down 0.054153 no expression 
(4.1) 






tumor suppressor involved in normal blood cell proliferation down 0.045032 no expression 
(4.6) 
CG2150 predicted to be a structural component of chitin-based cuticle and 
localize to the extracellular matrix 
down 0.041810 no expression 
(6.9) 
Punch isoforms are involved in eye pigment production and normal 
embryonic segmentation 
down 0.009554 moderate 
(119.6) 




encodes a protein that regulates normal tissue growth and 
development 
down 0.035028 very high 
(1042.5) 
raw encodes a membrane protein involved in dendritic patterning and 
localization of JNK signaling components 
down 0.006410 moderate 
(292.9) 
shotgun calcium-dependent cell adhesion protein and has roles in cell 
sorting, oogenesis and body asymmetry 
down 2.46E-31 no expression 
(9) 
scarlet encodes a protein component involved in transport of pigment 
precursor to pigment cells 




white ABC-type guanine transporter involved in transporting cyclic 
GMP, various amines and pigments 
up 4.06E-119 low (13) 
Cysteine string 
protein 
encodes a protein that is essential to maintaining synaptic 
function 
down 0.046875 very high 
(1093.9) 
Recombination 
repair protein 1 
involved in cellular response to oxidative stress via DNA repair 
mechanisms  










thought to be involved in GTPase activity down 0.027455 moderate 
(195.5) 
ALG3 predicted to be involved in regulating the tumor necrosis factor-
mediated signalling pathway  
up 0.002876 low (66.6) 
Heat shock 
protein 70Bb 
encodes a protein involved in heat shock and hypoxia response up 2.98E-45 no data 
Troponin C at 
41C 
encodes a protein that binds calcium and regulates muscle 
contraction 
down 0.000239 no expression 
(3.3) 
Rho-like involved in hemocyte maturation down 0.000138 low (72) 
Histone H3.3A variant histone that is enriched in active chromatin up 0.071674 high (636) 
cutlet thought to aid in DNA clamp loader activity and be a positive 
regulator of DNA polymerase activity 
down 2.49E-07 low (10.4) 
ɑ-Esterase-8 has carboxylesterase activity down 0.081458 low (84.3) 
Rab7 encodes a GTPase that is involved in regulation of vesicle 
trafficking 
down 0.006512 very high 
(1056.9) 
late bloomer facilitates synapse formation up 0.013701 low (30) 
Phm encodes a hydroxylating monooxygenase that is essential to 
neuropeptide biosynthesis 
down 0.012614 no data 
drongo thought to have GTPase activator activity and involvement in 
regulating GTPase activity 
down 0.001262 moderate 
(453.5) 
piopio encodes a zona pellucida domain protein that is involved in apical 
epithelial adhesion 
down 0.005852 no data 
Oxysterol 
binding protein 





encodes a protein involved in regulating alternative splicing, 
selecting a transcriptional start site and processing the 3’ end of 
mRNA 









encodes a growth inhibitor  down 0.042707 high (608.8) 











has proline-tRNA ligase and prolyl-tRNA aminoacylation activity up 0.077856 low (62.8) 
lilipod encodes a transmembrane protein that promotes ovarian stem 
cell maintenance 




encodes a dehydratase that is involved in catalyzing the hydration 
and dehydration of carbon dioxide 
down 2.25E-08 low (22.9) 
Sulfonylurea 
receptor 
predicted to encode an ATP-sensitive K[+] channel up 0.010093 low (24.2) 
Replication 
factor C 38kD 
subunit 
predicted to be involved in DNA clamp loading and DNA repair up 0.000214 low (79.7) 
CG3823 thought to have phosphatidylinositol biphosphate binding activity up 0.074056 low (7.3) 
CG4615 predicted to be involved in cytolysis down 2.11E-11 moderate 
(301.9) 
CG1636 known to be expressed in the adult head down 0.015781 moderate 
(165.5) 
CG8034 predicted to be involved in monocarboxylic acid transport and 
have monocarboxylic acid transmembrane transporter activity 




thought be involved in smell perception and have odorant binding 
activity 
down 0.062071 no expression 
(6.1) 
galectin encodes a galactoside binding protein with involvement in target 
recognition 
up 0.050380 moderate 
(853.7) 
CG3345 expressed in spermatozoa up 0.045032 low (14.9) 
CG4213 known to expressed in the embryonic brain down 0.042814 no expression 
(2.4) 
CG14340 thought to be involved in vesicle-mediated transport down 0.006512 low (57.1) 
CG5397 thought to localize to the extracellular space down 0.002797 low (29.3) 
calcutta-cup thought to localize to the membrane and endomembrane system up 4.66E-05 no expression 
(1.2) 
papi involved in the piwi-interacting RNA metabolic process down 0.011749 moderate 
(192.6) 
CG17224 predicted to have uridine phosphorylase activity and have 
nucleoside metabolic and catabolic processes 
up 0.019329 low (37.3) 
CG17264 no information up 0.000822 low (16.3) 
Cytochrome 
p450 28d2 
could be involved in metabolizing insect hormones and 
breakdown of insecticides 
down 0.043661 low (27.5) 
Cytochrome 
p450 6a16 
thought to have heme and iron ion binding activity and 
monooxygenase activity 




CG9107 predicted to be involved in rRNA procession, ribosomal subunit 
assembly and nucleic acid binding activity 
up 0.001391 no data 





has acyl-coA-N-acyltransferase and aralkylamine N-
acetyltransferase activity 
up 3.72E-19 low (42.9) 
farjavit encodes lysophospholipid acyltransferase  up 0.003083 moderate 
(342.7) 
CG11319 is involved in proteolysis and dipeptidyl-peptidase activity down 0.007751 high (729.2) 
CG5973 has phosphatidylinositol biphosphate binding activity up 0.042707 moderate 
(103.8) 
CG13133 thought to be involved in protein folding up 0.044090 no expression 
(1.2) 
CG4839 thought to have cGMP-dependent protein kinase activity and be 
involved in protein phosphorylation 
up 0.006983 no expression 
(2.2) 
CG10383 encodes a hydrolase that regulates glycosylphosphatidylinositol 
metabolism 
up 0.071674 low (87.3) 
Tetraspanin 
42Ej 
encodes a lysosomal protein essential to degrading endocytosed 
rhodopsin 





interacts with JNK pathway and affects egg asymmetry down 1.80E-10 low (43.8) 
CG12164 no information down 1.52E-05 no expression 
(1.6) 





encodes an alcohol dehydrogenase enzyme that is involved in 
ethanol-induced apoptosis 
down 0.015354 very high 
(1364.2) 
CG2064 has NADP-retinol dehydrogenase activity up 0.000313 low (47.1) 
Transmembran
e protein 63 
has calcium activated cation channel activity down 0.054427 moderate 
(150) 
CG12910 thought to have UDP-galactosyltransferase and N-glycan 
processing activity 
up 0.044090 low (43.7) 
Cuticular 
protein 47Ef 
thought to be a structural component of chitin-based cuticle  down 0.006449 no data 
CG10257 involved in I-kappaB kinase/NF-kappaB signalling  down 0.050380 moderate 
(113.2) 
CG8157 no information down 0.071674 no expression 
(3.8) 
CG15706 localizes to the membrane down 0.028913 low (69.1) 




resilin encodes a component of the extracellular matrix down 0.006449 no data 
CG6472 thought to have lipase activity and be involved in lipid catabolism down 0.025441 no expression 
(3.6) 
CG6805 has phosphatidylinositol-4,5-biphosphate 5-phosphatase activity 
and be involved in inositol phosphate dephosphorylation 
down 4.95E-21 moderate 
(111) 
CG15611 has guanyl-nucleotides exchange factor activity and is involved in 
endoplasmic reticulum stress 
up 0.006247 low (64.6) 
Lysyl oxidase-
like 2 
predicted to have protein-lysine 6 oxidase activity and be involved 
in cell adhesion 










predicted to aid in the transport of hydrophobic odorants up 1.51E-32 low (13.1) 
CG11099 no information down 0.013701 high (863.1) 





thought to have alpha-tubulin binding activity and be involved in 
cilium assembly  
down 0.032580 low (11.8) 
dim ү-tubulin 3 plays a role in centrosome-independent spindle microtubule 
generation and is a part of the augmin complex 




predicted to have protein-lysine 6 oxidase activity and be involved 
in cell adhesion 
down 5.96E-09 no expression 
(5.4) 
CG11475 thought to be involved in regulating response to DNA damage, 
protein methylation and have enzyme binding an phosphatase 
activity 
up 0.002458 no expression 
(6) 
Golgi matrix 
protein 130 kD 




involved in detoxifying toxic compounds and encodes a 
cytochrome p460 oxidase protein 
up 0.016460 no expression 
(7.6) 
nahoda known to be expressed in the adult head down 0.069003 low (26.2) 
CG3500 thought to be involved in endoplasmic reticulum to Golgi vesicle 
mediated transport 







thought to have translation initiation involvement up 4.06E-10 moderate 
(113.1) 
CG5554 predicted be involved in cell redox and homeostasis and be 
involved in disulfide oxidoreductase activity 
down 1.39E-19 moderate 
(385.4) 






spatzle 5 acts as a ligand in promoting motor axon targeting and neuronal 
survival in the CNS 
down 0.006983 no expression 
(2.1) 
CG1136 thought to be a structural constituent of chitin-based larval cuticle down 0.070749 low (29.4) 
CG13705 known to be expressed in the embryonic dorsal epidermis down 0.054153 no expression 
(8.3) 
CG9953 has dipeptidyl-peptidase activity and thought to play a role in 
proteolysis 
down 1.00E-08 moderate 
(416) 





thought to have valine-tRNA ligase activity and to be involved in 
valyl-tRNA aminoacylation 
down 0.050380 low (55.9) 
CG5653 thought to have polyamine oxidase activity down 3.45E-05 no expression 
(5.1) 
CG4461 involved in heat response down 0.081458 no expression 
(6) 
Aps encodes a diphosphoinositol-polyphosphate diphosphatase with 
hydrolysis functions 




involved in ethanol-induced behavior and ethanol metabolism up 0.051862 low (55) 
CG13458 thought to localize to the mitochondrial inner membrane down 0.045032 low (48.1) 
CG17027 has inositol monophosphate 1-phosphatase activity and be 
involved in inositol metabolic processes 




thought to be a structural component of the ribosome and be 
involved in translation 
down 3.13E-07 moderate 
(237.1) 
artichoke encodes a leucine-rich extracellular matrix protein that contributes 
to cilium assembly and integrity 
up 0.090325 low (31.7) 
CG11370 expressed in the dorsal trunk primordium down 0.050380 no expression 
(0.7) 
CG18473 has hydrolase activity and is involved in catabolic processes up 4.08E-05 no expression 
(7.1) 
Pinin involved in mRNA splicing down 7.47E-05 moderate 
(123) 
CG14715 known to localize to the endomembrane system down 3.49E-05 moderate 
(114.5) 
CG9813 known to be expressed in the adult head down 0.046834 very high 
(2028.2) 





thought to have adenosine deaminase activity and be involved in 
the adenosine catabolic process 
down 0.077174 low (78.4) 




CG11951 thought to have metalloaminopeptidase activity and zinc ion 
binding activity 






predicted to have ATPase and TBP protein binding activity down 0.087649 no expression 
(5.5) 
PIP4K encodes an enzyme that that is involved in mTOR signaling and 
cell size control 
down 0.041810 no data 
UDP-
glycosyltransfer
ase family 317 
member A1 
thought to have UDP-glycosyltransferase activity down 0.098038 low (53.7) 
lncRNA:CR131
30 




predicted to be involved in insect hormone and synthetic hormone 
metabolism 
up 2.34E-11 no expression 
(5.6) 
Apollo involved in protein transport to the nucleus up 0.001535 no data 
Glutamate 
receptor IIC 
encodes a subunit of muscle glutamate receptor up 2.10E-07 no expression 
(6.8) 
CG30033 expressed in adult fat bodies down 0.000393 no expression 
(2.3) 
CG30082 thought to have serine-type endopeptidase activity down 0.071674 no expression 
(3.4) 
Ipk1 has a role in protein phosphorylation up 0.004797 no expression 
(7.6) 
Maltase A5 has alpha-glucosidase activity and is involved in metabolizing 
carbohydrates 
up 0.047306 moderate 
(453.6) 
CG30472 no information up 0.004797 no expression 
(0.7) 
CG31643 thought to have protein kinase activity up 0.032216 low (54.5) 
CG31664 no information up 0.008963 low (9.4) 
CG31997 known to localize to cytosol down 0.019329 moderate 
(290.5) 
CG32428 known to be expressed in the extended germ band embryo down 0.027758 moderate 
(213.4) 
Syndapin encodes a protein with roles in regulating cellularization, 
endocytosis and membrane tubulation 
down 0.071674 moderate 
(340.8) 
p24-related-2 encodes a protein involved in oviposition post-mating up 0.000122 low (17.9) 





encodes a protein that is expressed in the mesoderm and has 
roles in development 




CG7600 no information up 9.30E-06 moderate 
(218.9) 
debra encodes a transcriptional coactivator up 4.17E-06 moderate 
(157.7) 
CG34150 expressed in the embryonic midgut, endoderm and midgut 
primordium 
up 0.088378 low (21.1) 
CG34195 thought to be involved in tRNA methylation and has predicted 
tRNA methyltransferase activity 
up 1.56E-12 low (20.3) 




though to be involved in tetrahydrofolate interconversion  up 0.066414 no expression 
(12.2) 
palisade encodes a protein essential to coordinating assembly during 
oogenesis 
down 1.87E-07 no expression 
(6.1) 
CG42260 encodes a protein that makes up a subunit of a nucleotide-gated 
ion channel 




encodes a myosin light chain kinase-like protein that is required 
for starvation-induced autophagy 
down 0.006512 no data 




thought to have actin filament binding activity and be involved in 
lamellipodium assembly 
up 2.65E-19 low (17.9) 





encodes a membrane protein that has roles of regulating 
lipogenesis and activating the transcription of lipogenic genes 




no information down 0.084479 no data 
Nucleoporin 
160kD 
encodes a component of the nuclear pore complex and is 
involved in polyA+ RNA transport 
up 0.004320 no data 
Myc encodes a transcription factor that is involved in cell growth and 
proliferation 
up 0.071674 no data 
antisense 
RNA:CR43609 
no information up 0.042707 no data 
lncRNA:CR437
85 
no information up 0.083834 no data 
antisense 
RNA:CR43957 
no information up 1.49E-09 no data 
CR44391 
pseudogene 
no information up 1.95E-08 no data 
lncRNA:CR445
25 





no information down 0.003224 no data 
lncRNA:CR452
67 
no information up 0.074123 no data 
Table 2. Description of function of 172 KD//Gal4 DEGs, their direction of regulation, expression 
pattern in the brain. All gene descriptions were found via FlyBase (FB2021_03) and expression 













Process  cell adhesion 
ImpL2, His3.3A, PIP4K, Pnn, 
RhoL, lox2, shg 4.10% 7.20E-04 3.10E-01 
 transport 
CG2823, CG5973, Obp56a, 
Obp56h, p24-2, st 3.50% 9.60E-03 1.00E+00 
 sleep 
Amy-p, CG10383, Rab27, 
CG5973, Drat, l(2)tid 3.50% 1.30E-02 1.00E+00 
 hemocyte migration Ras85D, RhoL, shg 1.80% 2.00E-02 1.00E+00 
 insecticide catabolic process Cyp6d2, Cyp28d2, Cyp6a2 1.80% 2.80E-02 1.00E+00 
 regulation of cell shape raw, His3.3A, PIP4K, RhoL, sqa 2.90% 3.20E-02 1.00E+00 
 protein folding 
CG14715, CG5554, Csp, Hsp68, 
l(2)tid 2.90% 3.50E-02 1.00E+00 
 response to DDT Cyp6d2, Cyp28d2, Cyp6a2 1.80% 4.10E-02 1.00E+00 
 cell proliferation Adgf-C, Myc, cutlet, Ras85D 2.30% 4.10E-02 1.00E+00 
 positive regulation of cell growth Myc, PIP4K, Ras85D 1.80% 4.30E-02 1.00E+00 
 cellular response to ethanol CrzR, Drat 1.20% 4.50E-02 1.00E+00 
 gonad development raw, en, shg 1.80% 4.60E-02 1.00E+00 
 
negative regulation of ATPase 
activity CG34423, CG34424 1.20% 5.60E-02 1.00E+00 
 eye pigment precursor transport st, w 1.20% 5.60E-02 1.00E+00 
 response to hypoxia Drat, Hsp70Bb, Sur 1.80% 5.80E-02 1.00E+00 
 border follicle cell migration Rab7, Ras85D, RhoL, flr, shg 2.90% 6.40E-02 1.00E+00 
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 gonad morphogenesis raw, shg 1.20% 6.70E-02 1.00E+00 
 exosomal secretion Rab27, Rab7 1.20% 6.70E-02 1.00E+00 
 regulation of apoptotic process Myc, Ras85D, l(2)tid 1.80% 7.70E-02 1.00E+00 
 
gonadal mesoderm 





CG14715, Cyp309a2, Cyp6d2, 
Cyp28d2, Cyp6a2, Rtnl1, SREBP, 
l(2)not, p24-2 5.30% 5.80E-03 4.70E-01 
 synapse 
Rab27, CG5397, Rab7, GluRIIC, 
Jhe, lbm 3.50% 8.60E-03 4.70E-01 
 membrane 
CG11210, CG14340, drongo, 
Phm, Ras85D, SREBP, c-cup, 
lox2, st, w 6.40% 2.10E-02 7.60E-01 
 plasma membrane 
CG11951, raw, CG4839, CG5807, 
Rab7, Csp, FER, Fas3, PRL-1, 
PIP4K, Ras85D, RhoL, Synd, 
l(3)mbn, st, shg, w 9.90% 3.00E-02 8.40E-01 
 nuclear membrane CG32165, Fas3, SREBP 1.80% 6.50E-02 1.00E+00 
 organelle membrane 
Cyp309a2, Cyp6d2, Cyp28d2, 
Cyp6a2 2.30% 7.30E-02 1.00E+00 
 extracellular matrix 
CG13670, resilin, Cpr47Ef, atk, 
l(3)mbn 2.90% 9.70E-02 1.00E+00 
Molecular 
Function  ATP binding 
Act87E, Ipk1, cutlet, CG34424, 
CG4839, CG5660, FER, Hsp68, 
Hsp70Bb, Aats-pro, Pka-C3. 
Rpt6R, Sur, l(2)tid, st, sqa, w 9.90% 2.20E-02 1.00E+00 
 monooxygenase activity 
Cyp309a2, Cyp6d2, Cyp28d2, 
Cyp6a16, Cyp6a2 2.90% 2.40E-02 1.00E+00 
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 heme binding 
Cyp309a2, Cyp6d2, Cyp28d2, 
Cyp6a16, Cyp6a2, c-cup 3.50% 2.40E-02 1.00E+00 
 
oxidoreductase activity, acting 
on paired donors, with 
incorporation or reduction of 
molecular oxygen 
Cyp309a2, Cyp6d2, Cyp28d2, 
Cyp6a16, Cyp6a2 2.90% 2.60E-02 1.00E+00 
 oxidoreductase activity 
Cyp309a2, CG2064, Cyp6d2, 
CG5653, Cyp28d2, Cyp6a2, Drat 4.10% 3.30E-02 1.00E+00 
 ATPase inhibitor activity CG34423, CG34424 1.20% 3.70E-02 1.00E+00 
 structural constituent of cuticle 
CG1136, CG13670 resilin, 
Cpr47Ef, l(3)mbn 2.90% 5.00E-02 1.00E+00 
 pigment binding st, w 1.20% 6.00E-02 1.00E+00 
 receptor activity CG5397, Fas3, Jhe, shg 2.30% 6.20E-02 1.00E+00 
 GTP binding 
Rab27, Rab7, Pu, Ras85D, RhoL, 
Srp54k 3.50% 6.70E-02 1.00E+00 
 GTPase activity 
Rab27, Rab7, Ras85D, RhoL, 
Srp54k 2.90% 8.30E-02 1.00E+00 
 ATPase binding CG34423, CG34424 1.20% 9.50E-02 1.00E+00 
 
ATPase activity, coupled to 
transmembrane movement of 
substances Sur, st, w 1.80% 
9.90E-02 
1.00E+00 
Table 3. Summary of the GO terms tagged for each category (biological process, cellular 
component and molecular function), genes involved in each term, the percentage of total DEGs 





Cluster 1 Enrichment Score 1.46 Count p-value 
Benjamini adj. p- 
value 
 endoplasmic reticulum membrane 9 5.80E-03 4.70E-01 
 monooxygenase activity 5 2.40E-02 1.00E+00 
 heme binding 6 2.40E-02 1.00E+00 
 
oxidoreductase activity, acting on paired donors, with incorporation 
or reduction of molecular oxygen 5 2.60E-02 1.00E+00 
 insecticide catabolic process 3 2.80E-02 1.00E+00 
 oxidoreductase activity 7 3.30E-02 1.00E+00 
 response to DDT 3 4.10E-02 1.00E+00 
 organelle membrane 4 7.30E-02 1.00E+00 
 oxidation-reduction process 9 1.00E-01 1.00E+00 
 iron ion binding 5 1.10E-01 1.00E+00 
Annotation 
Cluster 2 Enrichment Score 1.15 Count p-value 
Benjamini adj. p-
value 
 border follicle cell migration 5 6.40E-02 1.00E+00 
 GTP binding 6 6.70E-02 1.00E+00 
 GTPase activity 5 8.30E-02 1.00E+00 
Annotation 
Cluster 3 Enrichment Score 0.93 Count p-value 
Benjamini adj. p-
value 
 structural constituent of cuticle 5 5.00E-02 1.00E+00 
 extracellular matrix 5 9.70E-02 1.00E+00 
 structural constituent of chitin-based larval cuticle 4 1.40E-01 1.00E+00 
 chitin-based cuticle development 4 2.70E-01 1.00E+00 
Annotation 
Cluster 4 Enrichment Score 0.24 Count p-value 
Benjamini adj. p-
value 
 catalytic step 2 spliceosome 3 4.80E-01 1.00E+00 
 precatalytic spliceosome 3 5.50E-01 1.00E+00 
 mRNA splicing, via spliceosome 3 7.40E-01 1.00E+00 
Table 4. Summary of functional annotation clusters, their enrichment scores, number of genes 




An initial goal for our analysis was to determine whether our 172 KD vs Gal4 DEGs were 
represented or overrepresented within:  
- our six candidate genes of interest (spin, unc79, Bx, CtBP, Fas2 or For, Chapter 2, 
Table 5) 
- the 342 genes bound by Mef2 (Sivachenko et. al 2013) 
- known fly alcohol genes and orthologs of worm alcohol genes (Grotewiel & Bettinger 
2015) 
- fly orthologs of genes nominally associated with SRE (Schmitt et. al 2019) 
- human genes associated with externalizing behavior (Danielle Dick, personal 
communication) 
As necessary, we used fly genes or fly orthologs of human and worm genes (defined by 
DIOPT scores ≥5) for these analyses. We found that eight fly genes overlapped between the 
172 DEGs and 342 Mef2 bound genes (Sivachenko et. al 2013), no fly genes overlapped 
between the DEGs and our 6 candidate genes (unc79, spin, Bx, CtBP, Fas2, for), two fly genes 
overlapped between the DEGs and known fly alcohol genes (reviewed by Grotewiel & Bettinger 
2015), one fly gene overlapped between the DEGs and fly orthologs of worm alcohol genes 
(reviewed by Grotewiel & Bettinger 2015), no fly genes overlapped between the DEGs and fly 
orthologs of SRE-related genes (Schmitt et. al 2019), and nine genes overlapped between the 
DEGs and fly orthologs of human genes associated with externalizing behavior (Dick, personal 
communication 2020, Linnér et. al 2020) (Table 5). To determine whether the amount of overlap 
between the DEGs and each other gene lists was significantly more than expected by chance, 
we performed Fisher’s exact test using a custom R script (generously provided by Mike Miles 
and Maren Smith, Virginia Commonwealth University, detailed in the Appendix). The number of 
overlapping genes was not significantly greater than expected by chance for any of the six gene 
sets (Table 6), suggesting that the 172 DEGs and the other gene sets of interest might be 
involved in biologically distinct processes. The inclusion of the white gene is of somewhat 
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suspect biological value given that it is a marker for the Gal4 and RNAi transgenes used in our 
study, but is included here for completeness. 
The lack of overlap between the 342 Mef2 bound genes and 172 KD//Gal4 DEGs could be 
due to several reasons. First, if Mef2 regulates the same or similar sets of genes in muscle and 
neurons, it is possible that the expression of Mef2 regulated genes in the muscle could mask 
the effect Mef2 knockdown on gene expression in neurons. If this is the case, then it is possible 
this study primarily identified neuron-specific genes downstream of the 342 Mef2 bound genes 
identified by Sivachenko et. al (Sivachenko et. al 2013). Another possibility is that Mef2 
knockdown during development and into adulthood could have led to gene expression changes 
that are not represented by the 342 Mef2 bound genes, as these genes are experimentally 
defined as being Mef2 bound in adulthood. Additionally, because Sivachenko et. al identified the 
initial Mef2 bound genes using head tissue, it may be possible that their study largely identified 
genes bound by Mef2 in head muscle. If that is the case, and the genes Mef2 is bound by or 
regulates do not substantially overlap with those bound or regulated in neurons, we would not 
necessarily expect to observe a large overlap between our 172 KD//Gal4 DEGs and the 342 













DEGs vs. Mef2 bound 
genes 
DEGs vs. 6 
candidate 
genes 
DEGs vs. fly 
alcohol 
genes 









DEGs vs. fly orthologs of 





- PRL-1 phosphatase 
- lilipod 




- Reticulon-like 1 






none - Cytochrome P450 6a2 





- Valyl-tRNA synthetase, 
mitochondrial 
- Syndapin 
- Sterol regulatory element 
binding protein 
Table 5. Summary of each of the genes that overlap between the 172 genes identified as 















 Gene Set 1   Gene Set 2 Genome Overlap Expected Odds Ratio p-value 
172 DEGs 342 Mef2 bound Fly        
(13,968 genes) 
8 4.2113 1.8286 0.0936 
172 DEGs 6 candidate 
genes 
Fly        
(13,968 genes) 
0 0.0739 0.0 1.0 
172 DEGs 91 fly alcohol 
genes 
Fly        
(13,968 genes) 
2 1.1206 1.7509 0.3229 
172 DEGs 51 fly orthologs 
of worm alcohol 
genes 
Fly        
(13,968 genes) 
1 0.6280 1.5667 0.4776 
172 DEGs 22 fly orthologs 
of human SRE 
genes 
Fly        
(13,968 genes) 
0 0.2709 0.0 1.0 




Fly        
(13,968 genes) 
9 10.0604 0.8307 0.7503 
Table 6. Fisher’s exact test data to determine whether the number of overlapping genes 
between our 172 identified DEGs and each gene list of interest is significant. The amount of 













3e. Analysis of KD//Gal4//RNAi DEGs 
Our initial analysis indicated that 51 genes were differentially expressed in both the KD 
vs Gal4 comparison and the KD vs RNAi comparison (Figure 10). We surmised that the most 
relevant genes would be consistently up-regulated or consistently down-regulated in these two 
sets of DEGs. Among these 51 DEGs, we therefore identified those genes that were up-
regulated or down-regulated within both the KD//Gal4 and KD//RNAi. We found 13 genes that 
were up-regulated in both the KD//Gal4 and KD//RNAi sets (Figure 11A, Table 7), and similarly 
found 18 genes that were consistently down-regulated in these same two gene sets (Figure 
11B, Table 7). Of these 31 genes, 27 have brain expression data available for them (FlyAtlas-
RNA.adult, FB2021_03). Twelve of these 27 genes are moderately, highly or very highly 
expressed in the brain, with 23 total having detectable expression in this tissue (Table 7), again 
strongly suggesting that our workflow led to genes with potential roles in nervous system 
function and behavior. Interestingly, four of the genes in this set of 31 DEGs were also identified 
as being bound by Mef2 (Sivachenko et. al 2013) which was greater than expected by chance 
(Tables 8 and 9). Although this set of 31 DEGs did not significantly overlap with the other five 
gene sets of interest (Table 8), three of the four genes common to the KD//Gal4//RNAi DEGs 
(raw, PRL-1 phosphatase and CG9813) and the 342 genes bound by Mef2 (Table 9) could be 
high priority candidates for future studies on the role of genes directly downstream of Mef2 in 
ethanol sedation. The inclusion of the fourth overlapping gene, white, is of somewhat suspect 
biological value, given that it is a marker for the Gal4 and RNAi transgenes used in our study, 
but is included here for completeness. 
PRL-1 phosphatase has three human orthologs with DIOPT scores ≥ 8 each: PTP4A2, 
PTP4A1 and PTP4A3 (DIOPT scores are 12, 11, 8, respectively). Neither PTP-1 phosphatase 
nor its orthologs have been implicated in fly or human ethanol responses. Raw and CG9813 do 
not have any human orthologs. 
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Ontology analysis of the 31 genes (Table 10) indicates that none of the enriched GO 
terms are significant based on their Benjamini-Hochberg adjusted p-value. The relatively small 
size of the gene set (31) and lack of significantly terms limits interpretation of these results.  
  






Figure 11. Venn diagrams showing the number genes found to be up or down regulated both in 
comparison of the knockdown group vs. Gal4 control and the RNAi control. Panel A shows 





Up - KD//Gal4 Up – KD//RNAi 












involved in breakdown of synthetic insecticides and insect 
hormone metabolism 
up low (47.7) 
Fushi tarazu predicted to play a role in specifying neuronal identity and known 
to be required in embryogenesis 










recruits Sin3A-HDAC1 by interacting with transcription factor up moderate 
(172.1) 





has acyl-coA-N-acyltransferase and aralkylamine N-
acetyltransferase activity 
up low (42.9) 
CG12910 thought to have UDP-galactosyltransferase and N-glycan 
processing activity 
up low (43.7) 
artichoke encodes a leucine-rich extracellular matrix protein that 
contributes to cilium assembly and integrity 
up low (31.7) 
Cytochrome 
p450 309a 
predicted to be involved in insect hormone and synthetic 
hormone metabolism 
up no expression 
(5.6) 




though to be involved in tetrahydrofolate interconversion  up no expression 
(12.2) 
white ABC-type guanine transporter involved in transporting cyclic 
GMP, various amines and pigments 
up low (13) 
Heat-shock 
protein-70Bb 
encodes a protein involved in heat shock and hypoxia response up no data 









raw encodes a membrane protein involved in dendritic patterning and down moderate 
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localization of JNK signaling components (292.9) 
shotgun calcium-dependent cell adhesion protein and has roles in cell 
sorting, oogenesis and body asymmetry 
down no expression 
(9) 
Recombination 
repair protein 1 




Troponin C at 
41C 
encodes a protein that binds calcium and regulates muscle 
contraction 
down no expression 
PRL-1 
phosphatase 
encodes a growth inhibitor  down high (608.8) 
CG4615 predicted to be involved in cytolysis down moderate 
(301.9) 
CG1636 known to be expressed in the adult head down moderate 
(165.5) 
CG14340 thought to be involved in vesicle-mediated transport down low (57.1) 
CG10257 involved in I-kappaB kinase/NF-kappaB signaling  down moderate 
(113.2) 
CG6805 has phosphatidylinositol-4,5-biphosphate 5-phosphatase activity 
and be involved in inositol phosphate dephosphorylation 
down moderate 
(111) 





thought to be a structural component of the ribosome and be 
involved in translation 
down moderate 
(237.1) 
CG9813 known to be expressed in the adult head down very high 
(2028.1) 
CG9759 no information down no data 





encodes a myosin light chain kinase-like protein that is required 
for starvation-induced autophagy 
down no data 
Table 7. Description of function of 31 DEGs, their direction of regulation, expression pattern in 
the brain. All gene descriptions were found via FlyBase (FB2021_03) and expression data was 






Gene Set 1   Gene Set 2 Genome Overlap Expected Odds Ratio p-value 
31 DEGs 342 Mef2 bound Fly        
(13,968 genes) 
4 0.3893 5.1263 0.0106 
31 DEGs 6 candidate 
genes  
Fly        
(13,968 genes) 
0 0.0133 0.0 1.0 
31 DEGs 91 fly alcohol  Fly        
(13,968 genes) 
1 0.2020 4.9060 0.1908 
31 DEGs 51 fly orthologs 
of worm alcohol  
Fly        
(13,968 genes) 
1 0.1132 0.0 1.0 
31 DEGs 22 fly orthologs 
of human SRE  
Fly        
(13,968 genes) 
0 0.0488 0.0 1.0 
31 DEGs 817 fly orthologs 
of human 
externalizing  
Fly        
(13,968 genes) 
1 1.8132 0.5180 1.0 
Table 8. Fisher’s exact test contingency tests to determine whether the number of overlapping 
genes between our 31 DEGs differentially expressed in the same direction and each gene list of 
interest is significant. The amount of overlap between our DEGs and 342 Mef2 bound genes is 
significant; the amount between our previously identified 6 genes of interest, known fly alcohol 
genes, fly orthologs of known worm alcohol genes, fly orthologs of previously identified genes 





DEGs vs. Mef2 bound 
genes 
DEGs vs. 6 
candidate 
genes 
DEGs vs. fly 
alcohol 
genes 









DEGs vs. fly orthologs of 




- PRL-1 phosphatase 
- CG9813 
none - white none none - Cytochrome p450 6a2 
Table 9. Summary of each of the genes that overlap between the 31 genes differentially 
















adj. p value 
Biological 
Process gonad morphogenesis raw, shg 6.5 1.3E-2 1.00E+00 
 
gonadal mesoderm 
development ftz, shg 6.5 1.7E-2 1.00E+00 
 
morphogenesis of an 
epithelium raw, shg 6.5 5.5E-2 1.00E+00 
 gonad development raw, shg 6.5 6.4E-2 1.00E+00 
 germ cell migration ftz, shg 6.5 8.2E-2 1.00E+00 
Cellular 
Process none     
Molecular 
Function ATP binding 
CG34424, Hsp70Bb, 
Pka-C3, sqa, w 16.1 6.2E-2 1.00E+00 
Table 10. Summary of the GO terms tagged for each category (biological process, cellular 
component and molecular function), genes involved in each term, the percentage of total DEGs 













We performed an RNA-seq study to better understand the role of Mef2 in ethanol 
sedation. We confirmed the quality of our RNA samples collected for this project in several 
ways: by measuring A260/A280 ratios, assessing data from the Agilent Bioanalyzer and 
interpreting RIN numbers and DV200 data provided by GeneWiz. Additionally, we confirmed 
that sequencing quality was reliable and accurate via the mean quality scores provided by 
GeneWiz, that sequencing read depths were comparable across samples, and that the 
genotypes of the flies collected and the identities of the resulting samples were accurate. We 
also designed the study to prevent batch effects, and normalized the genetic background of all 
flies used. We are therefore confident in the overall design of our study and the RNA-seq data 
derived from it.  
We were expecting to see larger-scale differences in gene expression in the KD//Gal4 
comparison and clear distinctions between the three genotypes in PCA analyses. The low 
number of DEGs could potentially indicate that Mef2 does not regulate many genes; however, 
given that it is a transcription factor (Black & Olson 1998; Taylor & Hughes 2017), is known to 
bind 342 genes (Sivachenko et. al 2013) and has a reproducible impact on ethanol sedation 
patterns (Schmitt et. al 2019, Myers 2020, Chapter 2), we do not think this is likely. A 
reasonable explanation might be that our experimental design might be masking the true impact 
of pan-neuronal Mef2 knockdown. Mef2 is highly expressed in head muscle (Velasco et. al 
2006), so sequencing RNA isolated from fly brains alone might provide increased sensitivity and 
allow us to capture the full scope of global gene expression changes caused by neuronal 
knockdown of Mef2. 
We used our RNA-seq data to address the biological functions of two differentially 
expressed gene sets (KD//Gal4 and KD//Gal4//RNAi) and to address whether these two sets of 
differentially expressed genes significantly overlapped with our previously identified candidate 
genes (Chapter 2), 342 Mef2 bound genes (Sivachenko et. al 2013), known fly alcohol genes 
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(Grotewiel & Bettinger 2015), fly orthologs of known worm alcohol genes (Grotewiel & Bettinger 
2015), fly orthologs of human genes previously implicated in SRE and fly orthologs of genes 
implicated in human externalizing behaviors. Although the set of 172 KD//Gal4 DEGs did not 
significantly overlap with any other gene list of interest, there are still some meaningful 
conclusions we may be able to draw. For one, approximately 70% of the DEGs were expressed 
in the brain at some level (FlyAtlas-RNA.adult, FB2021_03), indicating that our experimental 
design is able to capture expression changes occurring in the brain. Though the amount of 
overlap is not significant, the genes that are shared between the KD//Gal4 DEGs and each 
other set may still be worthwhile candidates to pursue in future studies. GO analysis highlighted 
a few terms of interest: sleep and ethanol response. Previous studies have shown that Mef2 is 
required for the daily fasciculation/defasciculation cycle, and that its transcription is regulated by 
the master circadian rhythm transcription complex (Sivachenko et. al 2013). Mef2’s role in 
ethanol response is a key focus of this thesis, as well as previous literature (Schmitt et. al 2019, 
Adhikari et. al 2018). The enrichment of these GO terms, which are consistent with Mef2’s 
previously identified functions, could serve as evidence of the validity of our experiment. 
However, only two genes are associated with the ethanol response GO term: Death resistor 
Adh domain containing target (Drat) and Corazonin receptor. While this is quite a low number of 
genes, it is interesting to note that both overlap with other gene lists of interest - Drat is known 
to bind Mef2, and Corazonin receptor is a known fly alcohol gene. This indicates that these 
genes could be potential candidate genes for future behavioral studies.  
The amount of overlap (four genes) between the 31 KD//Gal4//RNAi genes and the 342 
Mef2 bound genes is significant, and each of the four are expressed in the brain at least some 
extent, indicating that these genes may also be high priority candidates for future experiments. 
Additionally, two of the four (white and PRL-1 phosphatase) have multiple strong orthologs 
(defined as DIOPT≥5), indicating that studies done on these genes could eventually impact 
understanding of AUD in humans. white is also a known fly alcohol gene. PRL-1 phosphatase 
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and the other two overlapping DEGs (raw and CG9813) are not known to be involved in any 
aspect of ethanol response, experiments pertaining to them could still be meaningful in that they 
may provide a better understanding of the role of other genes downstream of Mef2 in ethanol 
sedation, as well as a better understanding of Mef2’s interactions with its downstream genes. In 
the larger set of 31 KD//Gal4//RNAi genes, Juvenile hormone esterase (Jhe), is known to be 
involved in ethanol response and is known to be upregulated in both KD//Gal4 and KD//RNAi 
comparisons, indicating that it may also be a promising candidate gene. 
Future iterations of this experiment might be successful in identifying more DEGs if fly 
brains were used as the starting material. Additionally, we could perform qPCR of fly heads with 
a knockdown of Mef2 to see whether we get the same results in terms of decrease of Mef2 
expression. If we do, this could be further evidence to extract RNA from fly brains in the future. 
We could also perform qPCR with reagents specifically for the six candidate genes identified in 
Chapter 2, or the potential new candidate genes laid out in this chapter to understand how 















CHAPTER 4: DISCUSSION 
 
 GWAS performed by Schmitt et. al (Schmitt et. al 2019) identified human MEF2B as a 
gene implicated in SRE. Mef2, the fly ortholog of MEF2B has been shown to have an impact on 
ethanol sedation behaviors in Drosophila (Schmitt et. al 2019, Myers 2020); flies with pan-
neuronal expression RNAi transgenes against Mef2 and mutations in the gene display 
significantly decreased ethanol sedation sensitivity. Mef2 is a transcription factor (Black & Olson 
1998, Taylor & Hughes 2017), and a ChIP-seq was performed to identify any genes bound by 
Mef2 (Sivachenko et. al 2013). Additionally, work by other groups has shown that a gene 
downstream of Mef2 influences ethanol tolerance and preference (Adhikari et. al 2018) The goal 
of our first aim of this study was to begin testing the hypothesis that one or more genes of 
interest downstream of Mef2 might influence ethanol sedation.  
 Through a collaboration with Danielle Dick, we determined that 38 human orthologs of 
the genes bound by Mef2 were associated with human externalizing behavior (Dick 2020, 
personal communication, Lanier et. al 2020). We found that six of these 38 genes had been 
implicated in behavioral responses to alcohol in flies and worms (Grotewiel & Bettinger 2015) 
and confirmed that 1 of them (spin) was associated with gene expression changes related to 
alcohol consumption in humans (Bacanu, personal communication). These six genes (spin, 
unc79, Bx, CtBP, Fas2 and for) became our high priority candidate genes for analysis in 
Chapter 2. Using available RNAi reagents, these genes were tested to determine whether 
RNAi-mediated knockdown of any of the genes influenced ethanol sedation.  
Pan-neuronal expression of RNAi targeting two genes, spin and unc79, produced 
consistent changes in ethanol sedation. Expression of all viable RNAi transgenes targeting 
these genes decreased ethanol sedation sensitivity. Expression of RNAi targeting other 
candidate genes either did not produce an effect on ethanol sedation or did not produce a 
consistent effect when multiple RNAi transgenes against one gene were tested. This could be 
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due to the genes potentially not functioning in neurons, or the specific RNAi transgenes not 
adequately knocking down the target gene. To address this, future iterations of this study could 
focus on manipulating the candidate genes via mutations rather than RNAi transgenes. 
Additionally, assessing the impact of overexpression or expression of dominant negatives could 
also provide insight into the potential role each candidate gene plays in ethanol sedation. 
Several of the RNAi reagents we tested were lethal. Expressing these genes only in adulthood 
or only in specific neurons to bypass lethality might also aid in better understanding of the role 
these genes play in ethanol sedation.  
The second component of this project was an RNA-seq to identify the genes regulated 
by Mef2. We isolated RNA from fly heads of three genotypes, the elav-GAL4/+;v15550/+ 
knockdown genotype (KD), an elav-Gal4/+ control (Gal4) and a v15550/+ control (RNAi) and 
sent them for sequencing. We established confidence in the RNA quality, sequencing quality 
and that there was no disordering of samples.  
In total, we identified 172 DEGs in the KD//Gal4 comparison, 1,063 DEGs in the 
KD//RNAi comparison and 2,238 DEGs in the Gal4//RNAi comparison. Though we do not 
understand and were not expecting to observe such large expression differences between our 
two controls, we know that the differences do not stem from differences in genetic background, 
mix-up of RNA samples, sample or sequence quality or batch effects, due to our experimental 
design. As the two controls consistently do not show behavioral differences in sedation 
experiments, we focused the first part of our analyses on the 172 KD//Gal4 DEGs.  
We found that 70% of these DEGs were expressed in the fly brain to some extent, 
indicating that our experiment was able to identify gene expression changes at the neuronal 
level. Gene ontology terms representing an expansive spectrum of biological, cellular and 
molecular processes were found to be enriched, indicating that these DEGs may have a far-
reaching scope. Specific GO terms such as sleep and ethanol response were also enriched – 
these terms are consistent with previously identified functions of Mef2 (Sivachenko et. al 2013; 
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Schmitt et. al 2019; Adhikari et. al 2018), further highlighting the validity of our experiment. We 
conducted overlap analyses to understand whether genes differentially expressed between the 
KD and Gal4 groups overlapped significantly with other gene lists of interest: our six candidate 
genes (Chapter 2), known Mef2 bound genes (Sivachenko et. al 2013), known fly alcohol genes 
and fly orthologs of known worm alcohol genes (reviewed in Grotewiel & Bettinger 2015), fly 
orthologs of human SRE genes (Schmitt et. al 2019) and fly orthologs of human externalizing 
factor genes (Dick, personal communication; Linnér et. al 2020). While we did not find that 
overlap between the DEGs and any other list of interest was significant, the two genes 
associated with the ethanol response GO term (Drat and corazonin receptor) are known to be 
Mef2 bound, and a known fly alcohol gene, respectively, and may be promising candidates for 
future experiments.  
54 genes were shown to be differentially expressed between both the KD//Gal4 and 
KD//RNAi comparisons. We found that 31 of these genes were regulated in the same direction 
(18 are downregulated in both comparisons, and 13 are upregulated in both comparisons). 
76.7% of these genes (23 out of 31) are expressed in the brain at some level, again 
demonstrating that our experimental design is able to identify gene expression changes in 
neurons and identify genes with neuronal roles. Interpretation of GO results is limited by the 
small number of DEGs; however, these genes may be involved in regulating development and 
GTP-dependent processes. Overlap analysis showed that a significant number of genes (PTP-1 
phosphatase, raw, white and CG9813) are shared between the 31 DEGs and known Mef2 
bound genes. PTP-1 phosphatase and white both have three strong human orthologs (DIOPT ≥ 
5) each, and while neither they nor their human orthologs have known function in ethanol 
behaviors or response, they may be promising candidate genes. Additionally, while raw and 
CG9813 do not have human orthologs, studying them further may still provide insight into 




Overall, the results from the RNA-seq were not what we expected. There could be 
several explanations for this, (i) that Mef2 doesn’t actually regulate many genes. However, this 
is unlikely, due to the multiple studies that have implicated Mef2 as a transcription factor (Black 
& Olson 1998, Taylor & Hughes 2017), the large number of genes that Mef2 is known to bind to 
(Sivachenko et. al 2013) and the behavioral differences that we observe in ethanol sedation 
when the gene is knocked down. Another possible reason is batch effects, though this is also 
not likely as we took great care to collect flies, separate fly heads and perform RNA preps in a 
rotating manner and representatives from GeneWiz confirmed that the possibility of large-scale 
batch effects was highly unlikely from their end as well. Therefore, a more viable explanation 
may be that our starting material for the RNA-seq was not optimal. Mef2 is expressed in 
neurons (Schmitt et. al 2019, Crittenden et. al 2018), but it is also expressed in head muscle 
(Valasco et. al 2006). Our knockdown of Mef2 was pan-neuronal, not in the entire fly head. 
Therefore, in the future, sequencing RNA from fly brains might provide increased sensitivity to 
capture changes resulting from gene expression changes Mef2 in future repetitions of this 
project. Targeting qPCR can also be done to understand individual relationships between Mef2 
and its downstream genes. 
Overall, these types of experiments can provide a better understanding of the molecular 
mechanisms underlying AUD in humans, especially if implicated genes have orthologs in other 
model organisms or humans, as they could then be studied across species to get a better sense 
of their potentially conserved role in ethanol behaviors. Drosophila are powerful tools to study 
alcohol use, as their behavioral responses to ethanol, including locomotor and sedation 
behaviors, withdrawal and tolerance are quite conserved to human responses to alcohol 
(Grotewiel & Bettinger 2015). Therefore, identifying genes that are relevant to ethanol behaviors 
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Basic Fly Handling and Husbandry 
 
A. Standard Fly Lab Lingo: 
1. Stock or strain: a culture of flies with a particular genotype. Balanced stocks have a special 
chromosome called a balancer that is marked with a dominant phenotype and suppresses 
recombination on the corresponding sister chromosome. Balanced stocks are often weak (i.e. 
grow poorly). 
 
2. Seeding: putting adult flies into a new bottle or vial. Also called ‘setting-up’. 
 
3. Transfer: moving flies without anesthesia from one vial or bottle to another. One-to-one 
transfer means moving flies from one bottle/vial to one new bottle/vial. Two-to-one transfer 
means moving flies from 2 vials/bottles to 1 new vial/bottle. Also called ‘flipping’. 
 
4. Clearing: removing all of the adults from a bottle or vial. Can be done with or without 
anesthesia. 
 
5. Anesthesia: CO2 used to temporarily immobilize flies. 
 
6. Brood: refers to the number of times a set of adults has been used to seed bottles. Using flies 
for 2 broods is common, with 3 broods being possible in some cases. 
 
7. white plus (w+): indicates eye color. white minus (w-) flies have white eyes. w+ flies have eyes 
that can vary from light peach to deep red. 
 
8. Food: All of our fly food currently has antibiotics on it (ampicillin, tetracycline and 
chloramphenicol; i.e. ATC). Yeasted (Y) food vials and bottles have live yeast on added. 
Yeasted food should be used for seeding new vials and bottles for growing flies. Non-yeasted 
(NY) food has no yeast on it and should be used to house flies prior to behavioral studies and 
for storing virgin females and males prior to setting-up crosses. 
 
B. Standard Fly Husbandry 
1. Remove necessary number of yeasted bottles or vials from the cold room. Use bottles to 
grow lots of flies for behavioral or other large experiments. Use vials for smaller numbers of flies 
in limited scale crosses or other small scale experiments. 
 
2. Before putting in new flies, bottles and vials must be dried 2 hours to overnight in the 
environmental chamber so that all condensation on the walls evaporates. The food will pull 





3. Turn on the CO2. Clean microscope, CO2 pad and counter with ethanol. Clean before 
starting, between each genotype and after you are finished. Be sure the CO2 is on before 
putting ethanol on the pad. 
 
4. Open CO2 to pipette, invert bottle or vial, insert pipette along cotton plug and tap bottle/vial 
gently. Flies will become anesthetized quickly and should fall onto the plug and/or the neck of 
the bottle/vial. 
 
5. Click off CO2 to pipette, remove CO2 pipette from vial/bottle. Hold inverted bottle/vial over 
CO2 pad. Remove plug and gently shake/tap flies onto pad into a pile. Return plug to bottle/vial 
and set aside. 
 
6. Use brush or spatula to place anesthetized flies in a row and sort flies according to needs. 
Short CO2 times are important. For collecting flies that will be used in behavioral studies, goals 
are (1) all genotypes experience the same CO2 exposure and (2) all flies are anesthetized for 
less than 5 minutes. 
 
7. Set-up new bottles/vials by putting sorted flies from step 6 into dried bottles/vials. 
Anesthetized flies should be kept on the wall of the bottle/vial. If they fall into the food, many of 
them will stick there and die. Robust strains such as w[A] will do well with 10 females (♀, see 
below) per bottle or 3 females per vial. It is good practice to include a comparable number of 
males (♂, see below). Weaker stocks will need more females, up to as many as 50 per bottle 
and 15 per vial. When working with a stock that is new to you it is good practice to seed bottles 
or vials with a range of females (10-25/bottle for example) and then use an optimum number 
thereafter based on how the various bottles/vials grow. 
 
8. Insert cotton plug, invert new bottle/vial and tap anesthetized flies onto the plug. Lay the 
bottle/vial on its side, label with genotype and date. First broods (i.e. bottles or vials in which the 
flies are new parents) are marked with a single slash. 
 
9. Wait for flies to regain locomotor activity. Turn bottles/vials upright and place in environmental 
chamber to grow. 
 
10. Beginning at around 4 days after seeding, check bottles/vials daily for larval activity (darkish 
band on top of food). When larval activity is obvious, either discard the adults or—if a second 
brood is needed—transfer adults to new bottles/vials (dried appropriately). Label second brood 
with genotype, date and two slashes.  
 
11. Beginning at around 4 days after seeding the second brood, check bottles/vials daily for 
larval activity. Discard adults when larval activity is obvious. If necessary, a third brood is 
possible in some cases. 
 
12. You should expect to see obvious larval activity 4 to 7 days after seeding and obvious 
pupae 5-10 days after seeding. New adults should begin emerging ~10 days after seeding. 
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Some strains, especially balanced strains, can take up to 4 additional days to generate adults. 
Perfectly seeded bottle/vials will have robust larval activity followed by large numbers of pupae 
that populate the bottom three-fourths of the wall of the vial or bottle. Pupae will not typically be 
in the food or on the plug in these bottles. Large numbers of healthy adults suitable for 
experiments will emerge from perfectly seeded bottles/vials. 
 
13. Common Problems: If your bottles/vials are too dry or wet (as described below), the 
resulting adults should not be used for behavioral, stress or gene expression studies. The 
resulting adults are fine genotype-wise and reproduction-wise, though, and can be used to set-
up new bottles/vials as necessary. 
 a. Food too dry after 4-7 days of new adults in bottle/vial: The food should not be so dry 
that it detaches from the wall of the bottle of vial and the pupae are in the food. In cases like 
this, the food was either over-dried, there were not enough females placed in the bottle/vial, or 
possibly both. If this occurs across several strains that have grown well in the past, it is likely 
due to over-drying. If it occurs with a subset of strains, it is more likely due to insufficient 
numbers of females being used for those specific strains. The appropriate fixes are to decrease 
drying time, add more females next time, or both.  
When you transfer flies from the first to second brood or when clearing the second brood, 
note the quality of the culture and food. If the food in some bottle/vials is detached from the wall 
after 7 days, go ahead and transfer/clear the adults and then add ddH2O (NOT ETHANOL!) to 
the bottle/vial until the gap between the food and the wall is filled. In many cases this will help 
the larvae quite a lot and you still might get a decent yield of adults, although they might be 
delayed a few days due to lack of water. 
 b. Food too wet after 4-7 days of new adults in bottle/vial: The food should not be so wet 
that it runs down the wall of the bottle/vial when it is inverted and the pupae are on the plug. If 
this happens, the food was not dried sufficiently before adults were added, too many adults 
were added, or possibly both. If this occurs across several strains that have not had this 
problem in the past, it is likely due to under-drying the food. If it occurs with only a subset of 
strains, it is more likely due to too many females being added in those specific strains. The fixes 
are to increase the drying time for bottles/vials, decrease the number of females used, or both. 
 If you notice that your bottles are too wet when transferring from the first to second 
brood or when clearing the second brood, you can put a folded Kim wipe in the bottle/vial so 
that it touches both the food and the plug. This will not result in a miraculous drying of the 
bottle/vial, but it can convert a bottle/vial that is far too wet into one that can be managed with 
some care. 
 
C. The Basics of Setting-Up Crosses 
1. You will need males (♂, mated or unmated) and virgin females (♀ with a ‘v’ on top) for your 
crosses. Grow bottles or vials as above for strains required to generate males and virgin 
females. For planning purposes, you can comfortably collect 50-100 males and/or 25-50 virgin 
females from a robust bottle. Likewise, you can probably count on collecting 15-20 males and 5-




2. Around day 10 after seeding, begin to collect virgin females, identified by their light body 
pigmentation and female genitalia (see below). Typically, one collects virgin females first thing in 
the morning, again around noon, and again last thing before leaving for the day. 
 
3. Keep virgin females in non-yeasted vials with no more than 25 females/vial. Label each vial 
with genotype, date and number of virgins collected. Keep collected virgins in environmental 
chamber until ready to use. One will often collect virgin females over several days until a 
sufficient number of virgin females has been collected. Also, it is convenient to store virgin 
females in upside-down vials. 
 
4. When sufficient numbers of virgin females have been collected (~10% more than you plan to 
use) or when it is obvious that you will be able to collect all the virgin females you will need, 
collect all males into non-yeasted vials needed for your crosses. Males are identified by their 
male genitalia (see below). 
 
5. Set-out yeasted bottles or vials to warm and dry as described above. On the day of the cross, 
check all virgin female vials for larvae using the microscope. Any vials with larvae MUST be 
discarded because at least one of the females has mated. Use only virgin females from vials 
with no larvae. 
 
6. To set-up a cross, anesthetize the males and check them, anesthetize the virgin females on 
the same plate and check them, and put appropriate numbers of males and females into 
yeasted bottles/vials as described in steps B7-B9 above. Handle them thereafter as described in 
B10-B12 above. 
 





Ethanol Sedation Assay 
 
A. Day before assay 
 
1. Collect flies (reared for behavioral assays) in groups of 11 (single sex) under brief CO2 (~5 
minutes) following standard procedures for behavioral assays. Collect only those flies that look 
healthy, are relatively the same size, have normal wings, and appear dry. Flies should be 
transferred from the CO2 plate into an Eppendorf tube using a funnel and then dumped from the 
Eppendorf tube into a non-yeasted vial. 
 
2. Allow flies to recover overnight in upside-down non-yeasted food vials in the environmental 
chamber. It is possible to test a maximum of 24 vials of flies in a single experiment. 
 
3. Dilute ethanol solution as necessary (85% is our standard concentration). ~250 ml of ethanol 
solution can be stored in a sealed 500ml bottle or other sealed container for a week without a 
problem. Make ethanol fresh weekly. Diluted ethanol is exothermic and should be stored 
overnight at room temperature before use. 
 
B. Day of assay 
  
1. For each vial of flies to be tested, you will need (a) a clean, empty food vial; i.e. testing vial, 
(b) a new Flug, (c) a silicone #4 plug and (d) 1.0 ml of ethanol solution (85% ethanol is our 
standard concentration). 
 
2. Turn on humidifier and allow relative humidity in testing room to rise to 55-65%. Temperature 
should be 20-23°C. Record humidity and temperature on test log. 
 
3. Have someone else in the lab assign a unique code to each group of vials for each genotype 
and—IMPORTANTLY—record the code for later. Place coded vials with flies in testing room to 
acclimate. 
 
4. Label empty testing vials to match codes on fly vials from B.3. 
 
5. Construct a testing log by entering the code for each vial into the Test Log E or Test Log EE 
sheet within the Excel Sedation file SA E EE 6 min SIGMOIDAL 2015.10.05. Use a random or 
cycling order. Add other pertinent information (% ethanol, sex, etc.) to the Test Log worksheet 
and print for use during testing. 
 
6. Using the Test Log as a guide, arrange coded food vials with flies and empty testing vials into 
matching arrays with 4 vials in each row. The maximum possible number of vials that can be 




7. Transfer flies from food vials into matched/labeled testing vials one at a time and immediately 
insert Flugs into testing vials until Flugs are a uniform distance below the vial tops. Use the 
Fluginator to push Flugs down into vials. 
 
8. Time 0 assessment: Grasp each vial individually with thumb and forefinger, tap gently on the 
table three times to knock flies to the bottom of the vial, wait 30 seconds and then count the 
number of flies that are immobile. Typically, this is 0 or 1 at time 0. Record the number of 
immobile flies for each vial at time 0 in the printed Testing Log. 
 
9. Hereafter, each row of four vials will be handled as a set at staggered one-minute intervals.  
 
Start timer counting up at time 0 and immediately begin adding 1 ml of ethanol to the Flug in the 
vials for the first row/set of 4 vials. Add ethanol to the vials at 5 second intervals in the order 
they will be tested. Add ethanol to the Flugs in a circular motion so that all ethanol is absorbed 
as uniformly as possible. When ethanol has been added to all four testing vials in the set, insert 
a silicone #4 plug in each vial to seal it. 
 
At times 1, 2, 3, 4 and 5 minutes on the timer, add 1 ml of ethanol to the second, third, fourth 
and fifth sets of 4 vials, respectively. Continue inserting #4 plugs after adding ethanol to each 
set of 4 vials. 
 
10. At time 6 minutes, test the first set of 4 vials by grasping the first vial with thumb and 
forefinger and then tapping gently on the table three times to knock flies to the bottom of the 
vial. Tap the other 3 vials in the set the same way at 5 second intervals. 30 seconds after 
tapping the first vial, count and record the total number of flies that are sedated. Count and 
record the number of sedated flies in the other 3 vials at 5 second intervals. Flies are scored as 
sedated if they do not appear to have productive locomotion. 
 
The specific schedule is: 
Vial Tap Assess 
1 6 min 0 s 6 min 30 s 
2 6 min 5 s 6 min 35 s 
3 6 min 10 s 6 min 40 s 
4 6 min 15 s 6 min 45 s 
 
At times 7, 8, 9, 10 and 11 minutes, test the second, third, fourth, fifth and sixth sets of vials, 
respectively, as done for the first set. 
 
11. At time 12 minutes, test the first set of 4 vials again as described in B10 and continue testing 
the second, third, fourth, fifth and sixth sets of vials at 13, 14, 15, 16 and 17 minutes, 
respectively.  
 





12. Record the total number of flies in each vial. 
 
13. Clean-up is (a) turn off humidifier, (b) remove #4 plugs for washing and reuse, (c) discard 
Flugs/vials/flies, (d) remove any trash from and straighten up testing room and (e) turn off light 
in testing room. 
 
14. Enter the total number of flies in each vial and the number of flies sedated at each time point 
in the Test Log within the Excel worksheet. Percent Active flies will be automatically calculated 
and graphed below the Test Log. Press ‘Ctrl + s’ to calculate ST50s for each vial and sort the 
data by group in the Sorted Data worksheet. 
 
15. Note any flagged data in Sorted Data worksheet. Consider excluding data that looks 
qualitatively poor. 
 















































































Part A: Fly collection 
Whole body fly collection 
1. Collect 25 flies of desired age, genotype and gender in a 1.5mL snap cap tube. 1 tube = 1 n. 
Place tubes on ice immediately after flies enter tube.  
 




1. Collect whole body flies of desired age, genotype and gender in a conical tube. 1 tube = 1 n. 
For head preps, about 250 flies should be in each tube (absolute minimum = 150 flies, but 
this is not recommended). Store flies on ice at all times. After each collection, place flies 
immediately back in the -80 freezer.  
 
2. Once collected, bring the following equipment to the cold room 
• large plastic box 
• styrofoam box with sieve and tube holder in it 
• large metal forceps 
• a vortex 
• funnel(s) 
• large orange-capped conical tubes → ONLY USE CAPS WITH HOLES 
• labeled 1.7 snap-cap tubes for the number of preps you are doing 
• Cryogloves → WEAR AT ALL TIMES 
 
3. Obtain liquid N2 (in dewar) and dry ice (in styrofoam container) from 6th floor supply center. 
3/4th full liquid N2 and 1/2 full dry ice is sufficient for ~12 preps. 
 
4. Store samples on dry ice before and after prep. 
 
5. Fill conical tube 3/4 full (in styrofoam container) with liquid N2. 
 
6. Add flies to tube, screw on cap WITH HOLES (or it will violently explode), and vortex 
(stopping as little as possible) until the liquid N2 is almost gone (~1 min). 
 
7. Repeat—filling tube with flies 1/2 full with N2 and vortexing again. 
 
8. Pour N2 into sieve so it is sufficiently cold (otherwise the flies will stick and you’ll get 
nothing). Dump flies into sieve and beat laterally with heavy forceps for several minutes. 
 
9. Using funnel, quickly collect heads (middle layer) or bodies (top layer) using funnel and 
labeled 1.7 snap-cap tube. 
 
9. Between genotypes: take a break to clean and completely dry sieve (or it will freeze together 
and form an ice layer over the holes). Get a new funnel and conical tube. 
 
10. Store at -80°C until use. 




Part B: RNA extraction 
** All water used is DEPC water 
** Samples must be kept on ice at all times, unless otherwise stated 
1. Wipe down bench and all pipettes, pipette boxes, ect with 100% ETOH. Place clean plastic 
pestles in 50mL conical tube, cover pestles with chloroform, and let them soak for 20 
minutes. Transfer pestles to new clean empty 50mL conical tube and allow to air dry for 20 
minutes.  
** all chloroform is stored under the hood, and any procedures involving chloroform should 
always be done under the hood 
 
2. While under the fume hood, add 250µL Trizol (pink, stored in fridge) to each tube of flies. 
Homogenize for 1 minute with drill and pestle 
 
3. Add 100µL of chloroform to each tube. Vortex for 15 seconds. Incubate for 3 minutes at 
room temperature 
 
4. Centrifuge samples at maximum speed (14,000 x g)  for 15 minutes in the cold room  
 
5. Label new 1.5mL tubes appropriately. Remove roughly 200µL of the upper aqueous phase 
and place in new tube. If you accidently pipette any fly parts or other liquid, centrifuge that 
sample again (i.e. repeat step 4) and then attempt this step. Discard tubes with fly parts and 
the pink liquid.  
 
6. Add 250µL isopropanol (labeled ISO in RNA reagents station) to each tube containing the 
upper aqueous sample. Invert the tube 10 times. Incubate samples for 10 minutes at room 
temperature. After, centrifuge samples at maximum speed (14,000 x g) for 10 minutes in 
cold room 
 





















Fisher’s Test R Script from Michael Miles 
 
The contingency table cells are as follows: n_A_B = overlapping genes between A and B 
n_A = number of genes in group A 
n_B = number of genes in group B 










































342 Mef2 bound genes and 581 human orthologs described in Chapter 2 
Mef2 Bound gene Human Ortholog DIOPT Score 
jar MYO6 14 
tlk TLK2 11 
 TLK1 8 
CG11405 ATF3 5 
 JDP2 4 
 FOS 3 
 FOSL1 3 
 FOSL2 3 
 ATF7 2 
 ATF2 2 
 CREB5 2 
l(1)G0007 DHX38 13 
Gga GGA1 13 
 GGA2 12 
 GGA3 13 
HDAC4 HDAC4 11 
 HDAC5 10 
 HDAC9 9 
 HDAC7 8 
Ptp61F PTPN2 11 
 PTPN1 11 
CG14186 none  
tara none  
CG34299 none  
l(2)k16918 none  
CG18317 SLC25A36 14 
 SLC25A33 10 
bun TSC22D1 10 
 TSC22D2 7 
 TSC22D4 5 
 TSC22D3 5 
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CG11873 none  
att-ORFA SLC25A42 14 
 SLC25A16 5 
for PRKG1 13 
 PRKG2 5 
Ntl SLC6A7 5 
CG4577 none  
CG31216 none  
fray STK39 14 
 OXSR1 13 
bnl FGF20 7 
 FGF16 6 
 FGF9 5 
 FGF10 5 
 FGF22 5 
 FGF13 5 
 FGF4 5 
 FGF6 5 
 FGF5 5 
 FGF11 5 
raw none  
CG17034 ATP8A1 14 
 ATP8A2 12 
CG32521 none  
stv BAG3 9 
 BAG4 6 
CG8036 TKTL2 14 
 TKT  14 
 TKTL1  
cbt KLF11 6 
CG5385 none  
c11.1 MROH1 13 
 MROH2B 9 
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 MROH2A 8 
Gpdh GPD1 14 
 GPD1L 12 
dpp BMP2 9 
 BMP4 8 
d none  
Hr38 NR4A2 13 
 NR4A3 11 
 NR4A1 10 
Pdp1 HLF 11 
 DBP 8 
 TEF 8 
jdp DNAJC12 11 
cwo HES1 2 
 HES2 2 
 HES4 2 
Kr-h1 none  
mrj DNAJB2 11 
 DNAJB6 11 
 DNAJB7 10 
 DNAJB8 9 
Atf-2 NPDC1 7 
 ATF7 6 
 CREB5 6 
 ATF2 6 
crp TFAP4 11 
CG18472 SPAG1 9 
 TOMM34 6 
mt:ATPase8 none  
Rim RIMS1 10 
 RIMS2 10 
 RIMS3 7 
 RIMS4 6 
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sr EGR2 6 
 EGR3 5 
 EGR1 5 
hts ADD1 14 
 ADD2 11 
 ADD3 11 
CG14322 none  
dnc PDE4B 12 
 PDE4D 10 
 PDE4C 9 
 PDE4A 8 
CG7337 WDR62 10 
 MAPKBP1 10 
spen SPEN 11 
CG9775 none  
Cyp6w1 CYP3A4 7 
 CYP3A43 7 
CG4662 MICU3 14 
 MICU2 5 
Eip75B none  
rdx SPOP 10 
 SPOPL 9 
l(2)k01209 UCKL1 13 
cnc NFE2L2 8 
 NFE2L1 8 
 NFE2 7 
 NFE2L3 5 
Mnt MNT 6 
CG14497 none  
NfI NFIA12  
 NFIC 11 
 NFIB 11 
 NFIX 10 
134 
 
mt:Cyt-b CYTB 10 
CG9005 FAM214A 8 
 FAM214B 5 
miple none  
CG32647 DGCR2 6 
CG4966 HPS4 9 
CG14509 none  
CG10365 CHAC1 12 
 CHAC2 5 
vri NFIL3 7 
CG9813 none  
PRL-1 PTP4A2 12 
 PTP4A1 11 
 PTP4A3 8 
milt TRAK1 13 
 TRAK2 11 
sif TIAM1 11 
 TIAM2 8 
CG15926 none  
CG31183 NPR2 13 
 NPR1 13 
IA-2 PTPRN 11 
 PTPRN2 10 
EDTP MTMR14 12 
ph-p PHC3 9 
 PHC2 6 
 PHC1 5 
CG1869 CHIT1 11 
 CHIA 10 
 CHI3L1 8 
 CHI3L2  
CG34360 ZNF704 10 
 ZNF395 9 
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 SLC2A4RG 6 
Hex-A GCK 13 
 HK1 10 
 HKDC1 9 
 HK3 9 
 HK2 9 
nmo NLK 14 
cpo RBPMS 9 
 RBPMS2 8 
NK7.1 none  
CdGAPr ARHGAP32 9 
 ARHGAP32 9 
 ARHGAP31 5 
Oscillin GNPDA2 14 
 GNPDA1 13 
kirre KIRREL3 11 
 KIRREL1 11 
 KIRREL2 10 
CG30389 MACO1 13 
mib none  
CG14515 none  
CG9339 TBC1D24 14 
CG10737 C2CD2 6 
lola none  
Fit1 FERMT2 14 
 FERMT1 13 
 FERMT3 10 
CG7272 SLC50A1 5 
CG4599 DNAJC7 13 
CG32626 AMPD2 13 
 AMPD3 5 
 AMPD1 5 
CG14207 HSPB1 5 
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 CRYAA 5 
fru none  
CG11347 none  
CG17836 none  
14-3-3zeta YWHAZ 13 
 YWHAB 11 
 YWHAH 6 
 YWHAG 6 
 YWHAQ 5 
 SFN 5 
l(3)82Fd OXR1 12 
 NCAO7 12 
 TLDC2 5 
nrv1 ATP1B1 14 
 ATP1B2 12 
 ATP1B3 10 
 ATP1B4 9 
 ATP4B 7 
Dad SMAD7 10 
 SMAD6 9 
Mi-2 CHD5 12 
 CHD3 12 
 CHD4 11 
CG32432 none  
CG9413 SLC7A9 14 
 SLC7A13 5 
 SLC7A6 5 
 SLC7A5 5 
 SLC7A8 5 
 SLC7A7 4 
capt CAP1 14 
 CAP2 12 
CG31183 NPR2 13 
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 NPR1 13 
CG10947 CAMKMT 12 
CG32486 CYHR1 15 
Argk CKM 11 
 CKMT2 10 
 CKB 10 
 CKMT1A 9 
 CKMT1B 5 
exba BZW1 14 
 BZW2 12 
CG33523 MOSPD2 14 
CG3161 HES1 7 
 ATP6V0C 13 
 HES4 7 
 HES2 5 
EcR NR1H3 10 
 NR1H2 9 
CG4068 SINHCAF 9 
CG34417 SMTNL1 5 
CG8321 ARL6IP6 5 
CG9990 none  
W ABCG2 8 
 ABCG1 6 
 ABCG4 5 
ttv EXT1 13 
 EXTL1 6 
Sdc SDC4 6 
 SDC1 6 
 SDC2 6 
 SDC3 5 
kst SPTBN5 13 
 SPTBN2 3 
 SPTBN1 3 
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 SPTBN4 3 
chic PFN4 9 
stv BAG4 6 
CG9005 FAM214A 5 
SelR MSRB3 14 
 MSRB2 7 
CG31915 COLGALT2 13 
 COLGALT1 12 
 CERCAM 11 
bocksbeutel none  
Cbp53E CALB2 11 
 CALB1 10 
 SCGN 9 
Sema-1a SEMA6A 8 
 SEMA6B 6 
 SEMA6C 6 
 SEMA3D 5 
 SEMA3A 5 
CG30421 USP31 11 
 USP43 10 
CG4766 MAB21L2 14 
 MAB21L1 12 
CG32813 none  
CG7458 SLC22A1 5 
CG7458 SLC22A13 5 
 SLC22A3 5 
 SLC22A12 5 
 SLC22A11 5 
 SCL22A14 5 
 SLC22AG 5 
 SLC22A4 5 
 SCL22A5 5 
 SLC22A13 5 
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 SLC22A3 5 
 SLC22A12 5 
 SLC22A11 5 
 SLC22A14 5 
CG7990 PGAP2 5 
Klp98A KIF16B 11 
CG3600 NR6A1 8 
wun PLPP1 14 
 PLPP3 12 
 PLPP2 9 
CG18812 GDAP2 14 
CG10311 none  
DopEcR none  
cdc14 CDC14B 10 
 CDC14A 9 
 CDC14 5 
ari-2 ARIH2 15 
CG8745 ETNPPL 14 
 PHYKPL 11 
drongo AGFG1 10 
 AGFG2 5 
Slob none  
wdb PPP2R5E 13 
 PPP2R5A 12 
 PPP2R5B 9 
 PPP2R5C 5 
kek4 none  
Sin3A SIN3A 13 
 SIN3B 13 
sty SPRY2 11 
 SPRY4 9 
 SPRY3 9 
 SPRY1 9 
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Pdk PDK3 14 
 PDK2 13 
 PDK1 13 
 PDK4 13 
Top1 TOP1  
 TOP1MT  
CG31140 DGKQ 14 
drp none  
Or45b/?   
CG11033 KDM2A 13 
 KDM2B 11 
CG12433 none  
sdk SDK2 11 
 SDK1 10 
RhoGAP19D ARHGAP23 8 
 ARHGAP21 7 
tai NCOA3 5 
 NCOA1 5 
 NCOA2 5 
CG12355 MPV17L  
5-HT7 HTR7 6 
 HTR1B 4 
CG14234 TMEM198 13 
comm3 none  
cn KMO 14 
Mef2 MEF2C 11 
 MEF2A 11 
 MEF2D 10 
 MEF2B 5 
CG33724 none  
Blimp-1 PRDM1 12 
 ZNF683 5 
CG10419 GEMIN2 13 
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cdi TESK2 8 
 TESK1 6 
Rtnl1 RTN4 9 
 RTN3 9 
 RTN1 9 
 RTN2 7 
CrebB-17A CREB1 13 
 CREM 11 
 ATF1 10 
kay FOSL2 6 
Bx LMO1 8 
 LMO3 7 
CG3703 RUNDC1 14 
CG6398 none  
stnA none  
CG18135 GPCPD1 8 
Cyp6v1 CYP3A43 5 
 CYP3A7-CYP3A51P 5 
 TBXAS1 4 
foi SLC39A10  
 SLC39A6  
 SLC39A4  
Pkn PKN2 13 
 PKN1 12 
 PKN3 10 
CG7378 DUPD1 8 
 DUSP13 8 
 DUSP26 7 
 DUSP3 5 
 DUSP10 5 
Hr38 NR4A2 13 
 NR4A3 11 
 NR4A1 10 
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pum PUM2 12 
 PUM1 11 
Idh IDH1 14 
 IDH2 5 
DopEcR none  
Fas2 NCAM1 11 
 NCAM2 11 
Hn PAH 14 
CG30190 REEP2 9 
 REEP4 8 
 REEP1 8 
 REEP3 7 
NFAT NFAT5 7 
 NFATC3 6 
 NFATC2 5 
Pino none  
CG30377 none  
CtBP CTBP2 14 
 CTBP1 12 
CG2162 R3HCC1L 10 
 R3HCC1L 6 
l(2)08717 SLC17A2 5 
 SLC17A3 5 
 SLC17A4 5 
 SLC17A5 5 
 SLC17A7 5 
 SLC17A8 5 
CG3249 AKAP1 11 
CG6934 FRMPD4 9 
 FRMPD3 5 
 FRMPD1 5 
CG34045 none  
CG14619 USP2 9 
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 SUP21 6 
 MPRIP  
osp MPRIP 9 
 TRIOBP 6 
Lasp LASP1 9 
CG4238 AREL1 13 
CG6191 CABLES1 10 
 CABLES2 8 
ph-d PHC3 7 
 PHC2 6 
 PHC1 4 
Ptr PTCHD3 11 
 PTCHD1 7 
 PTCHD4 7 
Bsg NPTN 8 
 BSG 7 
CG32369 LONRF3 12 
 LONRF2 12 
 LONRF1 11 
Thd1 TDG 10 
Fmr1 FXR1 12 
 FXR2 11 
 FMR1 11 
CG15630 NCAM2 4 
 NCAM1 4 
bin3 MEPCE 10 
spir SPIRE1 13 
 SPIRE2 11 
cg none  
tamo SPATA2 7 
 SPATA2L 5 
CG16944 SLC25A4 12 
 SLC25A5 10 
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 SLC25A6 9 
 SLC25A31 8 
CG9007 KMT2E 8 
 SETD5 8 
CG8032 PAOX 13 
 SMOX 10 
CG5122 CRAT 7 
bip1 none  
h none  
CHES-1-like FOXn3 6 
Smr NCOR 10 
 NCSO2 9 
CG1600 none  
shakB none  
CG1888 none  
sr none  
NK7.1 none  
CG8490 none  
CG6770 NUPR1 8 
 NUPR5 5 
Sema-1a none  
CG11489 SRPK3 9 
 SRPK1 8 
 SRPK2 8 
jim none  
CG14764 none  
tau MAPT 7 
 MAP4 6 
 MPA2 5 
Trp1 SEC6S 13 
elB ZNF703 9 
 ANF503 8 
CG30492 ZFAND6 12 
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 ZFAND5 11 
CG5237 UNC79 14 
Act5C ACTB 11 
 ACTG1 10 
 POTEJ 5 
 POTEI 5 
 POTEF 5 
Mbs PPP1R12B 13 
 PPP1R12A 10 
 PPP1R12C 5 
CG12214 TBCEL 14 
CG31150 none  
Nmdmc MTHFD2 14 
 MTHFD2 12 
CG13330 none  
sick NAV2 9 
 NAV3 7 
CG1090 none  
th DBH 15 
 TH 15 
 TXNRD2 10 
 XIAP 7 
 BIRC3 6 
 BIRC2 6 
 TXNRD1 5 
glob1 CYGB 9 
glob1 HBG2 5 
 HBE1 5 
 HBG1 5 
d none  
oa2 none  
Eip75B none  
CG5830 CTDSPI1 15 
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 CTDSPL 12 
 CTDSP2 12 
spin SPNS1 13 
 SPNS3 9 
 SPNS2 9 
CG10543 none  
Lis-1 PAFAH1B1 14 
ctp DYNLL2 13 
 DYNLL1 9 
CG8489 none  
Sp7 none  
CG9335 none  
stck LIMS1 14 
 LIMS2 13 
 LIMS4 5 
retn ARID3A 11 
 ARID3C 9 
 ARID3B 8 
aret CELF2 14 
 CELF1 14 
CG5807 LMBR1L 14 
 LMBR1  13 
CG7982 AGAP1 13 
 AGAP3 11 
 AGAP2 9 
 AGAP4 7 
 AGAP5 6 
 AGAP6 6 
CG7378 none  
Atg4 ATG4A 14 
 ATG4D 13 
 ATG4B 13 
 ATG4C 12 
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dpp none  
CG34113 none  
CG5346 none  
CG32138 FMNL3 13 
 FMNL1 13 
 FMNL2 11 
emc ID4 10 
 ID1 10 
 ID2 9 
 ID3 8 
CG10737 none  
Inos ISYNA1 13 
Alh MLLT6 7 
 MLLT10 6 
CG11791 none  
TepIII CD109 11 
 PZP 6 
 A2M 6 
 A2ML1 5 
 C5 5 
dl REL 9 
 RELB 7 
 RELA 6 
CG13624 CREBRF 8 
CG33967 WWC2 13 
 WWC1 13 
 WWC3 11 
mys ITGB1 14 
 ITGB2 10 
 ITGB7 10 
 ITGB3 8 
 ITGB6 6 
 ITGB5 5 
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 ITGB4 5 
Pk61C PDPK1 13 
 PDPK2P 5 
CG3927 KHDRBS3 7 
 KHDRBS1 7 
 KHDRBS2 6 
Pect PCYT2 14 
CG3847 none  
alt none  
InR IGF1R 12 
 INSR 10 
 INSRR 9 
Oda OAZ2 9 
 OAZ1 8 
 OAZ3 7 
lin-52 LIN52 12 
tud TDRD6 10 
 TDRD15 9 
unc-104 KIF1A 11 
 KIF1B 9 
 KIF1C 6 
puc DUSP10 8 
sgg GSK3B 12 
 GSK3A 11 
CG5758 none  
CG31738 FNDC3A 12 
 FNDC3B 9 
CG8486 PIEZO2 13 
 PIEZO1 10 
hig none  
CG31300 none  
CHES-1-like none  
CG32352 none  
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Pvf3 none  
caps LRRN2 5 
 LRRC70 2 
rdgBbeta PITPNC1 14 
jeb none  
CG12054 JAZF1 11 
CG2225 none  
CG33144 RNF144A 10 
 RNF144B 5 
aralar1 none  
tws PPP2R2D 15 
 PPP2R2A 13 
 PPP2R2B 13 
 PPP2R2C 11 
Hsromega none  
Ald ALDOC 13 
 ALDOA 13 
 TTK 10 
 ALDOB 11 
scyl DDIT4 11 
 DDIT4L 11 
mbc DOCK1 13 
 DOCK2 12 
 DOCK5 11 
 DOCK3 5 
CG31619 ADAMTSL3 10 
 ADAMTSL1 9 
Eip74EF ELF2 7 
betaTub56D TUBB4B 12 
 TUBB4A 8 
 TUBB 8 
 TUBB2B 8 
 TUBB2A 6 
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 TUBB6 5 
CG9086 UBR2 14 
 UBR1 12 
brk none  
Sara ZFYVE16 11 
 ZFYVE9 11 
PGRP-LC none  
Treh TREH 14 
beat-Iib none  
sba MBD5 7 
osp none  
beta-Spec SPTB 11 
Ack TBK2 12 
 TBK1 8 
pk PRICKLE2 12 
 PRICKLE1 11 
 PRICKLE3 10 
glec none  
scrib SCRIB 7 
Dhc93AB DNAH9 14 
 DNAH17 11 
 DNAH11 8 
SK KCNN1 11 
 KCNN2 10 
 KCNN3 10 
CG14207 HSPB1 5 
Rdl none  
CG5151 none  
l(1)G0232 PTPN9 11 
shep RBMS3 11 
 RBMS2 10 
 RBMS1 10 
LpR1 VLDLR 11 
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 LDLR 9 
 LRP8 9 
klg none  
Msp-300 SYNE1 5 
Pfrx PFKFB1 13 
 PFKFB3 12 
 PFKFB4 12 




































928 human externalizing behavior genes and respective fly orthologs described in 
Chapter 2 
gene # 928 genes fly ortholog DIOPT FBGN 
1 SEMA6D Sema1a 8 FBGN011259 
  
Sema1b 7 FBGN016059 
2 CADM2 none >5   
3 LSAMP Ama 8 FBGN0000071 
  
DIP-epsilon 8 FBGN0259714 
  
DIP-kappa 8 FBGN0051814 
  
DIP-alpha 7 FBGN0052791 
  
DIP-eta 7 FBGN0031725 
  
DIP-iota 7 FBGN0031837 
  
DIP-beta 7 FBGN0259245 
  
DIP-theta 6 FBGN0051646 
  
DIP-zeta 6 FBGN0051708 
  
DIP-gamma 6 FBGN0039617 
  
DIP-delta 6 FBGN0085420 
  
Lac 5 FBGN0010238 
4 TENM2 Ten-m 13 FBGN0004449 
  
Ten-a 11 FBGN0267001 
5 SDK1 sdk 10 FBGN0021764 
6 DCC fra 12 FBGN0011592 
7 MAGI2 Magi 10 FBGN0034590 
8 THSD7B none >5   
9 SORCS3 none >5   
10 MAML3 none >5   
11 MSRA Eip72CD 11 FBGN0000565 
12 DAB1 Dab 8 FBGN0000414 
13 PDE4B dnc 12 FBGN0000479 
14 ROBO2 robo1 11 FBGN0005631 
  robo3 7 FBGN0041097 
  robo2 5 FBGN0002543 
15 XKR6 CG32579 10 FBGN0053579 
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  CG18635 5 FBGN0034279 
16 HIST1H3I His3:CG33866 5 FBGN0053866 
  His3: CG33863 5 FBGN0053863 
17 CAMTA1 Camta 12 FBGN0259234 
18 LRRC4C kek3 5 FBGN0028370 
19 NCAM1 Fas2 11 FBGN0000635 
20 WDPCP frtz 13 FBGN0086698 
21 HS6ST3 Hs6st 13 FBGN0038755 
22 LAMA2 wb 8 FBGN0261563 
23 EFNA5 none >5   
24 NTM DIP-tehta 8 FBGN0051646 
  DIP-zeta 8 FBGN0051708 
  DIP-epsilon 8 FBGN0259714 
  DIP-kappa 8 FBGN0051814 
  DIP-alpha 7 FBGN0052791 
  DIP-delta 7 FBGN0085420 
  DIP-iota 7 FBGN0031837 
  DIP-beta 7 FBGN0259245 
  DIP-gamma 7 FBGN0039617 
  DIP-eta 7 FBGN0031725 
  Ama 6 FBGN0000071 
  Lac 5 FBGN0010238 
25 SNTG1 Syn2 14 FBGN0034135 
26 CTNNA2 alpha-Cat 13 FBGN0010215 
27 CELF2 bru1 14 FBGN0000114 
  bru2 10 FBGN0262475 
28 ST3GAL3 none >5   
29 HYAL1 none >5   
30 HIST1H4L His4r 5 FBGN0013981 
31 FOXP2 FoxP 8 FBGN0262477 
32 BDNF none >5   
33 CHD13 none >5   
34 PTPRF Lar 11 FBGN0000464 
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35 C10orf32 CG18065 9 FBGN0034519 
36 BTN3A2 none >5   
37 OTX1 oc 7 FBGN0004102 
38 ZSCAN12 none >5   
39 BTN2A1 none >5   
40 EXOC4 Sec8 14 FBGN0266672 
41 LAMB2 LanB1 13 FBGN0261800 
42 ZKSCAN3 none >5   
43 ZKSCAN5 none >5   
44 ERI1 none >5   
45 NEGR1 Lac 9 FBGN0010238 
  DIP-zeta 8 FBGN0051708 
  DIP-epsilon 7 FBGN0259714 
  DIP-eta 7 FBGN0031725 
  DIP-beta 7 FBGN0259245 
  DIP-kappa 6 FBGN0051814 
  DIP-iota 6 FBGN0031837 
  DIP-alpha 6 FBGN0052791 
  DIP-gamma 6 FBGN0039617 
  DIP-delta 6 FBGN0085420 
  Ama 5 FBGN0000071 
  DIP-theta 5 FBGN0051646 
46 ELAVL4 fne 13 FBGN0086675 
  Rbp9 12 FBGN0010263 
  elav 7 FBGN0260400 
47 OPCML DIP-iota 9 FBGN0031837 
  DIP-theta 8 FBGN0051646 
  DIP-epsilon 8 FBGN0259714 
  DIP-gamma 8 FBGN0039617 
  DIP-eta 8 FBGN0031725 
  DIP-alpha 7 FBGN0052791 
  Ama 7 FBGN0000071 
  DIP-zeta 7 FBGN0051708 
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  DIP-beta 7 FBGN0259245 
  DIP-kappa 7 FBGN0051814 
  DIP-delta 6 FBGN0085420 
  Lac 5 FBGN0010238 
48 MDH1 Mdh1 14 FBGN0262782 
49 INPP4B CG42271 13 FBGN0262782 
50 CAMKV none >5   
51 PGBD1 none >5   
52 MAD1L1 Mad1 12 FBGN0026326 
53 ZFHX3 zfh2 12 FBGN0004607 
54 ZIC4 opa 9 FBGN0003002 
55 HIST1H2BN His2B: CG33884 8 FBGN0053884 
56 FBXL16 CG32085 12 FBGN0052085 
57 CYP17A1 none >5   
58 ZSCAN16 none >5   
59 ZSCAN4 none >5   
60 FURIN Fur1 10 FBGN004509 
61 TCF4 da 12 FBGN0267821 
62 ZSCAN8 none >5   
63 TMEM161B CG7638 14 FBGN0036133 
64 STK32C CG32944 11 FBGN0052944 
65 ZSCAN9 none >5   
66 MFHAS1 none >5   
67 HIST1H3J His3: CG33830 5 FBGN0053830 
  His3: CG33863 5 FBGN0053863 
68 UTRN Dys 9 FBGN0260003 
69 ZNF789 none >5   
70 WDR24 Wdr24 14 FBGN0025718 
71 NT5C2 CG32549 14 FBGN0052549 
72 PINX1 CG11180 7 FBGN0034528 
73 HCN1 Ih 5 FBGN0263397 
74 FAM002A none >5   
75 RBFOX1 Rbfox1 9 FBGN0052062 
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76 ENO4 none >5   
77 ASCC3 obe 15 FBGN0038344 
78 RP1L1 none >5   
79 GSI-259H13.10 none >5   
80 TCF20 CG5098 6 FBGN0034300 
81 PPP6C PpV 15 FBGN0003139 
82 ESRRG ERR 14 FBGN0035849 
83 C10orf32-ASMT none >5   
84 ARID5B none >5   
85 CNNM2 uex 12 FBGN0262124 
86 RP11-159G9.5 none >5   
87 TCTA none >5   
88 CGGBP1 none >5   
89 WBP1L none >5   
90 ARL3 dnd 12 FBGN0038916 
91 C3orf38 CG13876 14 FBGN0035109 
92 ZNF423 Oaz 12 FBGN0284250 
93 GABRB1 Lcch3 13 FBGN0010240 
94 RABEPK none >5   
95 A3GALT2 none >5   
96 PRKG1 for 13 FBGN0000721 
  Pkg21D 7 FBGN0000442 
  CG4839 5 FBGN0032187 
97 BPTF E(bx) 13 FBGN0000541 
98 NDUFAF2 CG43346 6 FBGN0263051 
99 REV3L mus205 12 FBGN0002891 
100 HLA-G none >5   
101 KLHL29 none >5   
102 OR5V1 none >5   
103 BRINP1 none >5   
104 ZNF165 none >5   
105 NAALADL2 none >5   
106 NQO1 none >5   
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107 ZNF322 none >5   
108 ISL1 tup 14 FBGN0003896 
109 TNKS Tnks 12 FBGN0027508 
110 SFXN2 Sfxn2 14 FBGN0036843 
111 ARPC1B Arpc1 13 FBGN0001961 
112 LRRC4 none >5   
113 TRIM8 none >5   
114 ARPC1A Arpc1 14 FBGN0001961 
115 ZIC1 opa 9 FBGN0003002 
116 LRPPRC bsf 13 FBGN0284256 
  Lrpprc2 8 FBGN0027794 
117 ERCC8 none >5   
118 SOX7 Sox15 5 FBGN0005613 
119 HIC1 none >5   
120 AGBL4 CG31019 13 FBGN0051019 
121 SCAI CG13293 14 FBGN0035677 
122 ZNF655 none >5   
123 BIRC6 Bruce 15 FBGN0266717 
124 DAG1 Dg 10 FBGN0034072 
125 ZNF536 none >5   
126 RANBP17 Ranbp16 12 FBGN0053180 
127 MCTP1 Mctp 13 FBGN0034389 
128 PCCA Mccc1 5 FBGN0039877 
129 AKT3 Akt1 12 FBGN0010379 
130 MON1A Mon1 13 FBGN0031640 
131 CLU none >5   
132 YIPF4 none >5   
133 RASSF1 none >5   
134 CA10 CARPB 13 FBGN0052698 
  CARPA 10 FBGN0029962 
135 PCDH7 none >5   
136 PCDH15 Cad99C 11 FBGN0039709 
137 CDH8 none >5   
158 
 
138 RUNX1T1 nvy 11 FBGN0005636 
139 ICK CG42366 9 FBGN0259712 
140 ATP5J2 ATPsynF 12 FBGN0035032 
141 MLTK none >5   
142 GATA4 pnr 10 FBGN0003117 
  GATAe 6 FBGN0038391 
143 WWP2 Su(dx) 11 FBGN0003557 
  Nedd4 5 FBGN0259174 
144 NOB1 CG2972 14 FBGN0030177 
145 ELAVL2 fne 14 FBGN0086675 
  Rbp9 12 FBGN0010263 
  elav 7 FBGN0260400 
146 ICA1L ICA69 13 FBGN0037050 
147 CACNA1D Ca-alpha1D 13 FBGN0001991 
  cac 5 FBGN0263111 
148 UBE2E3 Ubc2 13 FBGN0015320 
  CG5440 5 FBGN0031331 
149 IP6K1 CG10082 12 FBGN0034644 
150 PDAP1 CG11444 13 FBGN0029715 
  CG4438 13 FBGN0032115 
151 SOX7 Sox15 5 FBGN0005613 
152 TRAIP nopo 10 FBGN0034314 
153 DHODH Dhod 14 FBGN0000447 
154 HP none >5   
155 NECAB1 none >5   
156 BTN1A1 none >5   
157 FAM167A none >5   
158 ACTN2 Actn 13 FBGN0000667 
159 KIA1919 none >5   
160 KCNJ6 Irk2 6 FBGN0039081 
  Irk1 5 FBGN0265042 
161 C15orf59 none >5   
162 NFAT5 NFAT 7 FBGN0030505 
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163 TRIM39 none >5   
164 EMB none >5   
165 AFF3 lilli 8 FBGN0041111 
166 GALNTL6 Pgant6 14 FBGN0035375 
  Pgant4 11 FBGN0051956 
  Pgant8 7 FBGN0036529 
  CG31776 6 FBGN0051776 
  CG7579 5 FBGN0036528 
  CG7304 5 FBGN0036527 
167 RP11-180C1.1 none >5   
168 WDR12 CG6724 14 FBGN0032298 
169 CCDC36 none >5   
170 AUTS2 none >5   
171 ARID4A htk 11 FBGN0085451 
172 ELOVL7 ELOVL 15 FBGN0037534 
  CG31522 14 FBGN0051522 
  CG31523 10 FBGN0051523 
  CG6660 7 FBGN0039030 
  eloF 6 FBGN0037762 
  CG18609 6 FBGN0034382 
  sit 6 FBGN0038986 
  CG33110 6 FBGN0053110 
  CG30008 5 FBGN0050008 
  CG8534 5 FBGN0037761 
  CG9458 5 FBGN0037765 
  CG9459 5 FBGN0037764 
  CG31141 5 FBGN0051141 
  CG5326 5 FBGN0038983 
  CG17821 5 FBGN0034383 
  bond 5 FBGN0260942 
  CG16904 5 FBGN0037763 
  Elo68beta 5 FBGN0036128 
173 CALB1 Cbp53E 10 FBGN0004580 
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174 OR2J2 none >5   
175 EYS eys 5 FBGN0031414 
176 CARF none >5   
177 C3orf84 none >5   
178 ACTR10 Arp10 14 FBGN0031050 
179 TRIM27 none >5   
180 HPR none >5   
181 C8orf12 none >5   
182 GOLGA1 cbs 12 FBGN0086757 
183 C17orf58 none >5   
184 TBC1D5 TBC1D5 9 FBGN0038129 
185 NFKB2 Rel 6 FBGN0014018 
186 EHBP1 Ehbp1 12 FBGN0034180 
187 AC025287.1 none >5   
188 NFIA NfI 12 FBGN0042696 
189 C20orf112 CG46301 7 FBGN0283651 
190 MST1R none >5   
191 MAPKAP1 Sin1 15 FBGN0033935 
192 NRXN3 Nrx-1 11 FBGN0038975 
193 HIST1H1B His1:CG33825 8 FBGN0053825 
  His1: CG33807 7 FBGN0053807 
  His1: CG33801 7 FBGN0053801 
  His1: CG33834 6 FBGN0053834 
  His1: CG33861 6 FBGN0053861 
194 OR2B2 none >5   
195 ANO4 CG6938 10 FBGN0036235 
  CG10353 7 FBGN0030349 
  subdued 7 FBGN0038721 
196 GBF1 garz 15 FBGN0264560 
197 ZNF23 none >5   
198 NKAIN2 NKAIN 9 FBGN0085442 
199 WFIKKN1 none >5   
200 ERBB3 Egfr 9 FBGN0003731 
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201 MTMR9 CG5026 15 FBGN0035945 
202 LRRC27 none >5   
203 FBXL17 none >5   
204 FHIT none >5   
205 TOX CG12104 5 FBGN0035238 
206 GRID1 none >5   
207 FOXP1 FoxP 8 FBGN0262477 
208 GRM8 none >5   
209 BNC1 disco-r 9 FBGN0285879 
  disco  9 FBGN0000459 
210 CNTNAP5 Nrx-IV 10 FBGN0013997 
211 CBX8 Pc 9 FBGN0003042 
212 KIAAI522 none >5   
213 BRWD1 BRWD3 9 FBGN0011785 
214 CUEDC2 CG9636 14 FBGN0037556 
215 ADAT1 Adat1 9 FBGN0028658 
216 KPNA2 Pen 12 FBGN0267727 
217 TFAP2B TfAP-2 9 FBGN0261953 
218 NPAS3 trh 9 FBGN0262139 
219 SUFU Su(fu) 14 FBGN0005355 
220 TNRC6A gw 8 FBGN0051992 
221 NCOA5 Neos 10 FBGN0024542 
222 WDR38 none >5   
223 PHACTR1 CG32264 8 FBGN0052264 
224 SND1 Tudor-SN 13 FBGN0035121 
225 PLXNA4 PlexA 12 FBGN0025741 
226 USP4 none >5   
227 CPNE4 none >5   
228 LNPEP CG3502 5 FBGN0046253 
  CG31445 5 FBGN0051445 
  SP1029 5 FBGN0263236 
229 NRXN1 Nrx-1 12 FBGN0038975 
230 ACTR1A Arp1 14 FBGN0011745 
162 
 
231 PRDX5 Prx5 13 FBGN0038570 
232 NRAP none >5   
233 ARID1B osa 12 FBGN0261885 
234 SMIM19 none >5   
235 HIVEP1 shn 7 FBGN0003396 
236 IQCJ-SCHIP1 Schip1 9 FBGN0032221 
237 TRAF3 none >5   
238 PIGQ PIG-Q 8 FBGN0086448 
239 TMEM163 none >5   
240 LRFN2 none >5   
241 PSD Efa6 10 FBGN0051158 
242 CADPS2 Cadps 11 FBGN0053653 
243 GGACT Tina-1 14 FBGN0035083 
  CG2811 14 FBGN0035082 
244 CABP1 none >5   
245 SGCD Scgdelta 13 FBGN0025391 
246 PSMA3 Prosalpha7 15 FBGN0023175 
247 PMFBP1 none >5   
248 USP28 none >5   
249 CDHR4 none >5   
250 TSR1 Tsr1 13 FBGN0037073 
251 RBMS CG4896 14 FBGN0031319 
  CG4887 11 FBGN0031318 
252 GAPVD1 Gapvd1 14 FBGN0030286 
253 BTBD1 none >5   
254 RNF123 CG6752 14 FBGN0038296 
255 SYNGAP1 CG42684 9 FBGN0261570 
256 ABT1 CG32708 13 FBGN0052708 
  CG10993 12 FBGN0030524 
  CG41562 11 FBGN0085693 
  CG40813 11 FBGN0085521 
  CG32706 10 FBGN0052706 
  CG6999 10 FBGN0030085 
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257 CTNNA3 alpha-Cat 7 FBGN0010215 
258 HMGN4 none >5   
259 TM6SF1 none >5   
260 KDM4B Kdm4A 11 FBGN0033233 
  Kdm4B 9 FBGN0053182 
261 FAM186B none >5   
262 HOOK1 hook 10 FBGN0001202 
263 NICN1 none >5   
264 FXR1 Fmr1 12 FBGN0028734 
265 RAB5B Rab5 13 FBGN0014010 
266 FHIT none >5   
267 MCRS1 Rcd5 14 FBGN0263832 
268 CYB561D2 CG10165 9 FBGN0032801 
  CG13078 7 FBGN0032809 
  CG13077 7 FBGN0032810 
269 PHC2 ph-p 6 FBGN0004861 
  pd-d 6 FBGN0004860 
270 KDM4A Kdm4A 11 FBGN0033233 
  Kdm4B 10 FBGN0053182 
271 RHOA Rho1 13 FBGN0014020 
272 BSN none >5   
273 SEMA3F Sema2a 7 FBGN0011260 
  Sema2a 6 FBGN0264273 
274 GNAT1 Galphai 6 FBGN0001104 
275 TMEM115 CG9536 12 FBGN0031818 
276 ZNF654 none >5   
277 ZSCAN31 none >5   
278 TRAF3IP2 none >5   
279 PTCD1 CG4611 10 FBGN0035591 
280 ATP5J2-PTCD1 CG4611 5 FBGN0035591 
281 BLK Src64B 6 FBGN0262733 
282 AS3MT none >5   
283 KIAA1598 none >5   
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284 FES FER 11 FBGN0000723 
285 WDR90 none >5   
286 RHOT2 Miro 12 FBGN0039140 
287 STUB1 STUB1 15 FBGN0027052 
288 MDGA1 none >5   
289 GRID1 none >5   
290 ELMO1 Ced-12 13 FBGN0032409 
291 HDGFRP3 CG7946 7 FBGN0039743 
292 CALB2 Cbp53E 11 FBGN0004580 
293 FEZF1 erm 9 FBGN0031375 
294 ESR1 none >5   
295 OR12D3 none >5   
296 C14orf37 none >5   
297 LONRF2 CG32369 12 FBGN0052369 
298 GABARAPL2 Atg8a 5 FBGN0052672 
299 NBEAL1 CG43367 8 FBGN0263110 
300 PDE11A Pde6 7 FBGN0038237 
  Pde11 6 FBGN0085370 
301 AMBRA1 none >5   
302 RAB19 Rab19 8 FBGN0015793 
303 ARFGAP2 ArfGAP3 14 FBGN0037182 
304 ATG13 Atg13 11 FBGN0261108 
305 AC117395.1 none >5   
306 TRIM26 none >5   
307 IGSF11 none >5   
308 HIST1H3C His3: CG33863 6 FBGN0053863 
309 DGKZ rdgA 14 FBGN0261549 
310 SLC24A3 zyd 9 FBGN0265767 
  CG17167 5 FBGN0039941 
311 TDRKH papi 11 FBGN0031401 
312 SCN2A para 11 FBGN0258944 
313 LRRTM4 none >5   
314 PRPF40B CG3542 13 FBGN0031492 
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315 REST none >5   
316 CCDC71 none >5   
317 CPSF4 Clp 15 FBGN0015621 
318 SUOX shop 15 FBGN0030966 
319 AF131215.5 none >5   
320 PSMD11 Rpn6 14 FBGN0028689 
321 SPAST spas 15 FBGN0039141 
322 ARHGAP15 none >5   
323 DIAPH3 dia 12 FBGN0011202 
324 CIT sti 12 FBGN0002466 
325 RAB40C Rab40 14 FBGN0030391 
326 ZNF207 BuGZ 10 FBGN0032600 
327 IGF1 none >5   
328 RBM6 CG4896 6 FBGN0031319 
  CG4887 5 FBGN0031318 
329 PARD3B baz 11 FBGN0000163 
330 TRIM31 none >5   
331 KIAA1328 none >5   
332 HYAL3 none >5   
333 HHLA2 none >5   
334 CCDC53 CCDC53 14 FBGN0031979 
335 FMNL3 Frl 13 FBGN0267795 
336 PLCB3 Plc21C 12 FBGN0004611 
337 PTK2 Fak 12 FBGN0020440 
338 HIST1H2AJ His2A: CG33832 6 FBGN0053832 
  His2A: CG33859 5 FBGN0053859 
339 DLG2 dlg1 11 FBGN0001624 
340 ABDH17C CG33096 12 FBGN0053096 
341 IPO13 cdm 14 FBGN0261532 
342 DEFB134 none >5   
343 AAGAB CG32109 8 FBGN0052109 
344 IMPDH2 ras 10 FBGN0003204 
345 ZSCAN23 none >5   
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346 CHD3 Mi-2 12 FBGN0262519 
  Chd3 7 FBGN0023395 
347 PPP1R3B Gbs-70E 9 FBGN0036428 
  Gbs-76A 5 FBGN0036862 
348 ASPG CG6428 13 FBGN0029689 
  CG8526 13 FBGN0037759 
349 POM121L2 none >5   
350 DUSP6 Mkp3 10 FBGN0036844 
351 OAZ3 Oda 7 FBGN0014184 
352 TMEM71 none >5   
353 RNF19B none >5   
354 RP11-463C8.4 none >5   
355 IMMP2L CG11110 15 FBGN0034535 
356 C8orf88 none >5   
357 TERF21P none >5   
358 IKZF2 none >5   
359 NYAP2 none >5   
360 NBN nbs 10 FBGN0261530 
361 RPS6KA4 JIL-1 8 FBGN0020412 
362 CNTN4 Cont 12 FBGN0037240 
363 ZNF19 none >5   
364 PARPBP none >5   
365 ELL Su(Tpl) 9 FBGN0014037 
366 S100PBP none >5   
367 TRAPPC1 Bet5 14 FBGN0260860 
368 SLC39A5 Zip71B 8 FBGN0035461 
369 BUD31 l(1)10Bb 14 FBGN0001491 
370 PTPRD Lar 12 FBGN0000464 
371 KCNH3 Elk 11 FBGN0011589 
372 C17orf75 none >5   
373 METTL16 CG7544 12 FBGN0033994 
374 GUCA1C none >5   
375 ITIH3 none >5   
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376 ZFYVE21 none >5   
377 PFN2 none >5   
378 NLRC4 none >5   
379 TMBIM6 BI-1 14 FBGN0035871 
380 RP11-481A20.11 none >5   
381 THBS4 Tsp 12 FBGN0031850 
382 ZNF652 none >5   
383 UNC79 unc79 14 FBGN0038693 
384 NUP37 Nup37 14 FBGN0039301 
385 PXDNL Pxn 11 FBGN0011828 
386 MST1 none >5   
387 NAA25 psidin 15 FBGN0243511 
388 MORC1 none >5   
389 ISYNA1 Inos 13 FBGN0025885 
390 XXcos-LUCA11.5 none >5   
391 CACNB4 Ca-beta 12 FBGN0259822 
392 VT11A Vti1a 14 FBGN0260862 
393 YARS TyrRS 15 FBGN0027080 
394 CYP2J2 Cyp18a1 9 FBGN0010383 
  Cyp305a1 6 FBGN0036910 
395 SLC30A6 none >5   
396 SFMBT1 none >5   
397 TXNL4B none >5   
398 BCL11A CG9650 11 FBGN0029939 
399 CHDH CG9514 8 FBGN0030592 
  Gld 7 FBGN0001112 
  CG12398 7 FBGN0030596 
  CG9518 7 FBGN0030590 
  CG9519 6 FBGN0030589 
  CG12539 6 FBGN0030586 
  CG9522 6 FBGN0030587 
  CG9521 6 FBGN0030588 
  CG6142 6 FBGN0039415 
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  CG9503 6 FBGN0030598 
  CG9512 6 FBGN0030593 
  fiz 6 FBGN0030594 
400 TTC29 none >5   
401 LINGO1 none >5   
402 PLEKHA5 CG34383 5 FBGN0085412 
403 ASPSCR1 CG33722 12 FBGN0064126 
404 LUZP2 none >5   
405 FAF1 casp 14 FBGN0034068 
406 NSF Nsf2 14 FBGN0266464 
  comt 14 FBGN0000346 
  CG31495 6 FBGN0051495 
407 TMEM55A CG6707 12 FBGN0036058 
408 MTX3 CG9393 11 FBGN0037710 
409 BAI3 none >5   
410 PTPRN2 IA-2 10 FBGN0031294 
411 XXbac-BPG2J3.20 none >5   
412 TMEM180 none >5   
413 SSBP4 Ssdp 12 FBGN0011481 
414 VARS ValRS 15 FBGN0027079 
  ValRS-m 7 FBGN0035942 
415 PTPRG Ptp99A 9 FBGN0004369 
416 NFATC2IP none >5   
417 SIPA1L2 none >5   
418 CPSF6 Cpsf6 13 FBGN0035872 
419 RAB7A Rab7 13 FBGN0015795 
420 C1orf87 none >5   
421 QK1 how 12 FBGN0264491 
422 BTN3A3 none >5   
423 HIST1H2AL none >5   
424 ITIH4 none >5   
425 CCDC88B Girdin 5 FBGN0283724 
426 PITX3 Ptx1 8 FBGN0020912 
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427 TRIM39-RPP21 none >5   
428 TGFBRAP1 none >5   
429 IQCH none >5   
430 PPP1R13B ASPP 14 FBGN0034606 
431 USMG5 Neb-cGP 7 FBGN0083167 
432 DPP10 CG17684 9 FBGN0263780 
  CG11319 9 FBGN0031835 
  CG11034 9 FBGN0031741 
  ome 8 FBGN0259175 
  CG45002 6 FBGN0266354 
433 CHST10 none >5   
434 CD40 none >5   
435 ZKSCAN2 none >5   
436 OTX2 oc 6 FBGN0004102 
437 PSME4 none >5   
438 CD47 none >5   
439 KCNJ3 Irk2 5 FBGN0039081 
440 AGBL1 none >5   
441 ZNF408 none >5   
442 DXO CG9125 14 FBGN0030793 
  cuff 7 FBGN0260932 
443 CUL3 Cul3 13 FBGN0261268 
444 SLC39A13 none >5   
445 HIST1H4A His4: CG33887 5 FBGN0053887 
446 HTR1F none >5   
447 SPOCK1 Cow 9 FBGN0039054 
448 CYP3A43 Cyp9f2 8 FBGN0038037 
  Cyp9c1 7 FBGN0015040 
  Cyp9b1 7 FBGN0015038 
  Cyp6a17 7 FBGN0015714 
  Cyp9h1 6 FBGN0033775 
  Cyp9b2 6 FBGN0015039 
  Cyp6a8 6 FBGN0013772 
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  Cyp6a2 6 FBGN0000473 
  Cyp6a23 6 FBGN0033978 
  Cyp6a18 6 FBGN0039519 
  Cyp6a22 6 FBGN0013773 
  Cyp6a9 6 FBGN0013771 
  Cyp6a19 6 FBGN0033979 
  Cyp6a13 5 FBGN0033304 
  Cyp6g1 5 FBGN0025454 
  Cyp6w1 5 FBGN0033065 
  Cyp6a20 5 FBGN0033980 
  Cyp6v1 5 FBGN0031126 
  Cyp6g2 5 FBGN0033696 
  Cyp6a21 5 FBGN0033981 
449 CD19 none >5   
450 DENND1B CG18659 10 FBGN0027561 
451 MARCH1 none >5   
452 HARBI1 CG12253 8 FBGN0026148 
  CG43088 5 FBGN0262534 
453 CLEC18A none >5   
454 GRIK2 KaiR1D 10 FBGN0038837 
  Ekar 9 FBGN0039916 
  Grik 8 FBGN0038840 
  GluRIID 7 FBGN0028422 
  clumsy 7 FBGN0026255 
  GluRIIE 7 FBGN0051201 
  CG11155 7 FBGN0039927 
455 BHLHE22 Oli 12 FBGN0032651 
456 C11orf49 none >5   
457 PLD5 CG9248 6 FBGN0032923 
  CG43345 5 FBGN0263050 
458 NRXN2 Nrx-1 12 FBGN0038975 
459 SLC1A5 Eaat1 7 FBGN0026439 
460 TECPR1 Pex23 14 FBGN0052226 
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461 ERBB4 Egfr 10 FBGN0003731 
462 GPR137 none >5   
463 HECTD4 none >5   
464 PWWP2B none >5   
465 MYT1L CG43689 7 FBGN0263772 
466 RBM43 none >5   
467 SPNS1 spin 13 FBGN0086676 
468 TNRC6B gw 8 FBGN0051992 
469 ALMS1 none >5   
470 JADE2 rno 7 FBGN0035106 
471 FAM135B CG32333 13 FBGN0052333 
472 DBNDD1 none >5   
473 C1orf173 none >5   
474 GABRA2 CG8916 10 FBGN0030707 
  Grd 6 FBGN0001134 
475 ARTN none >5   
476 EFTUD1 CG33158 15 FBGN0053158 
477 ZCCHC7 Zcchc7 6 FBGN0036668 
478 CTD-2330K9.3 none >5   
479 CNPY2 sel 12 FBGN0263260 
480 CACYBP CG3226 14 FBGN0029882 
481 RPL6 RpL6 14 FBGN0039857 
482 DCD1 none >5   
483 SGK223 none >5   
484 PHLPP2 Phllp 9 FBGN0032749 
485 DNAJC11 CG8531 14 FBGN0033918 
486 ARL17B none >5   
487 FAT3 kug 13 FBGN0251574 
488 KANSL1 nsl1 9 FBGN0262527 
489 HACE1 none >5   
490 FDFT1 none >5   
491 STON1-GTF2A1L TfIIA-L 5 FBGN0011289 
492 CPNE7 none >5   
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493 CCDC101 Sgf29 13 FBGN0050390 
494 ZNF75A none >5   
495 C6orf48 none >5   
496 SPI1 none >5   
497 MAPT tau 7 FBGN0266579 
498 QRICH1 none >5   
499 SZT2 none >5   
500 CPEB4 orb2 9 FBGN0264307 
501 GABRB2 Lcch3 12 FBGN0010240 
502 CRHR1 Dh44-R2 9 FBGN0033744 
  Dh44-R1 9 FBGN0033932 
503 ERP29 wbl 15 FBGN0004003 
504 RYR2 RyR 14 FBGN0011286 
505 FPGT-TNNI3K none >5   
506 TNNI3K none >5   
507 IGF1R InR 12 FBGN0283499 
508 NOTUM Notum 11 FBGN0044028 
509 APEH none >5   
510 MPL none >5   
511 STH none >5   
512 SLC20A2 NaPi-III 12 FBGN0260795 
513 STAT2 none >5   
514 WNT3 none >5   
515 RP11-977G19.10 none >5   
514 ABHD16A CG1309 14 FBGN0035519 
517 ATAT1 CG17003 10 FBGN0031082 
518 CS kdn 14 FBGN0261955 
  CG14740 7 FBGN0037988 
519 SMG6 Smg6 11 FBGN0039260 
520 SMYD2 Smyd3 10 FBGN0011566 
  SmydA-9 6 FBGN0030102 
  SmydA-5 5 FBGN0033061 
521 RP5-966M1.6 none >5   
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522 PAN2 PAN2 14 FBGN0033352 
523 ARIH2 ari-2 15 FBGN0025186 
524 POSTN mfas 10 FBGN0260745 
  Fas1 7 FBGN0285925 
  CG43333 5 FBGN0263038 
525 SCAND3 none >5   
526 ZNF385D none >5   
527 PIPOX none >5   
528 PHF10 e(y)3 9 FBGN0087008 
529 DALRD3 CG8097 11 FBGN0030660 
530 KLHDC8B none >5   
531 ASTN2 none >5   
532 PCGF6 none >5   
533 PSMG1 none >5   
534 AGO2 AGO1 14 FBGN0262739 
535 ZNF263 none >5   
536 AP1G1 AP-1gamma 13 FBGN0030089 
537 POU1F1 none >5   
538 RSRC1 none >5   
539 SLC17A3 CG3649 6 FBGN0034785 
  MFS12 6 FBGN0033234 
  CG30265 6 FBGN0050265 
  CG9825 6 FBGN0034783 
  dmGlut 6 FBGN0010497 
  MFS17 5 FBGN0058263 
  CG2003 5 FBGN0039886 
  CG7881 5 FBGN0033048 
  MFS1 5 FBGN0050272 
  MFS14 5 FBGN0010651 
  CG6978 5 FBGN0029727 
  CG9254 5 FBGN0028513 
  CG12490 5 FBGN0034782 
  CG15096 5 FBGN0034394 
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  MFS15 5 FBGN0034392 
540 USP19 none >5   
541 WDR27 none >5   
542 AC011239.1 none >5   
543 DPEP1 CG44837 8 FBGN0266100 
  CG42750 6 FBGN0261804 
  CG5282 6 FBGN0036986 
544 GPX1 none >5   
545 TRIM38 none >5   
546 LZTS2 CG15365 6 FBGN0030077 
547 DPYD su(r) 15 FBGN0086450 
548 SRR Srr 8 FBGN0037684 
549 SMIM15 none >5   
550 NLGN1 Nlg3 11 FBGN0083963 
  Nlg2 10 FBGN0031866 
  Nlg4 8 FBGN0083975 
  Nlg1 7 FBGN0051146 
551 ANKRD52 none >5   
552 AC010547.9 none >5   
553 TRAFD1 none >5   
554 SPPL2C none >5   
555 PTCRA none >5   
556 DEFB136 none >5   
557 BMPR2 wit 9 FBGN0024179 
558 ZNF407 none >5   
559 MACROD2 none >5   
560 TMEM110 none >5   
561 BRI3 CG12012 12 FBGN0035444 
562 FBXO9 CG5961 15 FBGN0038056 
563 TMEM110-MUSTN1 none >5   
564 PHF1 Pcl 10 FBGN0003044 
564 AC079354.1 none >5   
566 CCSER1 none >5   
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567 CDH12 none >5   
568 CAMK1D CaMKI 13 FBGN0016126 
569 ARHGAP1 RhoGAP68F 15 FBGN0036257 
570 RBM14 none >5   
571 QARS GlnRS 14 FBGN0027090 
572 ERAP2 CG3502 5 FBGN0046253 
  CG8773 5 FBGN0038135 
  CG31445 5 FBGN0051445 
  SP1029 5 FBGN0263236 
573 CHADL none >5   
574 MSH5-SAPCD1 none >5   
575 MSH5  none >5   
576 HPCA Nca 10 FBGN0013303 
577 KCNAB3 Hk 10 FBGN0263220 
578 GRIA4 GluRIB 12 FBGN0264000 
  GluRIA 11 FBGN0004619 
579 FAM13C CG6424 6 FBGN0028494 
580 WDR6 CG33172 13 FBGN0053172 
581 CTTNBP2 none >5   
582 MEF2C Mef2 11 FBGN0011656 
583 ATP6V0B VhaPPA-1 15 FBGN0028662 
  VhaPPA1-2 9 FBGN0262514 
584 ATP2A1 SERCA 14 FBGN0263006 
585 SLC22A12 CG8654 6 FBGN0034479 
  Orct 6 FBGN0019952 
  Orct2 6 FBGN0086365 
  CG6126 5 FBGN0038407 
  Balat 5 FBGN0033778 
  CG6356 5 FBGN0039178 
  CG7458 5 FBGN0037144 
  SLC22A 5 FBGN0037140 
  CG4630 5 FBGN0033809 
586 SLC25A20 colt 14 FBGN0019830 
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  MME1 10 FBGN0031881 
587 SLC4A2 none >5   
588 AHCYL1 AhcyL1 14 FBGN0035371 
  AhcyL2 10 FBGN0015011 
589 TET2 none >5   
590 GSTO2 GstO2 12 FBGN0035906 
  GstO3 12 FBGN0035904 
  se  12 FBGN0086348 
  GstO1 11 FBGN0035907 
591 PSMC3 Rpt5 13 FBGN0028684 
592 MLLT10 Alh 6 FBGN0261238 
593 FOXO3 foxo 9 FBGN0038197 
594 GPR135 none >5   
595 AP1S1 AP-1sigma 11 FBGN0039132 
596 C10orf2 mtDNA-helicase 14 FBGN0032154 
  Chmp1 12 FBGN0036805 
597 SLC35G5 none >5   
598 MSI1 Rbp6 11 FBGN0260943 
599 POLR2F RpII18 14 FBGN0003275 
600 MAPK14 p38b 15 FBGN0024846 
  p38a 13 FBGN0015765 
  p38c 5 FBGN0267339 
601 TRHDE none >5   
602 IGSF21 none >5   
603 PRKAR2A Pka-R2 13 FBGN0022382 
  Pka-R1 5 FBGN0259243 
604 UBXN1 CG8209 15 FBGN0035830 
605 GRID2 none >5   
606 RP11-894J14.5 none >5   
607 CCDC24 none >5   
608 CNTNAP4 Nrx-IV 10 FBGN001397 
609 LY6H none >5   
610 MEIS2 hth 11 FBGN0001235 
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611 RP11-410N8.4 none >5   
612 RFT1 CG3149 13 FBGN0027564 
613 KIF26A CG14535 7 FBGN0031955 
614 SPG7 Spg7 13 FBGN0024992 
615 LAT none >5   
616 FNDC5 none >5   
617 SULT1A2 St1 8 FBGN0034887 
  St3 7 FBGN0265052 
  St4 7 FBGN0033887 
  St2 6 FBGN0037665 
618 ARPC5L Arpc5 13 FBGN0031437 
619 XRCC3 spn-B 15 FBGN0003480 
620 RPL7L1 RpL7 6 FBGN0005593 
621 TMEM116 none >5   
622 GPC6 dlp 12 FBGN0041604 
623 PFKFB2 Pfrx 11 FBGN0027621 
624 CTDP1 Fcp1 13 FBGN0035026 
625 EP300 nej 12 FBGN0261617 
626 L3MBTL2 Sfmbt 10 FBGN0032475 
627 CCDC167 none >5   
628 IFRD2 CG31694 13 FBGN0051694 
629 BSCL2 Seipin 12 FBGN0040336 
630 GAS8 Gas8 13 FBGN0029667 
631 ATAD2B none >5   
632 IL23A none >5   
633 SORCS1 none >5   
634 HOMER2 homer 15 FBGN0025777 
635 ZBTB16 none >5   
636 COQ10A CG9410 13 FBGN0033086 
637 SREBF1 SREBP 12 FBGN0261283 
638 DPP4 CG11034 10 FBGN0031741 
  ome 9 FBGN0259175 
  CG17684 6 FBGN0263780 
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639 ANKS1B CG4393 10 FBGN0039075 
  CG11168 10 FBGN0039249 
640 MSI2 Rbp6 13 FBGN0260943 
  msi 5 FBGN0011666 
641 PLCL2 none >5   
642 STRIP1 Strip 14 FBGN0035437 
643 SEMA4G Sema2a 5 FBGN0011260 
  Sema2b 5 FBGN0264273 
644 PRR7 none >5   
645 CNPY3 CNPYb 10 FBGN0036847 
646 PDE1C Pde1c 8 FBGN0264815 
647 PLD1 Pld 12 FBGN0286511 
648 ARHGAP27 none >5   
649 MRPL43 mRpL43 14 FBGN0034893 
650 TMPO none >5   
651 ZAP70 Shark 7 FBGN0015295 
652 TTC9C none >5   
653 PLEKHM1 none >5   
654 DHX30 none >5   
655 ITIH1 none >5   
656 DEPDC1B none >5   
657 BPNT1 CG7789 12 FBGN0039698 
658 PACSIN3 Synd 11 FBGN0053094 
659 HNRNPUL2-BSCL2 none >5   
660 TOP2B Top2 12 FBGN0284220 
661 NAT16 none >5   
662 USF2 Usf 8 FBGN0029711 
663 FKRP CG15651 14 FBGN0034567 
664 KIAA1462 none >5   
665 TCAP none >5   
666 PIK3R3 PiK21B 13 FBGN0020622 
667 BTAF1 Hel89B 12 FBGN0022787 
668 NDFIP2 Ndfip 13 FBGN0052177 
179 
 
669 AMIGO3 none >5   
670 GMPPB CG1129 14 FBGN0037279 
671 CHMP3 Vps24 6 FBGN0037231 
672 PLAGL2 none >5   
673 AL645922.1 none >5   
674 P4HTM none >5   
675 BEND7 none >5   
676 CMTR1 CG6379 12 FBGN0029693 
677 RP11-831H9.11 none >5   
678 TEAD3 sd 12 FBGN0003345 
679 RNF103-CHMP3 Vps24 10 FBGN0037231 
680 TPM3 Tm2 11 FBGN0003721 
  Tm1 11 FBGN0003721 
681 NKAPL CG6066 11 FBGN0039488 
682 RABEP2 none >5   
683 CCNJ CycJ 8 FBGN0010317 
684 PHF13 none >5   
685 MKRN1 CG5347 13 FBGN0030578 
  Mkrn1 11 FBGN0029152 
  CG5332 10 FBGN0030577 
  CG12477 7 FBGN0036809 
686 TOM1L2 CG3529 13 FBGN0035995 
687 DHX16 l(2)37Cb 14 FBGN0086444 
688 PHYHIPL none >5   
689 CASP7 Drice 12 FBGN0019972 
  Dcp-1 12 FBGN0010501 
690 RORA Hr3 9 FBGN0000448 
691 HNRNPUL2 CG30122 8 FBGN0050122 
692 DLX6 Dll 7 FBGN0000157 
693 LYZ LysP 13 FBGN0004429 
  LysE 12 FBGN0004428 
  LysD 11 FBGN0004427 
  LysS 11 FBGN0004430 
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  LysB 11 FBGN0004425 
  CG7798 10 FBGN0034092 
  LysX 10 FBGN0004431 
  CG16799 8 FBGN0034538 
  CG11159 8 FBGN0034539 
  CG16756 7 FBGN0029765 
  CG30062 6 FBGN0050062 
  CG8492 5 FBGN0035813 
694 ADAM15 Meltrin 9 FBGN0265140 
695 SORL1 none >5   
696 MCHR2 none >5   
697 JKAMP CG2126 14 FBGN0039876 
698 HYI Gip 14 FBGN0011770 
699 LIN7C veli 12 FBGN0039269 
700 SLIT2 sli 12 FBGN0264089 
701 CYP7B1 none >5   
702 C15orf40 CG14966 12 FBGN0035415 
703 VPS54 scat 14 FBGN0011232 
704 MAP2K5 none >5   
705 AC005544.1 none >5   
706 SFTA2 none >5   
707 C11orf48 none >5   
708 SIKE1 Fgop2 11 FBGN0031871 
709 CIPC none >5   
710 LMO3 Bx 7 FBGN0032196 
711 NSUN3 none >5   
712 CUX1 ct 10 FBGN0004198 
713 USP3 none >5   
714 BAD none >5   
715 PNMA2 none >5   
716 ZBTB46 none >5   
717 LINGO4 none >5   
718 PSORS1C2 none >5   
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719 DYPSL2 CRMP 10 FBGN0023023 
720 HLA-B none >5   
721 HSPA5 none >5   
722 KLHL21 none >5   
723 TMEFF2 none >5   
724 GSTO1 se 14 FBGN0086348 
  GSTO1 13 FBGN0035907 
  GSTO2 11 FBGN0035906 
725 AZGP1 none >5   
726 CTBP1 CtBP 12 FBGN0020496 
727 B4GLT2 beta4GalNAcTA 12 FBGN0027538 
728 VPS33B Vps33B 7 FBGN0039335 
729 FTO none >5   
730 KIAA1551 none >5   
731 BAIAP2L1 IRSp53 8 FBGN0052082 
732 C22orf23 CG5280 12 FBGN0035952 
733 SMARCC1 mor 13 FBGN0002783 
734 CSNK2B-LY6G5B-1181 none >5   
735 EXT1 ttv 13 FBGN0254974 
736 ADAP2 none >5   
737 SNRK CG8485 11 FBGN0033915 
738 BNIP3L CG5059 5 FBGN0037007 
739 FDPS Fpps 15 FBGN0025373 
740 ATXN2L Atx2 10 FBGN0041188 
741 ZBTB9 none >5   
742 SERPINC1 none >5   
743 CDKN2C none >5   
744 UBXN2A p47 8 FBGN0033179 
  CG42383 7 FBGN0259729 
745 MYO15A Myo10A 13 FBGN0263705 
746 ZBTB37 none >5   
747 RP11-10A14.4 none >5   
748 NOA1 CG10914 15 FBGN0034307 
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749 SGIP1 CG8176 8 FBGN0037702 
750 HISTH1A Hist1: CG33834 5 FBGN0053834 
  Hist1: CG33807 5 FBGN0053807 
  Hist1: CG33801 5 FBGN0053801 
  Hist1: CG33825 5 FBGN0053825 
751 C16orf11 none >5   
752 ARID2 Bap170 13 FBGN0042085 
753 REV1 Rev1 13 FBGN0035150 
754 C16orf3 none >5   
755 CLIC1 Clic 10 FBGN0030529 
756 RBM19 CG3335 15 FBGN0036018 
757 HMGA1 none >5   
758 COQ5 Coq5 13 FBGN0030460 
759 PWWP2A none >5   
760 GCAT CG10361 15 FBGN0036208 
761 GPR75-ASB3 none >5   
762 GRM7 none >5   
763 OLFM1 none >5   
764 CHMP1A none >5   
765 MAP4 tau 6 FBGN0266579 
766 SH2B1 Lnk 10 FBGN0028717 
767 ZFHX4 zfh2 12 FBGN0004607 
768 TMEM132B dtn 13 FBGN0262730 
769 MED17 MED17 14 FBGN0038578 
770 ACYP2 CG18371 10 FBGN0033893 
  CG14022 10 FBGN0031700 
  Acyp2 9 FBGN0038363 
  CG34161 8 FBGN0085190 
  Acyp 8 FBGN0025115 
  CG11052 7 FBGN0040524 
771 C2orf69 CG31122 13 FBGN0051122 
772 AQP8 none >5   
773 PSMA6 CG30382 12 FBGN0050382 
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  Prosalpha1 11 FBGN0263121 
774 MAST2 dop 11 FBGN0267390 
775 SPATA33 none >5   
776 TYW5 none >5   
777 NMD3 Nmd3 13 FBGN0023542 
778 NOL9 CG8414 9 FBGN0034073 
779 CTD-2260A17.2 CG3502 5 FBGN0046253 
  CG8773 5 FBGN0038135 
  CG31445 5 FBGN0051445 
  SP1029 5 FBGN0263236 
780 CTNNAL1 alpha-Catr 14 FBGN0029105 
781 DPCR1 none >5   
782 GSTA4 none >5   
783 MED27 MED27 14 FBGN0037359 
784 ALEX3 none >5   
785 FLJ27365 none >5   
786 C11orf80 none >5   
787 POLDIP2 POLDIP2 12 FBGN0037329 
788 UBA7 Uba1 7 FBGN0023143 
789 ANO10 Axs 12 FBGN0000152 
790 CSMD1 none >5   
791 UBE2E1 Ubc2 12 FBGN0015320 
792 HPSS p 9 FBGN0086679 
793 ATAD5 elg1 10 FBGN0036574 
794 U2SURP CG9346 13 FBGN0034572 
795 MTX1 CG9393 14 FBGN0037710 
796 BCL11B CG9650 12 FBGN0029939 
797 ASNS AsnS 11 FBGN0270926 
798 AL132989.1 none >5   
799 HFE none >5   
800 UVSSA none >5   
801 TMEM17 none >5   
802 TUFM mEFTu1 13 FBGN0024556 
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  mEFTu2 5 FBGN0033184 
803 RP11-529K1.3 none >5   
804 SEZ6 none >5   
805 PLEKHG5 CG42674 6 FBGN02161556 
806 DEF8 CG11534 15 FBGN0046296 
807 DYNC1I2 sw 13 FBGN0003654 
  Sdic1 12 FBGN0067861 
  Sdic4 11 FBGN0053499 
  SdicB 7 FBGN0283433 
  Sdic3 7 FBGN0052823 
  Sdic2 6 FBGN0053497 
  SdicC 5 FBGN0283434 
808 PTPRM none >5   
809 PRKAB1 alc 13 FBGN0260972 
810 BTBD9 BTBD9 14 FBGN0030228 
811 C6orf1 none >5   
812 MEGT1 none >5   
813 TMEM160 none >5   
814 CSPG5 none >5   
815 PRDM5 none >5   
816 ANKRD54 CG10809 10 FBGN0036052 
817 SLC26A7 Prestin 6 FBGN0036770 
818 BAIAP2 IRSp53 10 FBGN0052082 
819 TM9SF4 TM9SF4 14 FBGN0028541 
  TM9SF2 5 FBGN0032880 
820 ATXN1L Atx-1 7 FBGN0029907 
821 SOX10 Sox100B 5 FBGN0024288 
822 CHMP2B CHMP2B 14 FBGN0035589 
823 TSPAN2 none >5   
824 AKIRIN2 akirin 14 FBGN0082598 
825 CASC10 none >5   
826 CLN3 Cln3 13 FBGN0036756 
827 KLF7 luna 8 FBGN0040765 
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828 OR12D2 none >5   
829 LY6G6F none >5   
830 COPZ2 zetaCOP 7 FBGN0040512 
831 PRKD1 PKD 13 FBGN0038603 
832 ALS2CL Als2 9 FBGN0037116 
833 RP11-297N6.4 none >5   
834 CHCHD3 Chchd3 11 FBGN0010808 
835 MRPS14 mRpS14 13 FBGN0044030 
836 SGCE Scgalpha 14 FBGN0032013 
837 FAM216B none >5   
838 PKLR PyK 11 FBGN0267385 
  CG2964 6 FBGN0031462 
  CG7069 5 FBGN0038952 
  CG7362 5 FBGN0038258 
839 HSD17B12 spidey 14 FBGN0029975 
  CG31809 6 FBGN0051809 
  CG13284 6 FBGN0032614 
  CG31810 5 FBGN0051810 
840 ADCK1 Adck 14 FBGN0035039 
841 KCND2 Shal 13 FBGN0005564 
842 IQCJ none >5   
843 PROS1 none >5   
844 DNAJB1 CG5001 12 FBGN0031322 
  DnaJ-1 12 FBGN0263106 
  CG2887 6 FBGN0030207 
845 CACNA1E cac 9 FBGN0263111 
846 EMR2 none >5   
847 MTFR1 none >5   
848 HEYL Hey 7 FBGN0027788 
849 GRK6 Gprk2 12 FBGN0261988 
850 DRG2 CG6195 15 FBGN0038723 
851 REEP1 ReepA 8 FBGN0261564 
  CG5539 7 FBGN0034907 
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  Reepl1 5 FBGN0030313 
852 PIK3C2G Pi3K68D 8 FBGN0015278 
853 LY6G5C none >5   
854 CLN3 Cln3 13 FBGN0036756 
855 SLC6A9 GlyT 7 FBGN0034911 
856 PP1L CG7115 14 FBGN0027515 
857 DBN1 none >5   
858 TAS1R1 none >5   
859 KCNE1 none >5   
860 SLC6A10 kar 13 FBGN0001296 
861 UNC119B unc-119 12 FBGN0025549 
862 PCLO none >5   
863 L3HYPDH none >5   
864 FAM206A CG9288 13 FBGN0260464 
865 DXL5 none >5   
866 OVOL1 ovo 8 FBGN0003028 
867 KARS LysRS 15 FBGN0027084 
868 TNF none >5   
869 TMEM69 none >5   
870 SLC17A1 CG2003 5 FBGN0039886 
  CG7881 5 FBGN0033048 
  CG12490 5 FBGN0034782 
  CG3649 5 FBGN0034785 
  MFS12 5 FBGN0033234 
  CG30265 5 FBGN0050265 
  CG9825 5 FBGN0034783 
871 GNL1 Ns4 14 FBGN0032882 
872 KIF2B Klp10A 9 FBGN0030268 
  Klp59C 5 FBGN0034824 
  Klp59D 5 FBGN0034827 
873 HELZ CH9425 12 FBGN0036451 
874 TTL none >5   
875 RPL29 RpL29 9 FBGN0016726 
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876 LSM 2.00 none >5   
877 ZNF394 none >5   
878 HPCAL4 Nca 5 FBGN0013303 
  CG7646 5 FBGN0036926 
879 CCDC175 none >5   
880 PPP1R18 none >5   
881 ALS589765.1 none >5   
882 RIIAD1 none >5   
883 MSH6 Msh6 13 FBGN0036486 
884 KCNA4 Sh 8 FBGN0003380 
885 STON1 none >5   
886 TMIGD1 none >5   
887 CTSB CtsB1 14 FBGN0030521 
888 SMARCD3 Bap60 11 FBGN0025463 
889 KIAA0586 none >5   
890 TEAD1 sd 13 FBGN0003345 
891 AC068039.1 none >5   
892 CSNK2B CkIIbeta 13 FBGN0000259 
  CkIIbeta2 6 FBGN0026136 
  Ssl 5 FBGN0015300 
  Ste: CG33237 5 FBGN0053237 
893 VWA7 none >5   
894 ACTR1B Arp1 12 FBGN0011745 
895 GPT CG1640 13 FBGN0030478 
896 MICALL1 MICAL-like 12 FBGN0036333 
897 FAM19A5 none >5   
898 C11orf83 none >5   
899 TUBB betaTub56D 8 FBGN0284243 
  betaTub85D 7 FBGN0003889 
  betaTub60D 5 FBGN0003888 
900 TNXB none >5   
901 BAG5 none >5   
902 B3GALT4 none >5   
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903 SNX29 CG5439 9 FBGN0032476 
904 ZBTB20 none >5   
905 CELF3 bru3 10 FBGN0264001 
906 GID4 none >5   
907 GNAI2 Galphai 11 FBGN0001104 
908 ASXL1 Asx 6 FBGN0261823 
909 OR4C12 none >5   
910 C6orf136 CG16787 10 FBGN0034940 
911 ERMARD none >5   
912 PNMT none >5   
913 SHMT1 Shmt 14 FBGN0029823 
914 NRGN none >5   
915 ASZ1 Gasz 6 FBGN0033273 
916 TLR9 none >5   
917 TSPAN18 none >5   
918 CHEK2 lok 13 FBGN0019686 
919 OR14J1 none >5   
920 DOT1L gpp 12 FBGN0264495 
921 PPP1R16A MYPT-75D 12 FBGN0036801 
922 DLGAP1 vlc 7 FBGN0259978 
923 NMI none >5   
924 MARK3 par-1 12 FBGN0260934 
925 IP6K3 CG10082 11 FBGN0034644 
926 TRIM40 none >5   
927 HLA-F none >5   
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